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I. SUMMARY 
At the request of the Southampton Board of Health and in response to a legislative directive, the 
Massachusetts Department of Public Health (MDPH), Bureau of Environmental Health (BEH), 
Community Assessment Program (CAP) conducted an evaluation of possible environmental 
exposures and cancer incidence in the Barnes Aquifer region, which includes areas of 
Southampton, Easthampton, Holyoke, and Westfield in western Massachusetts.  In the 1950s, 
trichloroethylene (TCE) wastes were released at two Holyoke residential properties and the 
former Southampton Sanitary Engineering in Southampton.  Polychlorinated biphenyl (PCB) 
wastes were released at the two Holyoke residential properties.  This evaluation was initiated in 
response to community concerns about possible environmental exposures in relation to TCE 
contamination in public and private drinking water wells whose source is the Barnes Aquifer and 
community concerns about cancer.  Community concerns also included possible exposures to 
PCBs in soil, PCBs and benzene in private well drinking water, and dioxins in air.  
This public health assessment provides a review of available environmental data for Barnes 
Aquifer drinking water and soil near the identified sources of TCE.  It also considers potential 
ways people may have come in contact with the released contaminants and evaluates the pattern 
of cancer diagnoses in Easthampton, Holyoke, Southampton, and Westfield with a particular 
focus on neighborhoods where residents could have been exposed to TCE.   
In the past, Easthampton residents and some western Holyoke residents were at risk of exposure 
to TCE in municipal drinking water from the Barnes Aquifer.  Some residents of western 
Holyoke and eastern Southampton were at risk of exposure to TCE in drinking water from 
private wells that draw from the Barnes Aquifer.  Based on the contaminant levels detected since 
1980 in municipal wells and since 1997 in private wells, the frequency and duration of contact 
assumed, and a review of the scientific literature, it is unlikely that exposures to TCE in Barnes 
Aquifer drinking water resulted in adverse health effects.   
Currently, residents are not at risk of exposure to TCE in municipal water.  Holyoke and 
Southampton residents with TCE-contaminated private well water are no longer at risk of 
exposure if they properly maintain whole house charcoal filters or connected their households to 
municipal water not impacted by environmental contaminants.  However, a potential exposure 
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pathway could remain if residents with private wells within the extent of groundwater 
contamination do not properly maintain their filters or if they use unfiltered water.   
Children who lived and/or may have played in surface soil at the two Holyoke residences may 
have been at risk of exposure to PCBs; however, based on the levels detected and the frequency 
and duration of contact assumed, it is unlikely that potential exposures could have resulted in 
adverse health effects.  The contaminated soils have since been removed.  Potential exposures to 
PCBs in private well water were ruled out because PCBs have not been demonstrated to have 
migrated via groundwater from the release areas.   
Although it is unlikely that exposures to TCE in Barnes Aquifer drinking water resulted in 
adverse health effects, a review of cancer incidence data was conducted to address community 
concerns.  Using data from the Massachusetts Cancer Registry (MCR), incidence rates for eight 
cancer types were calculated for Easthampton, Holyoke, Southampton, and Westfield, as well as 
for specific census tracts (CTs) where some of the residents were at risk of exposure to TCE in 
drinking water.  The eight cancer types (Hodgkin’s disease, leukemia, non-Hodgkin’s 
lymphoma, and cancers of the bladder, esophagus, kidney, liver, and pancreas) were selected 
based on potential associations with TCE and residents’ concerns about particular types.  Cancer 
incidence data were evaluated from 1982 to 2000, the most recent and complete data available at 
the time of the analysis, and three shorter time periods (1982–1987, 1988–1993, and 1994–
2000).  Available information about risk factors related to the development of cancer was also 
analyzed.   
Although there were some statistically significant elevations observed during some time periods, 
no consistent trends were observed for any of the eight cancer types.  A review of the geographic 
distribution of cancer diagnoses revealed no apparent spatial patterns at the neighborhood level.  
Further, no unusual concentrations of cancer diagnoses were observed in areas where residents 
were at risk of exposure to TCE or in any other area of the four communities.   
In Easthampton CT 8223, non-Hodgkin’s lymphoma (NHL) among males was statistically 
significantly elevated from 1994 to 2000.  The histological types of NHL were consistent with 
the statewide distribution of NHL, and no unusual geographic concentrations of diagnoses were 
observed at the neighborhood level.  There was a statistically significant elevation in pancreatic 
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cancer among males and females townwide and males in Easthampton CT 8224 from 1994 to 
2000.  However, based on a review of available risk factor information, smoking may have 
played a role in some individuals’ diagnoses.   
In Holyoke CT 8121, males were diagnosed with leukemia statistically significantly more often 
than expected from 1994 to 2000.  Based on the location of their residences at the time of 
diagnosis, none of the 14 males were at risk of exposure to TCE in drinking water from the 
Barnes Aquifer.  Pancreatic cancer was statistically significantly elevated for females from 1988 
to 1993.  Of the 12 females, 11 were not at risk of exposure to TCE from the Barnes Aquifer, 
based on their residences.  It is unknown whether the remaining individual could have been 
exposed to TCE.   
In Southampton, a statistically significant elevation in bladder cancer among males from 1982 to 
2000 was attributed to elevations during two time periods, 1982–1987 and 1988–1993.  Ten of 
the 14 males diagnosed from 1982 to 1993 were not at risk of exposure to TCE from the Barnes 
Aquifer, based on the location of their residences.  While the residences of three of the 14 males 
were located within the extent of contaminated groundwater, it is unknown whether these males 
could have been exposed to TCE.  The remaining individual could have been exposed to TCE; 
therefore, if exposure did occur, it could have played a role in the development of bladder 
cancer.  Based on a review of available risk factor information, it is likely that smoking played a 
role in the development of bladder cancer among some of the males.   
In Westfield CT 8125, bladder cancer was statistically significantly elevated for males and 
females from 1982 to 2000.  This was largely due to elevations among males that were not 
statistically significant during the three smaller time periods.  Of the 22 males diagnosed with 
bladder cancer, 21 were not at risk of exposure to TCE from the Barnes Aquifer, based on the 
location of their residences.  It is unknown whether the remaining individual could have been 
exposed to TCE.  Based on a review of available risk factor information, it is likely that smoking 
played a role in the individual’s diagnosis.  Based on their residences, none of the six females 
diagnosed with Hodgkin’s disease, which was statistically significantly elevated from 1982 to 
2000, were at risk of exposure to TCE from the Barnes Aquifer.   
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Residents living in the Dupuis Road neighborhood in Holyoke could have been at risk of 
exposure to air contaminants when PCB wastes were reportedly burned at one of the residential 
properties where PCBs were released.  Because no air monitoring data were available for that 
time, it was not possible to quantitatively evaluate the potential for adverse health effects.  
However, a qualitative review of cancer diagnoses in the Dupuis Road neighborhood revealed no 
unusual pattern or concentration of diagnoses. 
Based on the MDPH evaluation of available environmental data, exposure pathways, and 
available risk factor information related to the cancer types evaluated, the U.S. Agency for Toxic 
Substances and Disease Registry (ATSDR) would classify the TCE-contaminated section of the 
Barnes Aquifer as posing an indeterminate public health hazard in the past due to incomplete 
historical sampling data for private wells prior to 1997.  Most exposure opportunities have been 
eliminated through municipal water treatment and well closures, whole house filters, and 
connections to municipal water not impacted by contaminants; however, for some residents with 
private wells (i.e., residents of a few households that declined testing, residents who might not 
properly maintain their filters, and residents who use unfiltered water), the ATSDR would 
classify the contaminated section of the Barnes Aquifer as posing an indeterminate public health 
hazard presently or in the future.  
In all, the information reviewed and analyzed for this public health assessment included available 
environmental data, cancer incidence data, available risk factor information for individuals 
diagnosed with cancer, residential history information, and a review of the relevant scientific 
literature.  Based on this information, it does not appear that a common factor (environmental or 
non-environmental) played a major role in the overall incidence of cancer in the census tracts 
where some residents were at risk of exposure to TCE from the Barnes Aquifer or in the 
communities of Easthampton, Holyoke, Southampton, and Westfield as a whole during the 19-
year time period, 1982–2000.   
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II. INTRODUCTION AND STATEMENT OF ISSUES 
At the request of the Southampton Board of Health and in response to a legislative directive, the 
Massachusetts Department of Public Health (MDPH), Bureau of Environmental Health (BEH), 
Community Assessment Program (CAP) conducted an evaluation of possible environmental 
exposures and cancer incidence in the Barnes Aquifer region, which includes areas of the towns 
of Southampton and Easthampton and the cities of Holyoke and Westfield in western 
Massachusetts.  In the 1950s, trichloroethylene (TCE) wastes were released at two Holyoke 
residential properties and the former Southampton Sanitary Engineering in Southampton.  
Polychlorinated biphenyl (PCB) wastes were released at the two residential properties in 
Holyoke.  The Massachusetts Department of Environmental Protection (MassDEP) believes that 
the wastes at two of the release locations originated from the former General Electric facility on 
Jackson Street in Holyoke.  TCE contamination now extends approximately 4.5 miles through 
the Barnes Aquifer from the identified sources north to municipal wells in Easthampton.  This 
evaluation was initiated in response to community concerns about cancer and possible 
environmental exposure in relation to TCE contamination in public and private drinking water 
whose source is the Barnes Aquifer.  Community concerns also included possible exposures to 
polychlorinated biphenyls (PCBs) in soil, PCBs and benzene in private well drinking water, and 
dioxins in air from the burning of PCB wastes.  This project was conducted under a cooperative 
agreement with the United States Agency for Toxic Substances and Disease Registry (ATSDR) 
for the MDPH to conduct public health assessments in Massachusetts.  Refer to Figure 1 for the 
location of the four communities included in the evaluation.   
This report provides a review of potential exposure pathways to contaminants, particularly TCE, 
in the Barnes Aquifer and a review of the pattern of cancer in Easthampton, Holyoke, 
Southampton, and Westfield through comparison of the incidence of eight cancer types with the 
incidence of these cancers in the state of Massachusetts as a whole.  There was a particular focus 
on cancer incidence in census tracts and neighborhoods where some of the residents were at risk 
of exposure to TCE-contaminated drinking water from the Barnes Aquifer.  Additionally, 
available information about risk factors, including environmental factors, related to the 
development of cancer was evaluated.  To evaluate concerns about potential environmental 
exposures from Barnes Aquifer drinking water, the MDPH contacted the MassDEP and 
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municipal water departments in the four communities to obtain and review available 
environmental data.  
Cancer incidence rates were evaluated for the towns of Easthampton and Southampton and the 
cities of Holyoke and Westfield for the years 1982–2000, the time period for which the most 
recent and complete cancer incidence data were available from the Massachusetts Cancer 
Registry (MCR) at the initiation of this public health assessment.  Cancer incidence rates were 
also evaluated for the census tracts that include residents who were at risk of exposure to TCE-
contaminated drinking water from the Barnes Aquifer (some of the census tracts also include 
residents who were not at risk of exposure to TCE from the Barnes Aquifer).  A census tract is a 
smaller geographic subdivision of a city or town designated by the United States Census Bureau.  
Because age group and gender-specific population information is necessary to calculate 
incidence rates, the census tract is the smallest geographic area for which cancer rates can be 
accurately calculated.   
Easthampton is divided into three smaller geographic areas, or census tracts (CTs).  The city of 
Holyoke comprises nine census tracts, the town of Southampton is one census tract, and the city 
of Westfield is divided into eight census tracts.  The five census tracts that are the focus of this 
evaluation are Easthampton CT 8223 and CT 8224, Holyoke CT 8121, Southampton CT 8225, 
and Westfield CT 8125.  The total population of the five census tracts combined is 42,410 (U.S. 
DOC 2000).  The location and boundaries of the five census tracts, along with the estimated 
extent of TCE contamination in groundwater according to the MassDEP, are shown in Figure 2.  
It is important to note that the actual extent of TCE-contaminated groundwater may be larger 
than the extent depicted in Figure 2 (C. Chamberlain, MassDEP, personal communication, 
2006). 
The results of this descriptive analysis can be useful in identifying cancer patterns or trends in a 
geographic context, to determine whether a common risk factor is possible, and can serve to 
identify areas where further public health investigations or other actions may be warranted.  
Descriptive analyses may also indicate that an excess of known risk factors associated with a 
disease, such as environmental exposures, exists in a certain geographic area.  This descriptive 
analysis of cancer incidence data cannot be used to establish a causal link between a particular 
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risk factor (either environmental or non-environmental) and the development of cancer.  The 
purpose of this evaluation is to report the findings on the patterns of cancer in the Barnes Aquifer 
region of Easthampton, Holyoke, Southampton, and Westfield and evaluate the findings in the 
context of the available environmental information to determine whether recommendations for 
further public health action are needed.   
III. OBJECTIVES 
The specific objectives of this investigation were as follows: 
 To evaluate opportunities for environmental exposure(s) of residents to contaminants in 
drinking water from the Barnes Aquifer; 
 To evaluate the incidence rates of eight cancer types (Hodgkin’s disease, leukemia, non-
Hodgkin’s lymphoma and cancers of the bladder, esophagus, kidney, liver, and pancreas) 
in Easthampton, Holyoke, Southampton, and Westfield and in the census tracts where 
some residents were at risk of exposure to contaminated drinking water to determine if 
cancer occurred more or less often than expected; 
 To evaluate the geographic distribution of the residences of individuals diagnosed with 
cancer in the four communities and see if there are any patterns in geographic areas 
within the communities, particularly in areas of potential environmental concern; 
 To review available descriptive information from the Massachusetts Cancer Registry for 
individuals diagnosed with cancer in the four communities, to see if there are any 
particular characteristics related to known or suspected risk factors, including 
environmental factors, for developing these diseases; and 
 To discuss possible exposure pathways related to the Barnes Aquifer and the results of 
the cancer incidence evaluation in the context of the available scientific and medical 
literature on cancer and the contaminants of concern in order to determine whether 
further investigation or public health action is warranted. 
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IV. BACKGROUND AND COMMUNITY ENVIRONMENTAL CONCERNS 
Community environmental concerns focus largely on the historical presence of trichloroethylene 
(TCE) in drinking water from the Barnes Aquifer.  TCE is a solvent that has wide industrial uses.  
It is most commonly used as a metal degreaser and has uses in metal finishing, textile 
manufacturing, rubber processing, paint and ink formulation, dry cleaning, and electronics 
manufacturing.  TCE does not adsorb strongly to soil and is mildly soluble in water; therefore, 
TCE leaches quickly into groundwater upon release to soil.  Because of these chemical 
properties and its many industrial uses, TCE is a common contaminant in groundwater that may 
impact drinking water sources.  The ATSDR has estimated that 9% to 34% of drinking water 
sources in the United States contain some level of TCE (ATSDR 1997).   
The Barnes Aquifer extends for 12 miles under parts of Easthampton, Holyoke, Southampton, 
and Westfield.  It supplies drinking water to over 60,000 people in the area (EWW 2001).  
Because it supplies more than 50% of the drinking water for Easthampton, a community that has 
no viable alternative sources, the Broad Brook Basin of the Barnes Aquifer was designated a 
Sole Source Aquifer by the United States Environmental Protection Agency (U.S. EPA) in 1995.   
In order to address community environmental concerns about TCE contamination in the Barnes 
Aquifer, the MDPH contacted the Western Regional Office of the MassDEP in Springfield, 
Massachusetts, Easthampton Water Works, Holyoke Water Works, the Southampton Water 
Department, and the Westfield Water Department to obtain and review available environmental 
information pertaining to groundwater in the aquifer and soil at the three properties where TCE 
was released.  In addition, information regarding other potential environmental sources located in 
the area and listed with the MassDEP as Chapter 21E sites was reviewed (MassDEP 2005). 
The public health assessment titled “Evaluation of Environmental Concerns Related to the 
Barnes Aquifer and Cancer Incidence, 1982–2000” was released on July 5, 2007, for a 30-day 
public comment period.  The MDPH received comments from the MassDEP during the public 
comment period.  Their comments, which were editorial in nature to clarify MassDEP’s source 
investigation efforts, were incorporated in this document.  
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A. Massachusetts Department of Environmental Protection Source Investigation 
The MassDEP Site Discovery Program prioritized the task of identifying the source of TCE 
contamination in the Barnes Aquifer in 1994 (Pine and Swallow, Inc. 2000).  Pine and Swallow 
installed 268 groundwater investigatory wells throughout the Barnes Aquifer region (C. 
Chamberlain, MassDEP, personal communication, 2004).  Some of the investigatory wells were 
sampled at discrete depth intervals beginning at the water table and ending at bedrock (Pine and 
Swallow, Inc. 2000).  Some of the wells were installed as water table wells only (C. 
Chamberlain, MassDEP, personal communication, 2004).   
The investigation identified two source areas in western Holyoke and one source area in 
Southampton.  TCE and PCBs, reportedly released once in 1955, were detected at a residential 
property on Apremont Highway in western Holyoke (Figure 2).  A residential property on 
Dupuis Road in western Holyoke was also identified as a source area (Pine and Swallow, Inc. 
2000).  Disposal and burning of PCB wastes reportedly occurred about every other weekend on 
this property during the early to mid-1950s (C. Chamberlain, MassDEP, personal 
communication, 2005).  The Potentially Responsible Party (PRP) for the Apremont Highway and 
Dupuis Road residential properties is General Electric.  The MassDEP believes that the wastes 
originated at the former General Electric facility on Jackson Street in Holyoke.  The 
Southampton Sanitary Engineering property on Pequot Road in Southampton, which once 
operated as a waste oil recycling facility and possibly received waste generated at the General 
Electric facility, was identified as the third TCE source area (Figure 2).  The MassDEP also 
determined that a fourth occurrence of TCE in groundwater exists beneath a residential property 
on Mueller Road in western Holyoke; however, the exact release location associated with this 
TCE occurrence has not been identified (C. Chamberlain, MassDEP, personal communication, 
2004).  There is also the possibility that other unidentified sources in the Pequot Pond area might 
have contributed to the Barnes Aquifer contamination (C. Chamberlain, MassDEP, personal 
communication, 2005).   
The maximum field screen TCE concentration detected at a source location was in an 
investigatory well [210 parts per billion (ppb)] on Mueller Road in Holyoke where TCE was 
retarded due to silty material beneath the surface (C. Chamberlain, MassDEP, personal 
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communication, 2005).  The Dupuis Road residential property has low TCE levels remaining in 
the groundwater.  TCE was also detected in the groundwater at Southampton Sanitary 
Engineering on Pequot Road.  Groundwater at the Apremont Highway residential property was 
not able to be sampled with investigatory wells because the MassDEP investigation did not 
include boring into bedrock, where the water table is contained.  TCE was not detected in the 
private well at this property; however, TCE was detected in soil, along with PCBs and other 
constituents of PCB transformer oil (C. Chamberlain, MassDEP, personal communication, 2005, 
2007).  
TCE and TCE breakdown products were detected in investigatory wells at Southampton Sanitary 
Engineering and in some investigatory wells downgradient to Southampton Sanitary 
Engineering, but were not detected in other investigatory wells (C. Chamberlain, MassDEP, 
personal communication, 2007).  PCBs, which adsorb strongly to soil particles and are not highly 
mobile through soil, were detected in groundwater at only one of the source areas and have not 
been demonstrated to have migrated via groundwater from any source area (C. Chamberlain, 
MassDEP, personal communication, 2004).  In 1997, benzene was detected above the MassDEP 
GW-1 standard (5 ppb) in two investigatory wells at Southampton Sanitary Engineering (C. 
Chamberlain, MassDEP, personal communication, 2006).  The maximum concentration detected 
was 35 ppb.   
Figure 2 shows the extent of the TCE contamination that the MassDEP delineated from the 
results of its investigation.  [It is important to note that the actual extent of TCE-contaminated 
groundwater may be larger than the extent depicted in Figure 2.]  Because groundwater in the 
Barnes Aquifer moves in a northern direction from the northern end of Pequot Pond, 
contamination from the source areas gradually migrated north to the Pequot Well in Holyoke and 
the Hendrick Street Wellfield and Pines Well in Easthampton (Figure 3) (Pine and Swallow, Inc. 
2000).  According to the MassDEP, TCE from the Apremont Highway and Dupuis Road 
residential properties in western Holyoke could have dispersed through bedrock fractures or 
sandy material west to Southampton and north to Easthampton (MassDEP 2004b).  The Coronet 
Homes Well in Holyoke, which is south of the source areas, likely pulled the contamination 
slightly to the south when the wells were drawing water to serve nearby homes (C. Chamberlain, 
MassDEP, personal communication, 2005).  TCE was detected at trace amounts in investigatory 
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wells south of Pequot Pond (MassDEP 2002).  In all, the MassDEP determined that TCE 
contamination extends for about 4.5 miles within the Barnes Aquifer.   
The Apremont Highway and Dupuis Road residential properties, for which General Electric is 
the PRP, have been remediated under Chapter 21E of the Massachusetts General Laws (C. 
Chamberlain, MassDEP, personal communication, 2005).  PCB-contaminated soil was excavated 
up to 8 feet deep, until the remaining soil had less than the MassDEP S-1 soil standard of 2 ppm 
on average, and removed from the properties.  Both properties have an Activity and Use 
Limitation (AUL), a deed restriction that limits the future uses of a property in order to be 
protective of public health, due to remaining PCB contamination below 8 feet.  The Southampton 
Sanitary Engineering site on Pequot Road is undergoing assessment and response actions 
according to Chapter 21E and has not yet been remediated.     
B. Municipal Water Supply 
Easthampton, Holyoke, Southampton, and Westfield obtain their municipal drinking water from 
a variety of sources.  Easthampton draws its municipal water solely from five wells located 
throughout the town that take water from the northern end of the Barnes Aquifer (Figure 3) 
(EWW 2001).  The Hendrick Street Wellfield and Pines Well are adjacent municipal wells that 
came online in 1908 and 1962, respectively (MassDEP 2003).  While most Easthampton 
residents received a portion of their drinking water from the Hendrick Street Wellfield and Pines 
Well, Easthampton residents living in the Plains area of southern Easthampton closest to the two 
wells received more water from them relative to Easthampton residents farther north (T. Newton, 
Easthampton Water Works, personal communication, 2005).  [For the purposes of this 
evaluation, the Plains area was defined as the entire southern part of town that is south of the 
Brook Street Well (Figure 3).]  This means that residents in the Plains area could have been at 
risk of exposure to a higher TCE concentration relative to the rest of Easthampton.  Due to the 
presence of TCE in the Hendrick Street Wellfield and Pines Well (other municipal wells were 
unaffected), the town disconnected them from the water distribution system between 1987 and 
1988 (T. Newton, Easthampton Water Works, personal communication, 2004).  Between 1990 
and 1991, both wells were blended with other sources in order to lower the TCE concentration 
and reconnected with the distribution system (T. Newton, Easthampton Water Works, personal 
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communication, 2004).  From that time until 1996, the Pines Well was used continually and the 
Hendrick Street Wellfield was used infrequently.  The town built a treatment plant in 1997 that 
treats water from both the Hendrick Street Wellfield and the Pines Well to remove TCE before it 
enters the distribution system.  The town continues to use other more northern wells that draw 
from the Barnes Aquifer and are not contaminated with TCE.     
Holyoke relies on surface water reservoirs, mainly the Tighe-Carmody Reservoir in 
Southampton, for municipal drinking water (HWW 2000).   Water from the McLean Reservoir in 
Holyoke supplements the drinking water supply (HWW 2000).  Historically, Holyoke drew some 
municipal water from the Barnes Aquifer via the Pequot Well and Coronet Homes Well in 
western Holyoke (Figure 3).  In 1974, the Pequot Well was constructed near Winterberry Circle 
in western Holyoke (B. Seidel, Holyoke Water Works, personal communication, 2002).  The 
well served about 600 Holyoke residents in the area near the well (B. Seidel; Holyoke Water 
Works; personal communication; 2002, 2005).  The Coronet Homes Well was constructed in 
1966 to supplement Holyoke’s water supply and served about 400 residents in the Coronet Road 
area (C. Chamberlain, MassDEP, personal communication, 2002; B. Seidel, Holyoke Water 
Works, personal communication, 2002).  In June of 1987, the distribution systems of the Pequot 
and Coronet Homes wells were connected (HWW 2002).  Both wells were closed in December 
1987 and are not maintained as emergency or future sources of municipal water (B. Seidel, 
Holyoke Water Works, personal communication, 2005).   
Southampton uses surface water from the Tighe-Carmody Reservoir in Southampton as its 
primary municipal drinking water source and also draws from the College Highway Well in 
Southampton (Figure 3) (SWD 2000).  The College Highway Well is separated from the main 
part of the Barnes Aquifer by a solid bedrock mountain range (Gary Swanson, Town of 
Southampton Moderator, personal communication, 2004).   
Westfield obtains the majority of its municipal water from the Granville Reservoir in Granville, 
Massachusetts, which borders the city to the southwest (WWD 1999).  The city also uses six 
groundwater wells, four of which (Well #1, Well #2, Well #7, and Well #8) draw from the 
Barnes Aquifer, but are separated by a groundwater divide from the contaminated area of the 
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aquifer (Figure 3) (C. Darling, Westfield Water Department, personal communication, 2004).  
The other two wells do not draw from the Barnes Aquifer.  
C. Private Wells 
The MassDEP investigation into the source of TCE in some Barnes Aquifer municipal wells 
revealed that TCE existed in some private wells in Southampton, Holyoke, Westfield, and 
Easthampton in 1997 (MassDEP 2002).  In Southampton, TCE was detected in 51 private wells 
in the Pequot Pond area in the southeast corner of town.  About 14 households subsequently 
connected to municipal water after the contamination was discovered (Gary Swanson, 
Southampton Water Department, personal communication, 2005).  Approximately 200–300 
Southampton households in this area continue to use private wells that draw from the Barnes 
Aquifer (Gary Swanson, Southampton Water Department, personal communication, 2004).  In 
Holyoke, TCE was detected in 27 private wells in the Rock Valley area near Southampton.  
There are about 250–350 residences in this area that might have used private wells that draw 
from the Barnes Aquifer (MassDEP 2002).  Some households connected to uncontaminated 
municipal water after TCE was identified in private wells in 1997 (D. Bresnahan, Holyoke Board 
of Health, personal communication, 2005).  Some Holyoke residents on Rock Valley Road, 
Keyes Road, Mueller Road, and Southampton Road where TCE was detected were not able to 
connect to municipal water because there is no city water main in the area (C. Chamberlain; 
MassDEP; personal communication; 2004, 2005).  In Westfield, TCE was identified in nine 
private wells in the Hampton Ponds area in the northeast corner of town.  There are about 150–
200 households in this general area that might have used private wells in the past.  
Approximately 20 households in the area of Westfield where TCE was detected connected to 
municipal water after 1997 (D. Reardon, Westfield Board of Health, personal communication, 
2005).  In Easthampton, TCE was detected in one private well on Fort Hill Road (MassDEP 
2002).  The private wells tested in Easthampton are located on Fort Hill Road, about 3 miles 
north of the approximate northern edge of TCE contamination (C. Chamberlain, MassDEP, 
personal communication, 2004).    
The MassDEP supplied residents who had private wells above about 1 ppb TCE with bottled 
water as a temporary measure and installed and maintained carbon filters for 2 years (MassDEP 
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2002, 2004b).  A daycare in Southampton with a trace TCE level was also supplied with bottled 
water.  Currently, residents are responsible for maintaining water quality in their private wells.   
D. Massachusetts Department of Environmental Protection 21E Hazardous Material 
and Oil Releases 
In 1983, the Massachusetts legislature established a statewide hazardous waste site cleanup 
program (the state Superfund program) under Chapter 21E of the Massachusetts General Laws 
(M.G.L c21E, 310 CRM 40.0000).  Under this legislation, the MassDEP administers 
investigation and cleanup of hazardous material and oil release sites, known as “21E sites,” in 
the Commonwealth.  The MDPH reviewed available information regarding these releases to 
determine the possibility that environmental exposures could have played a role in the overall 
incidence of cancer in Easthampton, Holyoke, Southampton, and Westfield.   
The 21E sites are characterized by one or more releases of oil or other hazardous material.  
Releases can result from a variety of sources, including trucks and other vehicles, underground 
storage tanks, and aboveground storage drums.  Releases vary widely with respect to materials 
involved, the relative amount of materials released, and the geographic extent of contamination.  
Depending on the relative severity of the release, the deadline for reporting a release to the 
MassDEP is 2 hours, 72 hours, or 120 days.   
The MassDEP Bureau of Waste Site Cleanup has information on hazardous material and oil 
releases, including assessment and remedial response measures, for 1977 to the present; 
however, records prior to 1984 are known to contain significant data gaps (MassDEP 2004a).  
The MDPH obtained the most recent information regarding all hazardous material and/or oil 
releases (approximately 1,000 records) located in Easthampton, Holyoke, Southampton, and 
Westfield.  The high number of releases in the study area precluded individual examination of 
each release in relation to patterns of cancer incidence.  Therefore, the MDPH focused the 
analysis on only those releases categorized by 2-hour or 72-hour reporting categories.  Releases 
categorized as 120-day reporting notifications and releases where reporting category information 
was unavailable were excluded.  The 120-day reports are releases thought unlikely to result in 
human exposure to contaminants.   
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Hazardous material and oil releases are potential sources of exposure to contamination.  It is not 
possible to determine whether individuals residing in the study area were actually exposed to 
contaminants without detailed information about contaminant movement through the 
environment, the population at risk of exposure, a location of actual human contact with the 
contaminant, and evidence that the contaminant actually entered the body of persons at risk of 
exposure through ingestion, dermal absorption, or inhalation.    
Using a geographic information system, the MDPH mapped the approximate location of 2-hour 
and 72-hour releases for which sufficient address information was available (ESRI 2005).  
According to the most current information, from 1985 to 2000, 44 releases were reported in the 
town of Easthampton; 124 releases were reported in Holyoke; five releases were reported in 
Southampton; and 125 releases were reported in Westfield (MassDEP 2005a).  The majority of 
these releases could be mapped to an address in one of the four towns (see Figure 4); however, 
approximately 5% of the releases (n = 14) could not be mapped because sufficient address 
information was not available. 
The majority of the 298 releases reported (62%) involved petroleum-based oil (e.g., gasoline, 
fuel oil, waste oil) or some combination of oil and another material (either known or unknown).  
Type of material was unknown for 96 (32%) of the releases.  Information specific to each release 
is provided in Table 1. 
The pattern of cancer in Easthampton, Holyoke, Southampton, and Westfield was reviewed in 
relation to these potential sources of environmental exposures and discussed in Section VII. 
V. REVIEW OF ENVIRONMENTAL SAMPLING DATA 
To address concerns about possible environmental exposures associated with the Barnes Aquifer, 
the MDPH reviewed information from several reports on file with the MassDEP and municipal 
water departments in Easthampton, Holyoke, Southampton, and Westfield.  Available 
environmental sampling data were reviewed, and a screening evaluation was conducted to 
identify those substances that are either not expected to result in adverse health effects or 
substances that need to be considered for further analysis to determine whether they may be of 
potential health concern.  The screening analysis identified maximum concentrations of 
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contaminants detected in various types of environmental media (i.e., air, soil, water) and 
compared these concentrations to health-based comparison values established by the ATSDR 
(2005a, 2005c).   
For compounds detected in groundwater, maximum concentrations were also compared with 
state or federal drinking water standards.  All public water supplies in Massachusetts are sampled 
on a regular basis to monitor the quality and ensure the safety of drinking water.  It is not unusual 
to detect some compounds in a drinking water supply.  For this reason, the MassDEP has 
established standards known as Massachusetts Maximum Contaminant Levels (MMCLs) for 
public drinking water supplies (MassDEP 2004c).  These standards dictate the maximum 
allowable concentration at which a chemical can be present in drinking water.  These standards 
are protective of public health.    
ATSDR comparison values are specific concentrations of a chemical for air, soil, or water that 
are used by health assessors to identify environmental contaminants that require further 
evaluation.  These comparison values are developed based on health guidelines and assumed 
exposure situations that represent conservative estimates of human exposure.  Chemical 
concentrations detected in environmental media that are less than a comparison value are not 
likely to pose a health threat.  However, chemical concentrations detected in environmental 
media above a comparison value do not necessarily indicate that a health threat is present.  In 
order for a compound to impact one’s health, it must not only be present in the environmental 
media, but one must also come in contact with the compound.  Therefore, if a concentration of a 
chemical is greater than the appropriate comparison value, the potential for exposure to the 
chemical should be further evaluated to determine whether exposure is occurring and whether 
health effects might be possible as a result of that exposure.  The factors related to exposure that 
are unique to the specific situation under investigation need to be considered to determine if an 
adverse health effect from this chemical could occur.    
A. Municipal Wells 
Prior to 1980, volatile organic compound (VOC) testing in public wells occurred when a 
hazardous waste disposal problem was identified near a well (MDEQE 1980).  In 1980, the joint 
MassDEP and U.S. EPA State Purgeable Organics Testing (SPOT) Program was implemented as 
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a more formal method of testing for VOCs.  The SPOT Program identified the first indication of 
TCE contamination in the Barnes Aquifer in 1980 at the Pequot Well (Figure 3) in western 
Holyoke (HWW 2002).  Of several VOCs tested for, TCE was detected in seven out of eight 
samples analyzed between 1980 and 1992, with six samples above the U.S. EPA Maximum 
Contaminant Level (MCL) and the MassDEP Massachusetts Maximum Contaminant Level 
(MMCL) of 5 ppb (MassDEP 1988, HWW 2002).  The maximum TCE level detected in the 
Pequot Well was 15.0 ppb in 1984.  Table 2 summarizes this sampling information.  The wells 
were shut down in December 1987, and residents were supplied with drinking water from 
surface water sources in Holyoke (B. Seidel, Holyoke Water Works, personal communication, 
2002).  
Also in western Holyoke, the SPOT Program collected six groundwater samples from the 
Coronet Homes Well (Figure 3) between 1980 and 1988 (MassDEP 1988, HWW 2002).  No 
VOCs were detected in 1980.  There were no samples collected again until 1984, when TCE (1.7 
ppb) was first detected in the well.  This was the highest TCE concentration detected in the 
Coronet Homes Well and was below the MCL.  Several other constituents were detected in other 
rounds of testing, but none were at levels that exceeded comparison values.  The TCE sampling 
data are summarized in Table 3.  The well was shut down in December 1987 (B. Seidel, Holyoke 
Water Works, personal communication, 2002).    
In 1980, TCE was not detected in either the Hendrick Street Wellfield or the Pines Well (Figure 
3), adjacent Easthampton municipal wells that draw from the Barnes Aquifer (C. Chamberlain, 
MassDEP, personal communication, 2005).  In 1984, the next time the wells were tested by the 
SPOT Program, TCE was detected at the Hendrick Street Wellfield (3.2 ppb) and the Pines Well 
(<1 ppb) (EWW 2002).  The wells were then monitored several times per year through 2003 for 
VOCs.  At the Hendrick Street Wellfield, TCE was detected in 105 of 127 samples and exceeded 
the MCL (5 ppb) in 89 samples (Table 4) (EWW 2002, MassDEP 1988, MassDEP 2004a
1
).  The 
maximum concentration of TCE detected at the Hendrick Street Wellfield was 12 ppb in 1991.  
Based on the available environmental data, the average TCE concentration detected in the 
wellfield from 1984 until the treatment plant was installed in 1997 was 7 ppb (EWW 2002, 
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MassDEP 1988, MassDEP 2004a).  Of these years, the annual average concentration exceeded 
the MCL yearly from 1988 to 1996, with a maximum annual average of 10 ppb in 1992.  At the 
Pines Well, TCE was detected in 70 of 72 samples and exceeded the MCL in 50 samples.  Prior 
to treatment plant installation, the maximum TCE concentration measured at the Pines Well was 
7.4 ppb in 1994.  The average concentration detected from the time the well was tested multiple 
times per year for TCE until installation of the treatment plant (1980–1996) was 5 ppb.  Of these 
years, the maximum annual average concentration of 6 ppb occurred yearly from 1990 to 1992.   
Easthampton Water Works (2002) tested various points in the water distribution system across 
town before the water treatment plant began operating in 1997.  In 1988, TCE was detected in 11 
out of 11 samples, four of which exceeded the MCL.  The highest TCE concentration detected 
was 8.4 ppb in drinking water at a property next door to Easthampton Water Works on Hendrick 
Street.  In 1992, after the Hendrick Street Wellfield and Pines Well were blended with other 
sources to lower the TCE concentration and reconnected to the distribution system (T. Newton, 
Easthampton Water Works, personal communication, 2004), TCE was detected in four out of 
eight samples.  Two of these samples had TCE concentrations greater than the MCL.  The 
maximum TCE concentration detected (6.7 ppb) in 1992 was at Johnson Metal Products, which 
is about 1.5 miles from the Hendrick Street Wellfield.   
The Hendrick Street Wellfield and the Pines Well were tested for other VOCs in addition to 
TCE.  No VOCs other than TCE were detected at the Pines Well.  Some other VOCs were 
detected in groundwater at the Hendrick Street Wellfield.  Of 71 groundwater samples, 
methylene chloride was detected twice (5.1 ppb and 5.4 ppb) at levels slightly above the ATSDR 
Cancer Risk Evaluation Guide (CREG) and MCL of 5 ppb.  Also, benzene was detected in 
Hendrick Street Wellfield groundwater once (0.6 ppb) at a level that equals the CREG, but is less 
than the MCL of 5 ppb.   
Westfield operates four groundwater wells (Well #1, Well #2, Well #7, Well #8) that draw from 
a section of the Barnes Aquifer that is separate from the main aquifer (C. Darling, Westfield 
Water Department, personal communication, 2004).  Groundwater from Well #8, located in the 
                                                                                                                                                             
1
The MassDEP cautions that the Drinking Water Program makes every attempt to ensure that these data are 
accurate, complete and current.  However, no guarantee is given that these data are error free.  In addition, since 
updates and corrections are occurring at all times, these data are time sensitive (MassDEP 2004a).  
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northeast area of Westfield (Figure 3), was tested 47 times for VOCs from 1990 to 2004.  TCE 
was detected once in 1993 (2.9 ppb) and once in 1996 (0.5 ppb) at levels below the MCL of 5 
ppb (Table 5) (MassDEP 1988, 2004a).  TCE was not detected in nine samples from Well #1 
from 1986 to 2003, in 45 samples from Well #2 from 1986 to 2004, and in 50 groundwater 
samples from Well #7 from 1986 to 2004.   
B. Private Wells 
From 1997 to 2005, as part of the MassDEP investigation to determine the source of municipal 
water contamination in Easthampton, 541 groundwater samples from 452 private wells in the 
Barnes Aquifer region were analyzed for VOCs (Table 6) (MassDEP 2002, 2005b).  Thirteen of 
these wells in the vicinity of the two Holyoke residential properties where PCBs were released 
were also tested for PCBs in 2000.  Private well water was sampled at the tap and before the 
filter, if a drinking water filter was present.  For most households with a filter where TCE was 
detected before the filter, a sample was also taken of the post-filter water.  Four households 
declined testing.   
TCE was detected in 51 of 240 Southampton, 27 of 146 Holyoke, nine of 64 Westfield, and one 
of two Easthampton private wells tested (MassDEP 2002, 2005b).  Of the 88 wells where TCE 
was detected, 60 wells had a maximum concentration less than 1 ppb and 15 wells had a 
maximum concentration between 1 and 5 ppb.  Thirteen wells had maximum TCE concentrations 
above the MCL of 5 ppb, with eight in southeastern Southampton near the Holyoke line and five 
in western Holyoke close to Southampton.  The average of the maximum concentration detected 
in each of the 88 wells where TCE was detected was 3 ppb.   
The maximum concentration of TCE detected in private well water was 34.2 ppb at a home on 
Camp Jahn Road in Southampton.  The maximum TCE concentration detected in Holyoke was 
19 ppb on Keyes Road.  No private well in Westfield or Easthampton had TCE detected above 1 
ppb.   
Households with private wells where TCE levels were around 1 ppb and above, plus a daycare 
with a trace TCE level, were offered bottled water delivery from the MassDEP as a temporary 
measure (MassDEP 2002).  Ten of the homes given bottled water were also supplied with whole 
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house granular-activated carbon filters, which remove TCE before drinking water enters the 
home.   
Methyl-tert-butyl-ether (MTBE) was detected once at 74 ppb, which is above the MassDEP 
MMCL of 70 ppb, at the residential property on Dupuis Road in Holyoke where wastes were 
released.  No other VOCs, including TCE breakdown products, were detected in private wells at 
levels above drinking water comparison values (Table 6).  Benzene, which was expressed as a 
community concern, was not detected in private well water.  PCBs were not detected in the 13 
private wells closest to the two Holyoke residential properties where PCBs were released.   
C. Surface Soil  
Surface soil samples from a depth of 0 to 6 inches at the three residential properties on Apremont 
Highway, Dupuis Road, and Mueller Road in Holyoke were analyzed for PCBs during the 
MassDEP source investigation (MassDEP 2000; Pine and Swallow, Inc. 2000).  The average 
PCB concentration of the 66 samples collected at the Apremont Highway residential property 
was 16 parts per million (ppm).  The maximum PCB concentration (411 ppm) was identified at 
the Apremont Highway residential property and was greater than the CREG (0.4 ppm).  The 
average concentration of the 66 samples from the Apremont Highway property was 16 ppm.  
PCBs were detected in surface soil at the Dupuis Road residential property at a maximum 
concentration of 68 ppm, which exceeds the CREG.  The average concentration of the 26 
samples from the Dupuis Road property was 4.1 ppm.  PCBs were not identified at the Mueller 
Road residential property (Pine and Swallow, Inc. 2000).   
VI. EVALUATION OF POTENTIAL COMMUNITY EXPOSURE PATHWAYS 
AND HEALTH CONCERNS 
An evaluation of potential pathways of exposure was conducted to determine whether TCE 
contamination in the Barnes Aquifer has the potential to impact residents in the surrounding 
neighborhoods in the past, present, or future.  Exposure to a chemical must first occur before any 
potential adverse health effects can result.  Five conditions must be present for exposure to 
occur.  First, there must be a source of that chemical.  Second, an environmental medium must 
be contaminated by either the source or by chemicals transported away from the source.  Third, 
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there must be a location where a person can potentially contact the contaminated medium.  
Fourth, there must be a means by which the contaminated medium could enter a person’s body, 
such as ingestion, inhalation, and dermal absorption.  Finally, the chemical must actually reach 
the target organ susceptible to the toxic effects caused by that particular substance at a sufficient 
dose and for a sufficient exposure time for an adverse health effect to occur (ATSDR 2005). 
A completed exposure pathway indicates that exposure to humans occurred in the past, is 
occurring in the present, or will occur in the future.  A completed exposure pathway exists when 
all five elements are present.  A potential exposure pathway exists when one or more of the five 
elements is missing or uncertain and indicates that exposure to a contaminant could have 
occurred in the past or could occur in the present or future.  An exposure pathway can be 
eliminated if at least one of the five elements is missing and will not likely be present in the 
future.  Refer to Table 7 for a summary of the exposure pathways discussed in this section.   
To evaluate the potential for health effects for the potential and completed exposure pathways 
listed in Table 7, exposure doses were estimated and compared to health guideline values.  An 
exposure dose is an estimate of how much of a substance a person may contact based on their 
actions and habits.  For noncancer health outcomes, the proposed U.S. EPA Reference Dose 
(RfD) for TCE was compared to exposure estimates for noncancer health effects
2
 due to TCE 
(U.S. EPA 2001).  The RfD is an estimate (with uncertainty spanning perhaps an order of 
magnitude) of a daily oral exposure to the human population that is likely to be without an 
appreciable risk of deleterious health effects during a lifetime.  To calculate potential cancer risk, 
                                                 
2
 Noncancer Health Effects Exposure Dose (Ingestion) = 
   
(Maximum Contaminant Concentration) (Water Ingestion Rate) (Noncancer Effects Exposure Factor*) 
     Body Weight 
 
*Noncancer Health Effects Exposure Factor = (F x ED) / AT 
where, 
F = Frequency of Exposure (days/year) 
ED = Exposure Duration (years) 
AT = Averaging Time (ED x 365 days/year) 
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exposure estimates for cancer effects
3
 were multiplied by U.S. EPA cancer slope factors
4
, which 
measure the relative potency of various carcinogens.   
A. Exposure to Groundwater 
Based on studies where TCE was shown to cause kidney and liver cancer in animals, TCE is 
currently classified as a probable human carcinogen by the International Agency for Research on 
Cancer (IARC) and is reasonably anticipated to be a carcinogen by the National Toxicology 
Program (NTP) of the United States Department of Health and Human Services.  Previously, the 
U.S. EPA classified TCE as a probable human carcinogen based on inadequate human evidence 
and sufficient animal evidence.  In 2001, the U.S. EPA proposed reclassifying the 
carcinogenicity (i.e., ability to cause cancer) of TCE to a probable human carcinogen based on 
sufficient animal evidence and limited human evidence (U.S. EPA 2001).  The proposed changes 
are due to stronger epidemiologic evidence and new mechanistic information about what 
happens when TCE enters the human body.   
The carcinogenicity of TCE in humans has been a matter of controversy within the scientific 
community.  Occupational studies of workers exposed to unmeasured levels of TCE in air were 
often limited by multiple chemical exposures and small numbers of study participants (ATSDR 
1997).  While some studies have shown no association between inhalation exposure to TCE and 
cancer, others have found slight increases in a number of cancer types such as cancers of the 
kidney, liver, bladder, and NHL.  However, problems with study design were often reported, and 
                                                 
3
 Cancer Effects Exposure Dose =  
 
(Maximum Contaminant Concentration) (Ingestion Rate) (Cancer Effects Exposure Factor*) (2
†
) 
     Body Weight 
 
*Cancer Effects Exposure Factor = (F x ED) / AT 
where, 
F = Frequency of Exposure (days/year) 
ED = Exposure Duration (years) 
AT = Averaging Time (70 years x 365 days/year) 
 
†
Exposure doses received from inhalation and dermal exposures while showering were considered to be equal to the 
estimated ingestion exposure dose (U.S. EPA 2000).   
 
4
 Cancer Risk = Cancer Effects Exposure Dose x Cancer Slope Factor 
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associations were often based on small numbers of individuals and complicated by confounding 
factors (ATSDR 1997).   
For humans, the evidence of TCE as a human carcinogen is strongest for kidney and liver cancer 
in workers exposed through inhalation (Wartenberg et al. 2000).  There is weak evidence of 
excess incidence of bladder cancer among dry cleaning and laundry workers.  The strongest 
support in the scientific literature for elevations in bladder cancer due to TCE exposure is among 
dry cleaning workers (Wartenberg at al. 2000).  Although an association between TCE exposure 
and dry cleaning workers who were employed before the 1950s and 1960s has been suggested, 
the elevation in bladder cancer incidence among these workers was probably due to exposure to 
tetrachloroethylene (PCE), instead of TCE (Wong 2004).  Prior to the 1950s or 1960s, PCE was 
used often and in large amounts for dry cleaning and TCE was used less often and in smaller 
amounts for spot-cleaning.  Studies of dry cleaners who were employed during that time period 
suggest that PCE was the likely carcinogen.   
Several researchers have concluded that TCE is carcinogenic at very high concentrations, but 
that there is little evidence to support its carcinogenicity at levels typically measured in the 
environment (Bruning and Bolt 2000, Bull 2000, Green 2001, Clewell and Andersen 2004, 
Wong 2004).  Wong (2004) estimated that an individual exposed daily to TCE in drinking water 
would have to ingest levels as high as 550,000 ppb TCE to have an exposure equivalent to a 
worker performing daily degreasing activities with TCE.  This level is several orders of 
magnitude higher than a typical TCE concentration in drinking water.  Considering the probable 
ways that TCE acts in the human body, Clewell and Andersen (2004) applied a conservative 
factor and concluded that a concentration of 265 ppb TCE in drinking water is unlikely to result 
in carcinogenicity in humans.   
For communities exposed to TCE through the ingestion of drinking water, the strongest evidence 
in the scientific literature is for elevated leukemia incidence (Wartenberg et al. 2000).  Five out 
of six regions where community studies were conducted showed an elevation in leukemia 
diagnoses in at least one gender.  However, conclusions from these studies are limited because 
other contaminants were present in the drinking water and because researchers did not adjust for 
confounding factors such as smoking (ATSDR 1997).  An additional community study 
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completed since Wartenberg’s review found no excess leukemia incidence (Morgan and Cassady 
2002).   
Some studies of communities exposed to TCE in drinking water suggest a relationship between 
exposure and elevated incidence of leukemia, while some studies have not shown an association.  
For example, a study of the Woburn, Massachusetts, community exposed to a maximum of 267 
ppb TCE reported a statistically significant elevation in leukemia incidence and a significant 
trend of increased risk with increased exposure opportunities (Costas et al. 2002).  In New 
Jersey, increased leukemia incidence among females was correlated with contaminated drinking 
water of up to 72 ppb TCE and other VOCs (Fagliano et al. 1990, Cohn et al. 1994).  In contrast, 
there was no difference between the observed and expected number of leukemia diagnoses in a 
California community that was exposed to up to 97 ppb TCE for a similar time frame as the 
Barnes Aquifer community (Morgan and Cassady 2002).  Rates of leukemia were not elevated in 
two Finnish villages where residents consumed water with up to 220 ppb TCE and 180 ppb PCE 
(Vartiainen et al. 1993).  In general, in most community studies, exposure to TCE was at a higher 
concentration than the levels detected in public and private wells drawing from the Barnes 
Aquifer.   
1. Municipal Water Supply   
In the past, the primary ways that Easthampton residents could have been exposed to TCE in 
municipal water from the Barnes Aquifer are via ingestion, inhalation (i.e., while showering), 
and/or dermal contact (i.e., washing hands or bathing with water containing TCE).  Easthampton 
residents supplied with drinking water from the Hendrick Street Wellfield or Pines Well may 
have potentially been exposed as early as the 1960s, depending on how long it took for TCE in 
groundwater to travel 4 miles from the source properties to the wells.  According to VOC 
sampling results, a completed exposure pathway is documented from 1984 to about 1988, when 
the wells were disconnected from the distribution system, and from about 1990, when the wells 
were reconnected, until the town water treatment plant came online in 1997.  Using conservative 
assumptions that an adult ingested 2 liters of water and a child ingested 1 liter with the maximum 
concentration of TCE detected in Easthampton municipal water (i.e., 12 ppb at the Hendrick 
Street Wellfield) for 350 days per year for the maximum potential exposure duration (35 years), 
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the estimated noncancer effects exposure dose is 0.0003 milligrams per kilograms per day 
(mg/kg/day) for adults and children
5
.  This estimated daily exposure dose is equal to the U.S. 
EPA draft RfD (0.0003 mg/kg/day), which represents an estimate of a daily oral exposure that is 
not expected to result in adverse noncancer health effects (U.S. EPA 2001).  The draft RfD for 
TCE is based on adverse noncancer health effects observed in studies of mice and rats that were 
exposed to 1 mg/kg/day (U.S. EPA 2001).  Because the estimated noncancer effects exposure 
dose for Easthampton residents in the above scenario is 3,000 times lower that the lowest 
exposure dose that resulted in adverse health effects in animal studies, noncancer health effects 
from past exposure to TCE in Easthampton municipal water were not expected. 
In order to evaluate the potential for carcinogenic health effects, exposure doses were estimated 
and compared to health guideline values for cancer.  TCE has been classified by the U.S. EPA in 
the past as a probable human carcinogen based on sufficient evidence in animals and inadequate 
or no evidence in humans.  TCE is currently undergoing review by the U.S. EPA for its 
carcinogenicity and, thus, was quantitatively evaluated for its cancer-causing potential among 
residents in the Barnes Aquifer region using both the newly proposed range of cancer slope 
factors (0.02–0.4 [mg/kg/day]-1), which are more conservative, and the old cancer slope factor 
(0.011 [mg/kg/day]
-1
).  For the purposes of evaluating cancer risk, the exposure dose received 
from inhalation and dermal exposures while showering were considered to be equal to the 
estimated ingestion exposure dose (U.S. EPA 2000).  Under the same assumptions as for the 
above noncancer health effects and using the proposed cancer risk guidelines, which are more 
                                                 
5
 Noncancer Health Effects Exposure Factor = (350 days/year) (35 years) = 0.96 
         (365 days/year) (35 years)  
 
Noncancer Health Effects Exposure = (0.012 mg/L) (2 L/day) (0.96) = 0.0003 mg/kg/day 
Dose (Ingestion) for Adult    70 kg  
 
Noncancer Health Effects Exposure = (0.012 mg/L) (1 L/day) (0.96) = 0.0003 mg/kg/day 
Dose (Ingestion) for Children   35 kg         
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conservative, past opportunities for TCE exposure via municipal water were unlikely to result in 
unusual cancer risks for either adults or children
6
.   
Exposures to TCE in municipal water from the Hendrick Street Wellfield and Pines Well in the 
present and future were eliminated as exposure pathways because a water treatment plant has 
removed TCE from municipal water since 1997.   
There is a completed exposure pathway for about 600 residents in western Holyoke who were 
supplied with drinking water from the Pequot Well.  Samples from the Coronet Homes Well 
never exceeded the MCL for TCE in six samples from 1980 to 1988; hence, the well was not 
further evaluated here.  Exposure to TCE in drinking water from the Pequot Well could have 
begun sometime between 1974, when the well was constructed, and 1980, when Pequot Well 
water was first analyzed for VOCs and TCE was detected.  Exposure could have continued from 
1980 until the Pequot Well was closed in 1987.  If it is assumed that the maximum detected 
concentration of TCE in the Pequot Well (15 ppb) was continually consumed by residents, the 
estimated exposure dose for adults who consumed 2 liters of water per day and children who 
consumed 1 liter per day for the longest potential exposure period (14 years) was 0.0004 
                                                 
6
 Note: The cancer slope factor used in the following cancer risk calculations [0.21 (mg/kg/day)
-1
] is the midpoint of 
the U.S. EPA newly proposed range of cancer slope factors: 0.02–0.4 (mg/kg/day)-1.  The midpoint assesses cancer 
risk in the general population (U.S. EPA 2001). 
   
Cancer Effects Exposure Factor (Adult) = (350 days/year) (35 years) = 0.48 
             (365 days/year) (70 years)  
 
Cancer Effects Exposure Dose (Adult) = (0.012 mg/L) (2 L/day) (0.48) (2) =  0.00033 mg/kg/day 
      70 kg  
 
Cancer Risk (Adult) = 0.00033 mg/kg/day x 0.21 (mg/kg/day)
-1 
= 7 x 10
-5 
 
Cancer Effects Exposure Factor (Child) = (350 days/year) (18 years) = 0.25 
           (365 days/year) (70 years)  
 
Cancer Effects Exposure Dose (Child) = (0.012 mg/L) (1 L/day) (0.25) (2) =  0.0002 mg/kg/day 
      35 kg  
 
Cancer Risk (Child) = 0.0002 mg/kg/day x 0.21 (mg/kg/day)
-1 
= 4 x 10
-5
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mg/kg/day
7
.  Because the estimated exposure dose is higher than the U.S. EPA draft RfD (0.0003 
mg/kg/day), this suggests that residents could have been exposed to a dose that could have 
resulted in adverse noncancer health effects.  However, because the estimated exposure dose for 
residents in this scenario is 2,500 times lower than the lowest exposure dose that resulted in 
adverse health effects in animal studies, noncancer health effects from past exposure to TCE in 
Pequot Well water were determined to be unlikely.  
Under the newly proposed cancer risk guidelines and the same assumptions, increased cancer 
risk from past exposure to TCE in drinking water from the Pequot Well was determined to be 
unlikely for adults and children
8
.    
Present and future exposures to TCE in drinking water from the Pequot Well and Coronet Homes 
Well were eliminated as exposure pathways because the wells closed in 1987 and are not 
maintained as emergency sources of water by Holyoke Water Works.   
TCE was never detected in Westfield municipal water above the MCL, and the Southampton 
municipal supply did not draw from the contaminated section of the Barnes Aquifer. 
                                                 
 
7
 Noncancer Health Effects Exposure Factor = (350 days/year) (14 years) = 0.96 
         (365 days/year) (14 years)  
 
Noncancer Health Effects Exposure = (0.015 mg/L) (2 L/day) (0.96) = 0.0004 mg/kg/day    
Dose (Ingestion) for Adults                       70 kg 
        
Noncancer Health Effects Exposure = (0.015 mg/L) (1 L/day) (0.96) = 0.0004 mg/kg/day 
Dose (Ingestion) for Children          35 kg 
  
8
 Cancer Effects Exposure Factor = (350 days/year) (14 years) = 0.19 
  (365 days/year) (70 years)  
 
Cancer Effects Exposure Dose (Adult) = (0.015 mg/L) (2 L/day) (0.19) (2) =  0.00016 mg/kg/day 
      70 kg  
 
Cancer Risk (Adult) = 0.00016 mg/kg/day x 0.21 (mg/kg/day)
-1 
= 3 x 10
-5 
 
Cancer Effects Exposure Dose (Child) = (0.015 mg/L) (1 L/day) (0.19) (2) =  0.00016 mg/kg/day 
      35 kg  
 
Cancer Risk (Child) = 0.00016 mg/kg/day x 0.21 (mg/kg/day)
-1 
= 3 x 10
-5 
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2. Private Wells 
There is a completed exposure pathway prior to 1997 for some residents in Holyoke and 
Southampton who consumed private well water from the contaminated section of the Barnes 
Aquifer.  The only Easthampton private wells are located about 3 miles north of the TCE 
contamination and had no TCE detections greater than 1 ppb.  There have been no detections 
above 1 ppb in any Westfield private well.   
In the past, the primary routes that residents could have been exposed to TCE in private well 
water are via ingestion, inhalation, and dermal contact.  TCE could have entered private wells 
sometime between the mid-1950s, when TCE was released, and 1997, when the MassDEP first 
detected TCE in private wells.  Assuming that an adult ingested 2 liters and a child ingested 1 
liter of water with the maximum concentration of TCE (34.2 ppb) detected in private well water 
for 350 days per year for the maximum potential exposure duration (45 years), the estimated 
noncancer health effects exposure dose is 0.0009 mg/kg/day for adults and children
9
.  Because 
the estimated exposure dose is higher than the U.S. EPA draft RfD (0.0003 mg/kg/day), this 
suggests that residents could have been exposed to a dose that could have resulted in adverse 
noncancer health effects.  However, because the estimated exposure dose for residents in this 
scenario is 1,000 times lower that the lowest exposure dose that resulted in adverse health effects 
in animal studies, noncancer health effects from past exposure to TCE in private well water were 
determined to be unlikely.     
In order to evaluate the potential for carcinogenic health effects, exposure doses were estimated 
and compared to both the newly proposed health guideline values, which are more conservative, 
and the old health guideline value.  Under the newly proposed health guideline values and 
conservative assumptions, if an adult ingested 2 liters and a child ingested 1 liter of water with 
the maximum concentration of TCE (34.2 ppb) detected in private well water for 350 days per 
                                                 
9
 Noncancer Health Effects Exposure Factor = (350 days/year) (45 years) = 0.96 
    (365 days/year) (45 years)  
 
Noncancer Health Effects Exposure = (0.0342 mg/L) (2 L/day) (0.96) = 0.0009 mg/kg/day 
Dose (Ingestion) for Adults   70 kg 
          
Noncancer Health Effects Exposure = (0.0342 mg/L) (1 L/day) (0.96) = 0.0009 mg/kg/day 
Dose (Ingestion) for Children   35 kg       
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year for the maximum potential exposure duration (45 years), they could have been exposed to 
TCE at a level that could have presented a low increased cancer risk
10
.  This scenario is 
considered a worst-case scenario.  Under a more reasonable scenario that assumes exposure to 
the average of the maximum TCE concentration detected in each of the 88 private wells where 
TCE was detected (3 ppb), an increased cancer risk would not be expected
11
.  Under the old 
health guideline value, residents who consumed the maximum TCE concentration (34.2 ppb) 
detected in private well water for 350 days per year over 45 years were not likely to have been 
exposed to TCE at a level that might present an increased cancer risk
12
.   
Because residents could have experienced a low increased risk of cancer under the conservative 
newly proposed guidelines, the above scenario was further evaluated by comparing the estimated 
                                                 
10
 Cancer Effects Exposure Factor (Adult) = (350 days/year) (45 years) = 0.62 
  (365 days/year) (70 years)  
 
Cancer Effects Exposure Dose (Adult) = (0.0342 mg/L) (2 L/day) (0.62) (2) =  0.0012 mg/kg/day 
      70 kg  
 
Cancer Risk (Adult) = 0.0012 mg/kg/day x 0.21 (mg/kg/day)
-1 
= 3 x 10
-4 
 
Cancer Effects Exposure Factor (Child) = (350 days/year) (18 years) = 0.25 
          (365 days/year) (70 years)  
 
Cancer Effects Exposure Dose (Child) = (0.0342 mg/L) (1 L/day) (0.25) (2) =  0.0005 mg/kg/day 
      35 kg  
 
Cancer Risk (Child) = 0.0005 mg/kg/day x 0.21 (mg/kg/day)
-1 
= 1 x 10
-4
  
 
11
 Cancer Effects Exposure Factor (Adult) = (350 days/year) (45 years) = 0.62 
  (365 days/year) (70 years)  
 
Cancer Effects Exposure Dose (Adult) = (0.003 mg/L) (2 L/day) (0.62) (2) =  0.0001 mg/kg/day 
      70 kg  
 
Cancer Risk (Adult) = 0.0001 mg/kg/day x 0.21 (mg/kg/day)
-1 
= 2 x 10
-5 
 
Cancer Effects Exposure Factor (Child) = (350 days/year) (18 years) = 0.25 
          (365 days/year) (70 years)  
 
Cancer Effects Exposure Dose (Child) = (0.003 mg/L) (1 L/day) (0.25) (2) =  0.000042 mg/kg/day 
      35 kg  
 
Cancer Risk (Child) = 0.000042 mg/kg/day x 0.21 (mg/kg/day)
-1 
= 9 x 10
-6
  
 
12
 Cancer Risk (Adult) = 0.0012 mg/kg/day x 0.011 (mg/kg/day)
-1 
= 1 x 10
-5 
 
Cancer Risk (Child) = 0.0005 mg/kg/day x 0.011 (mg/kg/day)
-1 
= 5 x 10
-7
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exposure dose to the Cancer Effect Level (CEL) for TCE (ATSDR 2001a).  The CEL is the 
lowest dose of a chemical that produces significant increases in cancer diagnoses in animal or 
human studies.  The estimated exposure dose for residents exposed to the maximum TCE 
concentration detected in a private well for 350 days per year over 45 years would be 800,000 
times lower for adults and 2,000,000 times lower for children than the CEL observed in scientific 
studies of mice exposed to high doses of TCE (1,000 mg/kg/day) that developed liver cancer and 
rats that developed kidney cancer (ATSDR 1997)
13
.  The large margin of safety (800,000 for 
adults and 2,000,000 for children), which is the ATSDR CEL divided by the estimated exposure 
dose for residents exposed to the maximum TCE concentration detected in a private well, 
indicates that residents are unlikely to have an unusually increased risk of developing cancer as a 
result of their exposure.   
Exposures to TCE in private well water in the present and future were eliminated as exposure 
pathways for the majority of residents because they accepted bottled water and carbon filters or 
connected to an uncontaminated municipal water supply after TCE was identified in their private 
wells in 1997.  However, because a carbon filter needs to be replaced periodically (C. 
Chamberlain, MassDEP, personal communication, 2004), there is the potential for present or 
future exposure if residents do not properly maintain the filter or if they use unfiltered water.  
There also exists a potential exposure pathway for four households that declined to allow the 
MassDEP to test their wells in 1997.   
Exposures to PCBs in private well water were eliminated as past, present, and future exposure 
pathways for residents.  PCBs have not been demonstrated to have migrated from the source 
properties via groundwater and were not detected in drinking water samples in 2000 (MassDEP 
2002).   
                                                 
13
 Margin of Safety (Adult) = 1,000 mg/kg/day  = 800,000 
    0.0012 mg/kg/day 
 
Margin of Safety (Child) = 1,000 mg/kg/day  = 2,000,000 
  0.0005 mg/kg/day    
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B. Exposure to Soil 
Past exposures to PCBs in surface soil may have been possible for children who lived and may 
have played in surface soil at two Holyoke residential properties (Apremont Highway and 
Dupuis Road) where PCB wastes were released.  They may have been exposed through 
incidental ingestion to PCBs in surface soil.  Assuming that a child resident ingested surface soil 
with the maximum PCB concentration detected in surface soil at either of the two properties (411 
ppm at the Apremont Highway property) for 7 days a week and 50 weeks per year over 18 years, 
exposure could have presented a moderate increased risk of cancer
14
.  However, these exposure 
assumptions are conservative, and it is very unlikely that a resident could have had consistent 
contact with soil containing the highest concentration of PCBs.  It is more likely that soil with a 
range of contaminant concentrations could have been ingested over time.  Based on readily 
available surface soil data from the Apremont Highway source property, the average 
concentration of PCBs was 16 ppm (MassDEP 2000)
15
.  Under the more realistic assumption that 
a child resident at either property could have been exposed to the average concentration of PCBs, 
an increased cancer risk would be unlikely
16
.   
Since PCB-contaminated soil was removed from the Apremont Highway property and Dupuis 
Road property and replaced with clean soil, in addition to the placement of Activity and Use 
Limitation (AUL) deed restrictions on the properties, present and future ingestion of 
contaminants in surface soils by residents were eliminated as exposure pathways.   
                                                 
14
 Cancer Effects Exposure Factor = (7 days/week) (50 weeks/year) (18 years) = 0.25 
(365 days/year) (70 years)  
 
Cancer Effects Exposure Dose = (411 mg/kg) (200 mg/day) (0.25) (1 kg/10
6
 mg) = 0.0006 mg/kg/day 
      35 kg  
 
Cancer Risk = 0.0006 mg/kg/day x 2.0 (mg/kg/day)
-1 
= 1 x 10
-3
 
 
15
 Because the detection limit was not available, the average was calculated assuming that all samples where PCBs 
were not detected were equal to zero.   
 
16
 Cancer Effects Exposure Factor = (7 days/week) (50 weeks/year) (18 years) = 0.25 
 (365 days/year) (70 years) 
 
Cancer Effects Exposure Dose = (16 mg/kg) (200 mg/day) (0.25) (1 kg/10
6
 mg) = 2.3 x 10
-5
 mg/kg/day 
      35 kg  
 
Cancer Risk =2.3 x 10
-5
 mg/kg/day x 2.0 (mg/kg/day)
-1 
= 5 x 10
-5
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C. Exposure to Air 
Some of the products of PCB combustion include chlorinated dibenzodioxins (commonly known 
as dioxins) and chlorodibenzofurans, as well as PCBs that might result from incomplete 
combustion (ATSDR 2000).  The community in the Barnes Aquifer area expressed concern that 
residents living in the Dupuis Road neighborhood in west Holyoke could have been exposed 
through inhalation to contaminants when PCB wastes were reportedly burned at a residential 
property about every other weekend from the early to mid-1950s.  Exposure to contaminants in 
smoke could have been possible in the past; however, air monitoring data were not available for 
that time.  Also, surface soil data were not available for PCB combustion products that could 
have been deposited at neighboring properties, which could help to evaluate potential past 
exposure opportunities to contaminants in ambient air.  Because no environmental data were 
available, it was not possible to quantitatively evaluate the potential for adverse health effects 
that could result from possible exposure.  Since the extent of exposure opportunities is not 
known, the MDPH examined the geographic pattern of cancer among individuals living in the 
Dupuis Road neighborhood to assess whether any unusual patterns might be evident in relation 
to the property where burning occurred.   
Present and future exposures at the Dupuis Road source property are not of concern because the 
soil contaminated with PCBs was removed and PCB wastes are no longer being burned.     
VII. ANALYSIS OF CANCER INCIDENCE 
A. Methods for Analyzing Cancer Incidence 
1. Case Identification/Definition 
Cancer incidence data, reports of new cancer diagnoses, for the years 1982–2000 were obtained 
for Easthampton, Holyoke, Southampton, and Westfield from the MCR, a division of the Bureau 
of Health Information, Statistics, Research, and Evaluation within the MDPH.  Eight cancers 
types were evaluated in this investigation: Hodgkin’s disease, leukemia, non-Hodgkin’s 
lymphoma, and cancers of the bladder, esophagus, kidney, liver, and pancreas.  [Coding for 
cancer types in this report follows the International Classification of Diseases for Oncology 
 33 
(ICD-O system).  See Appendix A for the incidence coding definitions used in this report for 
these cancer types.]  These cancer types were selected for evaluation based on potential 
associations with contaminants of concern, such as TCE, and residents’ concerns about suspected 
elevations in cancers of the esophagus and pancreas in the Barnes Aquifer region.  Only cases 
reported to the MCR as a primary cancer for one of the eight cancer types and diagnosed among 
a resident of Easthampton, Holyoke, Southampton, or Westfield were included in the analysis.  
Cases were selected for inclusion based on the address reported to the hospital or reporting 
medical facility at the time of diagnosis.  The address of each case was matched to its 
corresponding census tract.  Due to incomplete information, the addresses of six cases (3%) in 
Easthampton, six cases (0.9%) in Holyoke, one case (2%) in Southampton, and two cases (0.4%) 
in Westfield could not be assigned to a census tract. 
The MCR is a population-based surveillance system that has been monitoring cancer incidence 
in Massachusetts since 1982.  All new diagnoses of cancer among Massachusetts residents are 
required by law to be reported to the MCR within 6 months of the date of diagnosis (M.G.L. 
c.111s.111b).  This information is kept in a confidential database.  Data are collected on a daily 
basis and are reviewed for accuracy and completeness on an annual basis.  This process corrects 
misclassification of data (i.e., city/town misassignment) and deletes duplicate case reports.  Once 
these steps are finished, the data for that year are considered “complete.”  Due to the volume of 
information received by the MCR, the large number of reporting facilities, and the 6-month 
period between diagnosis and required reporting, the most current registry data that are complete 
will inherently be a minimum of 2 years prior to the current date.  At the time of this analysis, the 
most recent and complete data records available from the MCR included diagnoses that occurred 
from 1/1/1982 to 12/31/2000.   The cancer incidence statistics in Section VII, Part B, cover the 
19-year period of 1982 through 2000.  However, this surveillance system is ongoing and collects 
reports on a daily basis.  Therefore, it is possible for CAP staff to review case reports for more 
recent years (i.e., 2001 to the present
17
), which can provide a qualitative review of cancer 
patterns in a given area.  The geographic distribution of residences of individuals diagnosed in 
more recent years is evaluated in Section VII, Part D, and recent diagnoses in the Barnes Aquifer 
area are discussed along with diagnoses from 1982–2000 in Section VIII.  
                                                 
17
 Entered on MCR computer files before November 15, 2005.  
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The term "cancer" is used to describe a variety of diseases associated with abnormal cell and 
tissue growth.  Epidemiologic studies have revealed that different types of cancer are individual 
diseases with separate causes, risk factors, characteristics, and patterns of survival (Berg 1996).  
Cancers are classified by the location in the body where the disease originated (the primary site) 
and the tissue or cell type of the cancer (histology).  Therefore, each of the cancer types reviewed 
in this report was evaluated separately.  Cancers that occur as the result of the metastasis or the 
spread of a primary site cancer to another location in the body are not considered as separate 
cancers and, therefore, were not included in this analysis. 
It should be noted that the MCR research file might contain duplicate reports of individuals 
diagnosed with cancer.  Duplicate cases are additional reports of the same primary site cancer 
case.  The data in this report have been controlled for duplicate cases by excluding them from the 
analyses.  The decision that a case was a duplicate and should be excluded from the analyses was 
made by the MCR after consulting with the reporting hospital/diagnostic facility and obtaining 
additional information regarding the histology and/or pathology of the case.  However, reports of 
individuals with multiple primary site cancers were included as separate cases in the analyses in 
this report.  A multiple primary cancer case is defined by the MCR as a new cancer in a different 
location in the body, or a new cancer of the same histology (cell type) as an earlier cancer, if 
diagnosed in the same primary site (original location in the body) more than 2 months after the 
initial diagnosis (MCR 1996).  Therefore, duplicate reports of an individual diagnosed with 
cancer were removed from the analyses whereas individuals who were diagnosed with more than 
one primary site cancer were included as separate cases.  Two duplicate reports in Easthampton, 
four duplicate reports in Holyoke, and four duplicate reports in Westfield were identified during 
the years 1982–2000 and excluded from the analyses.   
2. Calculation of Standardized Incidence Ratios (SIRs) 
To determine whether elevated numbers of cancer cases occurred in Easthampton, Holyoke, 
Southampton, or Westfield, cancer incidence data were tabulated by gender according to 18 age 
groups to compare the observed number of cancer cases to the number that would be expected 
based on the statewide cancer rate.  Standardized incidence ratios (SIRs) were then calculated for 
the period 1982–2000 for each of the eight primary cancer types for each of the four 
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communities as a whole, as well as for the specific census tracts in the Barnes Aquifer region.  
SIRs were also calculated for three smaller time periods, 1982–1987, 1988–1993, and 1994–
2000, in order to evaluate patterns or trends in cancer incidence over time.  However, because 
statewide data for 2001 to the present were not complete at the time of analysis, as discussed 
above, incidence ratios cannot be calculated for recent years. 
In order to calculate SIRs, it is necessary to obtain accurate population information.  The 
population figures used in this analysis were interpolated based on 1980, 1990, and 2000 United 
States census data for each census tract (U.S. DOC 1980, 1990, 2000).  Midpoint population 
estimates were calculated for each time period evaluated (i.e., 1984, 1990, and 1997).  To 
estimate the population between census years, an assumption was made that the change in 
population occurred at a constant rate throughout the 10-year interval between each census
18
.   
Because accurate age group and gender specific population data are required to calculate SIRs, 
the census tract is the smallest geographic area for which cancer rates can be accurately 
calculated.  A CT is a smaller statistical subdivision of a county as defined by the United States 
Census Bureau.  Census tracts usually contain between 2,500 and 8,000 persons and are designed 
to be homogeneous with respect to population characteristics (U.S. DOC 1990). 
According to the United States Census Bureau, the four cities and towns encompassed by this 
evaluation are currently divided into 21 smaller census tracts.  Easthampton is divided into three 
census tracts, Holyoke is comprised of nine census tracts, Southampton has one census tract, and 
Westfield is divided into eight census tracts.  Census tracts can change over time.  For instance, 
in 1990, Easthampton CT 8224 and Holyoke CT 8121 were both split into two census tracts each 
(CT 8224.01, 8224.02 and CT 8121.01, 8121.02, respectively) by the United States Census 
Bureau.   Because this evaluation analyzes cancer incidence for a long time period (1982–2000), 
the census tracts that split in 1990 were combined and thus considered as the original 1980 
census tracts throughout this entire evaluation.   
                                                 
18
 Using slightly different population estimates or statistical methodologies, such as grouping ages differently or 
rounding off numbers at different points during calculations, may produce results slightly different from those 
published in this report. 
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The focus areas of this evaluation were CT 8223 (eastern Easthampton) and CT 8224 (western 
Easthampton), CT 8121 (western Holyoke), CT 8225 (Southampton), and CT 8125 (eastern 
Westfield) (Figure 2).  [Fifteen cases (0.1%) for which census tract designation was not possible 
were included in the city/town total for each community.]  These particular census tracts were 
chosen for evaluation because they include residents who were at risk of exposure to TCE in 
Barnes Aquifer drinking water.  Most residents of Easthampton CT 8223 and CT 8224 were at 
risk of exposure to TCE from the Barnes Aquifer because the majority of households were 
connected to municipal water when TCE was present in Easthampton drinking water.  It is 
important to note that most residents of Holyoke CT 8121, Southampton CT 8225, and Westfield 
CT 8125, were not at risk of exposure to TCE from Barnes Aquifer drinking water.  These three 
particular census tracts have a combined population of 26,416 (U.S. DOC 2000).  Of those 
26,416 residents, a conservative estimate is that at most about 7% (n = 1,900) were at risk of 
exposure to TCE in drinking water from the Barnes Aquifer.   
3. Interpretation of a Standardized Incidence Ratio (SIR) 
An SIR is an estimate of the occurrence of cancer in a population relative to what might be 
expected if the population had the same cancer experience as a larger comparison population 
designated as "normal" or average.  Usually, the state as a whole is selected to be the comparison 
population. Using the state of Massachusetts as a comparison population provides a stable 
population base for the calculation of incidence rates. 
Specifically, an SIR is the ratio of the observed number of cancer cases in an area to the expected 
number of cases multiplied by 100.  The population structure of each town is applied to the 
statewide incidence rate to calculate the number of expected cancer cases.  The SIR is a 
comparison of the number of cases in the specific area (i.e., city/town or census tract) to the 
statewide rate.  Comparisons of SIRs between towns or census tracts are not possible because 
each community has different population characteristics. 
An SIR of 100 indicates that the number of cancer cases observed in the population being 
evaluated is equal to the number of cancer cases expected in the comparison or "normal" 
population.  An SIR greater than 100 indicates that more cancer cases occurred than were 
expected, and an SIR less than 100 indicates that fewer cancer cases occurred than were 
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expected.  Accordingly, an SIR of 150 is interpreted as 50% more cancer cases than the expected 
number; an SIR of 90 indicates 10% fewer cancer cases than expected. 
Caution should be exercised, however, when interpreting an SIR.  The interpretation of an SIR 
depends on both the size and the stability of the SIR.  Two SIRs can have the same size but not 
the same stability.  For example, an SIR of 150 based on four expected cases and six observed 
cases indicates a 50% excess in cancer, but the excess is actually only two cases.  Conversely, an 
SIR of 150 based on 400 expected cases and 600 observed cases represents the same 50% excess 
in cancer, but because the SIR is based upon a greater number of cases, the estimate is more 
stable.  It is very unlikely that 200 excess cases of cancer would occur by chance alone.  As a 
result of the instability of incidence rates based on small numbers of cases, SIRs were not 
calculated when fewer than five cases were observed for a particular cancer type. 
4. Calculation of the 95% Confidence Interval 
To help interpret or measure the stability of an SIR, the statistical significance of each SIR was 
assessed by calculating a 95% confidence interval (95% CI) to determine if the observed number 
of cases is “significantly different” from the expected number or if the difference may be due 
solely to chance (Rothman and Boice 1982).  Specifically, a 95% CI is the range of estimated 
SIR values that have a 95% probability of including the true SIR for the population.  If the 95% 
CI range does not include the value 100, then the study population is significantly different from 
the comparison or "normal" population.  "Significantly different" means there is less than a 5% 
chance that the observed difference (either increase or decrease) is the result of random 
fluctuation in the number of observed cancer cases. 
For example, if a confidence interval does not include 100 and the interval is above 100 (e.g., 
105–130), there is a statistically significant excess in the number of cancer cases.  Similarly, if 
the confidence interval does not include 100 and the interval is below 100 (e.g., 45–96), the 
number of cancer cases is statistically significantly lower than expected.  If the confidence 
interval range includes 100, the true SIR may be 100.  In this case, it cannot be determined with 
certainty that the difference between the observed and expected number of cases reflects a real 
cancer increase or decrease or is the result of chance.  It is important to note that statistical 
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significance does not necessarily imply public health significance.  Determination of statistical 
significance is just one tool used to interpret SIRs. 
In addition to the range of the estimates contained in the confidence interval, the width of the 
confidence interval also reflects the stability of the SIR estimate.  For example, a narrow 
confidence interval, such as 103–115, allows a fair level of certainty that the calculated SIR is 
close to the true SIR for the population.  A wide interval, for instance 85–450, leaves 
considerable doubt about the true SIR, which could be much lower than or much higher than the 
calculated SIR.  This would indicate an unstable statistic.  Due to the instability of incidence 
rates based on small numbers of cases, statistical significance was not assessed when fewer than 
five cases were observed. 
5. Evaluation of Cancer Risk Factor Information 
Available information reported to the MCR related to risk factors for cancer development was 
reviewed and compared to known or established incidence patterns for the cancer types 
evaluated in this report.  This information is collected for each individual at the time of cancer 
diagnosis and includes age at diagnosis, stage of disease, smoking history and occupation.  One 
or even several factors acting over time can be related to the development of cancer.  For 
example, tobacco use has been linked to bladder, kidney, lung and bronchus, and pancreatic 
cancers.  Other risk factors for various cancer types may include lack of crude fiber in the diet, 
high fat consumption, excessive alcohol consumption, and reproductive history.  Heredity, or 
family history, is an important factor for several cancers.  To a lesser extent, some occupational 
exposures, such as jobs involving contact with asbestos, have been shown to be carcinogenic 
(cancer-causing).  Environmental contaminants have also been associated with certain types of 
cancer.  The available risk factor information from the MCR was evaluated for Easthampton, 
Holyoke, Southampton, and Westfield residents diagnosed with any of the eight cancer types 
included in this report.  However, information about personal risk factors that might include 
family history, hormonal events, diet, and other factors that may also influence the development 
of cancer is not collected by the MCR; therefore, it was not possible to consider their 
contributions to cancer in this investigation. 
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6. Determination of Geographic Distribution of Cancer Cases 
In addition to calculation of SIRs, address at the time of diagnosis for each individual diagnosed 
with cancer was mapped using a computerized geographic information system (GIS) (ESRI 
2005).  This allowed assignment of census tract location for each case as well as an evaluation of 
the spatial distribution of individual cases at a smaller geographic level within a census tract (i.e., 
neighborhoods).  The geographic pattern was assessed by qualitatively evaluating the point 
pattern of cases in all areas of Easthampton, Holyoke, Southampton, and Westfield.  In instances 
where the address information from the MCR was incomplete (that is did not include specific 
streets or street numbers) efforts were made to research those cases using telephone books and 
town residential lists issued within 2 years of an individual's diagnosis.  For confidentiality 
reasons, it is not possible to include maps showing the locations of individuals diagnosed with 
cancer in this report.  [Note: The MDPH is bound by Massachusetts General Law not to reveal 
the name or identifying information of an individual diagnosed with cancer whose case is 
reported to the MCR.] 
B. Results of Cancer Incidence Analysis 
The following section presents cancer incidence rates for the 19-year time period, 1982–2000, 
for Easthampton, Holyoke, Southampton, Westfield, and selected census tracts in the 
communities: Easthampton CT 8223 and CT 8224, Holyoke CT 8121, and Westfield CT 8125.  
Because the town of Southampton has one census tract, only townwide cancer incidence rates 
were evaluated.  To evaluate possible trends over time, these data were also analyzed by three 
smaller time periods, 1982–1987, 1988–1993, and 1994–2000.  Table 8a through Table 15d 
summarize cancer incidence data for the towns and the selected census tracts.  Consistent with 
MDPH policy, SIRs were not calculated for some cancer types due to the small number of 
observed cases (less than five).  However, the expected number of cases was calculated during 
each time period, and the observed and expected numbers of cases were compared to determine 
whether excess diagnoses of cancer were occurring. 
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1. Cancer Incidence in Easthampton 
The eight cancer types evaluated in this report generally occurred approximately at or near 
expected rates in the town of Easthampton as a whole during the 19-year time period 1982–2000, 
as well as smaller time periods (i.e., 1982–1987, 1988–1993, and 1994–2000) (see Table 8a 
through Table 8d).  One exception was pancreatic cancer, which occurred more often than 
expected (34 observed versus 29.7 expected, SIR = 115, 95% CI = 79–160).  This elevation was 
not statistically significant and was largely due to a statistically significant elevation in the 
incidence of pancreatic cancer during the most recent time period, 1994–2000 (21 diagnoses 
observed versus 12.6 expected, SIR = 167, 95% CI = 103–255).  This elevation was due to non-
statistically significant elevations among both males (11 diagnoses observed versus 5.9 expected, 
SIR = 186, 95% CI = 93–332) and females (10 diagnoses observed versus 6.6 expected, SIR = 
151, 95% CI = 72–277).  During the earlier two time periods, pancreatic cancer occurred about 
as or less than expected.   
Bladder cancer, esophagus cancer, leukemia, liver cancer, and NHL all occurred approximately 
equal to or less often than expected during the 1982–2000 time period.  There were 47 diagnoses 
of bladder cancer during 1982–2000, whereas approximately 53 diagnoses were expected (SIR = 
89, 95% CI = 65–118).  Fewer bladder cancer diagnoses were also observed than were expected 
during each of the three smaller time periods evaluated.  Fifteen diagnoses of esophagus cancer 
were observed in Easthampton during 1982–2000 versus about 16 expected.  When examined 
over time, esophagus cancer occurred about as expected in the three time periods.  Residents of 
Easthampton experienced leukemia at a less than expected rate during 1982–2000 (23 diagnoses 
observed versus 27.8 expected, SIR = 83, 95% CI = 52–124) and during each of the three smaller 
time periods.   There were seven diagnoses of liver cancer observed versus approximately eight 
diagnoses expected (SIR = 89, 95% CI = 36–183).  Liver cancer occurred less often than 
expected during time periods 1982–1987 and 1994–2000 and slightly more often than expected 
during the middle time period, 1988–1993 (4 diagnoses observed versus 2.2 expected).  NHL 
occurred less often than expected during the 1982–2000 time period.  There were 45 diagnoses 
of NHL during 1982–2000, whereas approximately 49.3 diagnoses were expected (SIR = 91, 
95% CI = 67–122).  Fewer NHL diagnoses were observed than were expected during the middle 
 41 
time period, 1988–1993, while NHL diagnoses occurred about as expected for the other two time 
periods. 
Diagnoses of Hodgkin’s disease, kidney cancer, and pancreatic cancer each occurred more often 
than expected in Easthampton during 1982–2000, but none of the elevations was statistically 
significant.  There were 13 diagnoses of Hodgkin’s disease during 1982–2000, whereas 
approximately 11 diagnoses were expected (SIR = 118, 95% CI = 62–201).  Five individuals 
were diagnosed with Hodgkin’s disease during 1982–1987, while 3.5 diagnoses were expected.  
Diagnoses of Hodgkin’s disease occurred about as expected for the two subsequent time periods.  
Kidney cancer occurred more often than expected in Easthampton during 1982–2000 (36 
diagnoses observed versus 32.1 expected, SIR = 112, 95% CI = 79–155).  This elevation is 
largely attributed to kidney cancer incidence during the earliest time period, 1982–1987 (11 
diagnoses observed versus 7.6 expected, SIR = 145, 95% CI = 72–260).  Neither elevation was 
statistically significant.  Kidney cancer occurred about as expected in the subsequent two time 
periods.   
2. Cancer Incidence in Easthampton Census Tract 8223 and Census Tract 8224 
The eight cancer types evaluated in this report generally occurred approximately near or below 
expected rates in Easthampton CT 8223 during the 19-year time period 1982–2000 (see Table 9a 
through Table 9d).  More esophagus cancer diagnoses were observed during the overall time 
period (10 diagnoses observed versus 6.9 expected, SIR = 145, 95% CI = 69–266); however, the 
observed increase was not statistically significant.   
In general, when cancer rates in CT 8223 were evaluated for smaller time periods, no consistent 
trends over time were observed.  The overall elevation in esophagus cancer in CT 8223, which 
was not statistically significant, was primarily due to an elevation among males during the latest 
time period (i.e., 1994–2000), which also was not statistically significant (5 diagnoses versus 2.0 
expected, SIR = 254, 95% CI = 82–592).  There was one statistically significant elevation in 
NHL among males during the most recent time period (10 diagnoses observed versus 4.3 
expected, SIR = 233, 95% CI = 111–428).  NHL occurred about as or less than expected among 
males during the other two time periods and about as expected among females during all three 
time periods in this census tract.  An elevation in pancreatic cancer diagnoses among females 
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during 1994–2000 was borderline statistically significant (7 diagnoses observed versus 2.8 
expected, SIR = 249, 95% CI = 100–513).  Pancreatic cancer in the two earlier time periods 
occurred less than expected for females and about as expected for males in all three smaller time 
periods.  In general, bladder cancer, Hodgkin’s disease, kidney cancer, leukemia, and liver 
cancer occurred about as expected in CT 8223 during each of the smaller time periods evaluated.   
Of the eight cancer types evaluated in this report, six (bladder cancer, esophagus cancer, 
Hodgkin’s disease, leukemia, liver cancer, and NHL) occurred about as or less often than 
expected in Easthampton CT 8224 during the 19-year time period, 1982–2000, among males and 
females combined.  More kidney cancer (25 diagnoses observed versus 18.9 expected) and 
pancreatic cancer (22 diagnoses observed versus 16.7 expected) diagnoses were observed during 
the overall time period; however, the observed increases were not statistically significant.   
For bladder cancer, esophagus cancer, Hodgkin’s disease, leukemia, and NHL, most occurred 
less frequently or about as expected during each smaller time period in CT 8224.  Any elevations 
observed were based on about one or two additional cases above the expected number.  The 
overall elevation in kidney cancer in CT 8224, which was not statistically significant, was 
primarily due to elevations during the earliest and latest time periods (i.e., 1982–1987, 1994–
2000).  Neither elevation was statistically significant.  There was one statistically significant 
elevation in pancreatic cancer among males during the most recent time period (9 diagnoses 
observed versus 3.7 expected, SIR = 246, 95% CI = 112–466).  Pancreatic cancer occurred less 
than expected among males during the other two time periods and about as expected among 
females during all three time periods.  Tables 10a through 10d provide additional details.   
3. Cancer Incidence in Holyoke 
Bladder cancer, Hodgkin’s disease, kidney cancer, liver cancer, NHL, and pancreatic cancer all 
occurred approximately equal to or less often than expected during the 1982–2000 time period 
(Tables 11a–11d).  There were 149 diagnoses of bladder cancer during 1982–2000, whereas 
approximately 164 diagnoses were expected (SIR = 91, 95% CI = 77–107).  Diagnoses of 
bladder cancer occurred at about the expected rate during two of the smaller time periods, 1982–
1987 and 1994–2000.  Bladder cancer was diagnosed statistically significantly less often than 
expected during the middle time period, 1988–1993 (33 diagnoses observed versus 51.6 
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expected, SIR = 64, 95% CI = 44–90), for both males only and males and females combined.  
Diagnoses of esophagus cancer were elevated during 1982–2000, but the elevation was not 
statistically significant (58 diagnoses observed versus 49.0 expected, SIR = 118, 95% CI = 90–
153).  When examined over time, residents of Holyoke experienced esophagus cancer at about 
the expected rate during 1982–1987 and at elevated rates during 1988–1993 (18 diagnoses 
observed versus 15.1 expected, SIR = 119, 95% CI = 71–188) and 1994–2000 (25 diagnoses 
observed versus 18.6 expected, SIR = 134, 95% CI = 87–198).  Neither of these elevations was 
statistically significant.  Residents of Holyoke experienced Hodgkin’s disease at a less than 
expected rate during 1982–2000 and during each of the three smaller time periods.   Overall, 24 
diagnoses of Hodgkin’s disease were observed in the city of Holyoke during 1982–2000 versus 
about 29 expected.  Kidney cancer also occurred at a less than expected rate overall and for each 
smaller time period.  The incidence of leukemia was elevated from 1982–2000, although the 
elevation was not statistically significant (97 diagnoses observed versus 86.7 expected, SIR = 
112, 95% CI = 91–136).  During the first time period, 1982–1987, there were about two 
additional diagnoses above the expected number.  In the middle time period, 1988–1993, there 
was a statistically significant elevation among males and females combined (36 diagnoses 
observed versus 24.8 expected, SIR = 145, 95% CI = 102–201) and among females alone (20 
diagnoses observed versus 11.5 expected, SIR = 173, 95% CI = 106–268).  Leukemia among 
males during this time period was slightly elevated, but not statistically significantly (16 
diagnoses observed versus 13.3 expected, SIR = 121, 95% CI = 69–196).  In 1982–1987, there 
was about one additional diagnosis of leukemia in females, and leukemia occurred less than 
expected in females from 1994–2000 (12 diagnoses observed versus 16.5 expected, SIR = 73, 
95% CI = 38–127).  Both liver cancer and NHL occurred about as or less than expected in the 
city of Holyoke during 1982–2000 and the three smaller time periods.  There were 19 diagnoses 
of liver cancer, when about 23 were expected (SIR = 82, 95% CI = 49–128), and 140 diagnoses 
of NHL, when about 147 were expected for 1982–2000.  Residents of Holyoke experienced 
pancreatic cancer at about the rate expected during 1982–2000 (99 diagnoses observed versus 
95.1 expected, SIR = 104, 95% CI = 85–127).  Pancreatic cancer was diagnosed at about the 
expected rate for the first two time periods, 1982–1987 and 1988–1993, and was slightly 
elevated during the most recent time period, 1994–2000 (39 diagnoses observed versus 35.1 
expected, SIR = 111, 95% CI = 79–152).  This elevation was not statistically significant.  
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4. Cancer Incidence in Holyoke Census Tract 8121 
In general, when cancer rates in CT 8121 were evaluated for smaller time periods, no consistent 
trends over time were observed.  Among males, there was about one more leukemia diagnosis 
than expected during the first time period, 1982–1987, and leukemia occurred less than the rate 
expected during the second time period, 1988–1993.  In the most recent time period, 1994–2000, 
leukemia among males occurred statistically significantly more often than expected (14 
diagnoses observed versus 7.4 expected, SIR = 190, 95% CI = 104–318).  From 1982 to 1987, 
NHL diagnoses were elevated (21 diagnoses observed versus 14.2 expected, SIR = 148, 95% CI 
= 91–226).  The elevation during this time period was not statistically significant.  NHL 
diagnoses occurred less than expected during the next two time periods, 1988–1993 and 1994–
2000.  The overall elevation of pancreatic cancer among females in CT 8121 was primarily due 
to a statistically significant elevation during the middle time period, 1988–1993 (12 diagnoses 
observed versus 6.2 expected, SIR = 195, 95% CI = 101–304).  There was about one diagnosis 
above the expected number in the first time period and about two diagnoses above the expected 
number in the most recent period for pancreatic cancer among females.  Bladder cancer, 
Hodgkin’s disease, and kidney cancer occurred less frequently or about as expected during each 
of the smaller time periods evaluated.  Refer to Tables 12a through 12d for details.   
5. Cancer Incidence in Southampton 
The eight cancer types evaluated in this report generally occurred approximately near or below 
expected rates in the town of Southampton as a whole during the 19-year time period 1982–
2000, as well as smaller time periods (i.e., 1982–1987, 1988–1993, and 1994–2000), with some 
exceptions (see Table 13a through Table 13d).  The incidence of bladder cancer among males 
was statistically significantly elevated in Southampton during 1982–2000 (17 diagnoses 
observed versus 9.8 expected, SIR = 173, 95% CI = 101–277).  Among females, bladder cancer 
occurred as expected during the overall period (3 diagnoses observed versus 3.0 expected).  For 
males, bladder cancer was diagnosed more often than expected during the earliest time period, 
1982–1987 (6 diagnosis versus 2.8 expected, SIR = 216, 95% CI = 79–470), but the elevation 
was not statistically significant.  A statistically significant elevation did occur in the middle time 
period, 1988–1993 (8 diagnoses observed versus 3.0 expected, SIR = 266, 95% CI = 114–524).  
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Bladder cancer occurred slightly less than expected during the most recent time period, 1994–
2000 (3 diagnoses observed versus 3.8 expected).    
Kidney cancer occurred less often than expected in Southampton from 1982 to 2000, primarily 
due to a lower-than-expected rate among males in the town (1 diagnosis observed versus 5.4 
expected).  Among females, more cases occurred during 1982–2000 than expected (6 diagnoses 
observed versus 2.9 expected, SIR = 206, 95% CI = 75–448), but this elevation was not 
statistically significant.  No females were diagnosed with kidney cancer from 1982 to 1987.  
There was one diagnosis above the expected number during the middle time period, 1988–1993.  
Females were diagnosed more often than expected during the most recent time period, 1994–
2000 (4 diagnoses observed versus 1.5 expected).   
6. Cancer Incidence in Westfield 
From 1982 to 2000 in Westfield, cancer incidence rates were lower than expected for esophagus 
cancer, Hodgkin’s disease, leukemia, NHL, and pancreatic cancer (see Table 14a through Table 
14d).  NHL occurred statistically significantly less often than expected among both males and 
females combined (94 diagnoses observed versus 120.2 expected, SIR = 78, 95% CI = 63–96) 
and females alone (43 diagnoses expected versus 58.6 expected, SIR = 73, 95% CI = 53–99).  
Incidence rates were about as expected for kidney cancer and were higher than expected for 
bladder cancer and liver cancer, although neither elevation was statistically significant.  Overall, 
147 individuals were diagnosed with bladder cancer compared to about 129 expected (SIR = 
114, 95% CI = 96–134).  Bladder cancer was elevated among males (110 diagnoses observed 
versus 92.5 expected, SIR = 119, 95% CI = 98–143) and occurred about as expected among 
females (37 diagnoses observed versus 36.3 expected, SIR = 102, 95% CI = 72–140).  The 
elevations among both genders combined and among males separately were not statistically 
significant.  Twenty-one individuals in Westfield were diagnosed with liver cancer compared to 
about 19 expected (SIR = 110, 95% CI = 68–168).  Liver cancer occurred slightly higher than 
expected among males (16 diagnoses observed versus 13.7 expected, SIR = 117, 95% CI = 67–
190) and was about as expected among females.  Neither elevation was statistically significant.  
The lower-than-expected rate of pancreatic cancer among females was borderline statistically 
significant (27 diagnoses observed versus 39.1 expected, SIR = 69, 95% CI = 45–100).  
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In general, when cancer rates in Westfield were evaluated for smaller time periods, no consistent 
trends over time were observed.  Diagnoses of bladder cancer among males and females 
combined and among males separately occurred at a higher than expected rate during each of the 
smaller time periods, although none of the elevations was statistically significant.  When 
evaluated by smaller time periods, esophagus cancer, Hodgkin’s disease, leukemia, NHL, and 
pancreatic cancer occurred less than expected or about as expected over time.  Kidney cancer 
was slightly higher than expected in 1982–1987, lower than expected in the 1988–1993, and 
slightly higher than expected in 1994–2000.  None of the elevations was statistically significant.  
Citywide rates of liver cancer were lower than expected during 1982–1987 and higher than 
expected during the later two time periods.  Neither of the elevations was statistically significant.   
7. Cancer Incidence in Westfield Census Tract 8125 
In Westfield CT 8125, esophagus cancer, kidney cancer, liver cancer, NHL, and pancreatic 
cancer occurred approximately near or below expected rates during the 19-year time period, 
1982–2000.  More diagnoses of Hodgkin’s disease in males and females combined (8 diagnoses 
observed versus 4.6 expected, SIR = 174, 95% CI = 75–342) and leukemia (15 diagnoses 
observed versus 10.3 expected, SIR = 146, 95% CI = 82–241) were observed during the overall 
time period; however, the observed increases were not statistically significant.  Among females, 
Hodgkin’s disease was statistically significantly elevated for the overall time period (6 diagnoses 
observed versus 2.1 expected, SIR = 287, 95% CI = 105–624).  This elevation was due to small 
elevations in each of the three time periods (i.e., about one to two excess cases in each time 
period).  Hodgkin’s disease occurred less than expected among males from 1982 to 2000 (2 
diagnoses observed versus 2.5 expected).  Bladder cancer among males and females combined 
was statistically significantly elevated for 1982–2000 (28 diagnoses observed versus 18.1 
expected, SIR = 155, 95% CI = 103–223).  Bladder cancer among males was elevated and 
borderline statistically significant (22 diagnoses observed versus 13.8 expected, SIR = 160, 95% 
CI = 100–242).  Among females, bladder cancer was slightly elevated (6 diagnoses observed 
versus 4.4 expected, SIR = 137, 95% CI = 50–299), but not statistically significantly.      
In general, when cancer rates in CT 8125 were evaluated for smaller time periods, no consistent 
trends over time were observed.  Esophagus cancer, kidney cancer, liver cancer, and NHL 
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occurred about as expected in CT 8125 during each of the smaller time periods evaluated.  
Bladder cancer was consistently elevated, although not statistically significantly, for each of the 
three time periods.  This resulted in the statistically significant elevation during the overall 1982–
2000 time period.  For leukemia, there was about one diagnosis above the expected number 
during 1982–1987, about one fewer diagnosis than expected in the next time period, and about 
four additional diagnoses in the most recent time period.  The occurrence of pancreatic cancer in 
the smaller time periods was also inconsistent.  There were no diagnoses during 1982–1987, 
about two additional diagnoses during 1988–1993, and pancreatic cancer occurred about as 
expected during 1994–2000.  Refer to Table 15a through Table 15d. 
C. Review of Cancer Risk Factor Information 
As previously mentioned, cancer is not just one disease but is a term used to describe a variety of 
different diseases.  As such, studies have generally shown that different cancer types have 
different causes, patterns of incidence, risk factors, latency periods (the time between exposure 
and development of disease), characteristics, and trends in survival.  Available information from 
the MCR related to age and gender, as well as other factors related to the development of cancer 
such as smoking and occupation, was reviewed for individuals diagnosed with cancer in 
Easthampton, Holyoke, Southampton, and Westfield.  Information for each of the eight cancer 
types was compared to known or established incidence trends to assess whether any unexpected 
patterns exist among these cases.  It is important to note, however, that personal risk factors such 
as family history, pre-existing medical conditions, hormonal events, diet, and other factors also 
influence the development of many of these cancer types.  Unfortunately, this information is not 
collected by the MCR or any other readily accessible source, and therefore, it was not possible to 
evaluate the role these types of risk factors may have played in the incidence of cancer in 
Easthampton, Holyoke, Southampton, and Westfield.  For detailed information regarding risk 
factors associated with the cancer types evaluated in this report, please refer to Appendix B. 
Age and gender are risk factors for many types of cancers, including all eight types evaluated in 
this report.  Tobacco use is also a known or suggested causal risk factor in several types of 
cancer, including cancers of the bladder, esophagus, kidney, and pancreas.  The smoking history 
of individuals diagnosed with these cancer types was reviewed to assess the possible role tobacco 
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smoking may have played in the development of these cancers among residents of the four 
communities.   
In some studies, an association has been found with exposures specific to certain occupations 
and an increase in the incidence of bladder cancer, kidney cancer, leukemia, liver cancer, NHL, 
and pancreatic cancer.  Therefore, occupational information as reported by the MCR at the time 
of diagnosis was reviewed for individuals diagnosed with these cancer types to determine the 
role that occupational factors may have played in the development of these cancers in 
Easthampton, Holyoke, Southampton, and Westfield.  It should be noted, however, that 
occupational data reported to the MCR are generally limited to job title and often do not include 
specific job duty information that could further define exposure potential for individual cases.  
Further, these data are often incomplete as occupational information can frequently be reported 
as unknown, at home, or retired.  
Finally, histologic (cell type) distribution was reviewed for diagnoses of leukemia in the four 
communities because the various subtypes of leukemia occur with different frequencies in a 
population.  The frequencies of these subtypes in the four communities were compared to 
statewide incidence trends to assess whether any unusual patterns exist in the areas of evaluation. 
1. Bladder Cancer 
The American Cancer Society estimates that bladder cancer will affect 61,420 people in the 
United States in 2006 (ACS 2006).  White males have the highest prevalence of bladder cancer 
across all racial groups.  A male to female ratio of four to one has been observed among whites, 
while a slightly lower male to female ratio of three to one has been observed among most other 
racial groups.  Further, the occurrence of bladder cancer rises with increasing age.  The mean age 
at diagnosis in Massachusetts for the years 1982–2000 was 70 years.  
Because cigarette smoking is the most well-established risk factor for the development of 
bladder cancer, smoking history was reviewed for each individual diagnosed with this cancer 
type.  Smokers are more than twice as likely to develop bladder cancer compared to nonsmokers 
(ACS 2000a).  Tobacco use is associated with approximately 25-60% of all bladder cancers 
(Johansson and Cohen 1997).   
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Studies have revealed a number of occupations that are also associated with bladder cancer.  In 
fact, exposures to chemicals in the workplace account for an estimated 20-25% of all bladder 
cancers diagnosed among men in the United States (Johansson and Cohen 1997).  Occupational 
exposure to aromatic amines, such as benzidine and 2-naphthylamine, increases the risk of 
bladder cancer (ACS 2000a).  These chemicals were common in the dye industry in the past.  A 
higher risk of bladder cancer has also been observed among aromatic amine manufacturing 
workers as well as among workers in the rubber, leather, textiles, printing, and paint products 
industries (ACS 2000a, Silverman et al. 1996).  The development of new chemicals, worker 
exposure reduction strategies, and the elimination of many known bladder carcinogens in the 
workplace have caused shifts in those occupations considered to be high risk.  For example, risks 
among dye, rubber, and leather workers have declined over time, while other occupations such as 
motor vehicle operation (e.g., drivers of trucks, buses, and taxis) and the aluminum industry have 
emerged as potential high-risk occupations (Silverman et al. 1996).  However, specific 
occupational exposures in these occupations have not been confirmed and study findings are not 
consistent.  Further, the risk of bladder cancer from occupational exposures may be increased 
among smokers (ACS 2000a). 
a) Age and Gender 
A review of individuals diagnosed with bladder cancer in Easthampton from 1982–2000 revealed 
that the majority of diagnoses in the town were male (74%, n = 35).  Males comprised 72% of 
bladder cancers statewide for this time period.  Both males and females in Easthampton were 
diagnosed at a rate slightly below the expected rate.  The mean age at diagnosis was 72 years, 
which is consistent with statewide bladder cancer incidence.     
In Holyoke, the majority of individuals diagnosed with bladder cancer were male (66%, n = 99).  
Males were diagnosed slightly less often than expected and females were diagnosed about as 
expected.  The average age of individuals diagnosed with bladder cancer during 1982–2000 was 
72 years, which is comparable to that observed in the general population.  The majority of those 
diagnosed (97%, n = 144) were age 50 or older at the time of diagnosis.   
The majority of bladder cancer diagnoses in Southampton were among males (85%, n = 17).  
Females experienced bladder cancer at about the rate expected, while males were diagnosed 
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statistically significantly more often than expected based on the state rate.  The average age of 
individuals diagnosed with bladder cancer in Southampton during 1982–2000 was 71 years.  All 
of the individuals diagnosed were age 50 or older at the time of diagnosis.  This pattern is 
consistent with what would be expected in the general population.  The statistically significant 
elevation in bladder cancer incidence among males in Southampton was the result of increased 
diagnoses among males aged 55 and older.   
The majority of bladder cancer diagnoses in Westfield were male (75%, n = 110).  The overall 
elevation in bladder cancer incidence among males, which was not statistically significant, was 
the result of increased diagnoses among males aged 55–84 years.  Females experienced bladder 
cancer at approximately the rate expected.  The average age of individuals diagnosed with 
bladder cancer in Westfield during 1982–2000 was 70 years, which is also the mean age at 
diagnosis statewide.  Ninety-five percent (n = 139) were over the age of 50 at the time of 
diagnosis.   
b) Tobacco Use 
Of the 20,402 individuals diagnosed with bladder cancer from 1982 to 2000 in Massachusetts, 
15,493 reported a smoking status.  Of those individuals with a reported smoking status, 67% 
were current/former smokers and 33% were nonsmokers.  Smoking history was unknown for 
4,909 (24%) individuals.  
Of the 47 individuals in Easthampton who were diagnosed with bladder cancer during the years 
1982–2000, 30 reported a smoking status.  Seventy percent (n = 21) of those with known 
smoking history were current/former smokers, which is slightly higher than the 67% of 
individuals diagnosed with bladder cancer in Massachusetts during 1982–2000 with known 
smoking history who were current/former smokers.  Nine (30%) were nonsmokers.  Smoking 
history was unknown for 17 (36%) individuals.   
In Holyoke, 123 of 149 individuals diagnosed with bladder cancer reported a smoking status.  Of 
those 123 individuals with a reported smoking status, 56% (n = 69) were current/former smokers 
and 44% (n = 54) were nonsmokers.  Smoking history was unknown for 26 (17%) individuals.   
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In Southampton, where there was a statistically significant elevation in bladder cancer among 
males, 13 of 20 individuals reported a smoking status.  Of those 13 individuals with a reported 
smoking status, 85% (n = 11) were current/former smokers and 15% (n = 2) were nonsmokers.  
Of the 17 males with bladder cancer, ten reported a smoking status.  Of those 10 males with a 
reported smoking status, eight (80%) were current/former smokers and two (20%) were 
nonsmokers.  Smoking history was unknown for seven (35%) individuals.   
In Westfield, 110 out of 147 individuals with bladder cancer reported a smoking status.  Of those 
110 individuals with a report smoking status, 71% (n = 78) were current/former smokers and 
29% (n = 32) were nonsmokers.  Smoking history was unknown for 37 (25%) individuals.  In 
Westfield CT 8125, where bladder cancer for males and females combined was statistically 
significantly elevated, 21 out of 28 individuals reported a smoking status.  Of those 21 
individuals with a reported smoking status, 86% (n = 18) were current/former smokers and 14% 
(n = 3) were nonsmokers.  Smoking history was unknown for seven (25%) individuals. 
In summary, it is likely that smoking played a role in the development of bladder cancer among 
some residents of Easthampton, Holyoke, Southampton, and Westfield.  
c) Occupation 
Review of occupation for individuals diagnosed with bladder cancer in Easthampton revealed 
that at least six individuals (13%) might have worked at a job in which occupational exposures 
potentially related to the development of bladder cancer may have been possible.  However, 
information regarding specific job duties that could help to further define exposure potential for 
these individuals was not available.  Occupations reported for the remaining individuals are not 
likely to be related to an increased risk of this cancer type.  Occupation was reported as retired or 
unknown for a number of these individuals (17%, n = 8). 
In Holyoke, at least eleven individuals (7%) might have worked at a job in which an 
occupational exposure potentially related to the development of bladder cancer may have been 
possible.  Occupation was reported as retired or unknown for 36% of individuals diagnosed with 
bladder cancer (n = 54).   
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In Southampton, at least two individuals (10%) might have worked at a job in which an 
occupational exposure potentially related to the development of bladder cancer may have been 
possible.  Occupation was reported as retired or unknown for two individuals diagnosed with 
bladder cancer (10%).   
In Westfield, at least 17 individuals (12%) might have worked at a job in which an occupational 
exposure potentially related to the development of bladder cancer may have been possible.  
Occupation was reported as retired or unknown for 48% of individuals diagnosed with bladder 
cancer (n = 70).   
2. Esophagus Cancer 
The American Cancer Society estimates that esophagus cancer will affect 14,550 people in the 
United States in 2005 (ACS 2006).  Esophagus cancer is three times more common among men 
than women.  It is also three times more common among African-Americans than among whites.  
The occurrence of esophagus cancer rises with increasing age.  It is rarely diagnosed in 
individuals under 40.  The mean age at diagnosis in Massachusetts for the years 1982–2000 was 
68 years.  
There are several risk factors associated with cancer of the esophagus (ACS 2005a).  Esophagus 
cancer is strongly associated with a history of cigarette smoking, and the risk of developing this 
cancer type rises with length of tobacco use.  In Massachusetts from 1982–2000, 80% of 
individuals diagnosed with esophagus cancer with known smoking history were current or 
former smokers.  Long term heavy alcohol use, long term heartburn, a diet low in fruits and 
vegetables and certain vitamins and minerals, and ingestion of lye as a child are also associated 
with increased risk of esophagus cancer.  Studies have revealed that dry cleaning workers have a 
greater risk of developing esophagus cancer (ACS 2005a).  Inhalation of tetrachloroethene (PCE) 
in the workplace may be responsible for this increased risk.   
a) Age and Gender 
A review of individuals diagnosed with esophagus cancer in Easthampton from 1982–2000 
revealed that most were male (87%, n = 13).  Males were diagnosed at about the expected rate 
and females were diagnosed below the expected rate.  The mean age at diagnosis was 70 years, 
 53 
which is consistent with statewide esophagus cancer incidence.  All of the individuals were over 
the age of 55 at the time of diagnosis.     
In Holyoke, the majority of individuals diagnosed with esophagus cancer were also male (64%, n 
= 37).  Both males and females were diagnosed more often than expected, although the 
elevations were not statistically significant.  The average age of individuals diagnosed with 
esophagus cancer during 1982–2000 was 70 years, which is comparable to that observed in the 
general population.   
In Southampton, males experienced esophagus cancer less than the rate expected and females 
were diagnosed at approximately the expected rate.  The two individuals diagnosed with 
esophagus cancer in Southampton were both over age 65.     
The majority of esophagus cancer diagnoses in Westfield were male (78%, n = 29).  Esophagus 
cancer among males occurred at about the rate expected and less than expected for females.  The 
average age of individuals diagnosed with esophagus cancer in Westfield was 67 years, which is 
nearly the mean age at diagnosis statewide.  All of the individuals were over the age of 40 at the 
time of diagnosis.   
b) Tobacco Use 
Of the 6,234 individuals diagnosed with esophagus cancer from 1982 to 2000 in Massachusetts, 
5,041 reported a smoking status.  Of those individuals with a reported smoking status, 80% were 
current/former smokers and 20% were nonsmokers.  Smoking history was unknown for 1,193 
(19%) individuals. 
In Easthampton, 12 of the 15 individuals diagnosed with esophagus cancer reported a smoking 
status.  Of those 12 individuals with a reported smoking status, 83% (n = 10) were current/former 
smokers and 17% (n = 2) were nonsmokers.  Smoking history was unknown for three (20%) 
individuals.    
In Holyoke, 51 of the 58 individuals with esophagus cancer reported a smoking status.  Of those 
51 individuals with a reported smoking history, 75% (n = 38) were current/former smokers and 
25% (n = 13) were nonsmokers.  Smoking history was unknown for seven (12%) individuals. 
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Both of the individuals diagnosed with esophagus cancer in Southampton from 1982 to 2000 
were current/former smokers.   
In Westfield, 28 of the 37 individuals with esophagus cancer reported a smoking status.  Of those 
28 individuals with a reported smoking status, 86% (n = 24) were current/former smokers and 
14% (n = 4) were nonsmokers.  Smoking history was unknown for nine (24%). 
In summary, it is likely that smoking played a role in the development of esophagus cancer 
among some residents of Easthampton, Holyoke, Southampton, and Westfield.  
c) Occupation 
Among the 15 individuals in Easthampton diagnosed with esophagus cancer, an occupation was 
reported for eight individuals.  None of these eight individuals reported occupations where 
exposures to PCE or secondhand smoke were likely to have occurred, based on the available 
information.   
In Holyoke, at least one individual might have worked at a job in which occupational exposures 
potentially related to the development of esophagus cancer may have been possible.  However, 
information regarding specific job duties that could help to further define exposure potential for 
these individuals was not available.  Occupations reported for the remaining individuals are not 
likely to be related to an increased risk of this cancer type.  Occupation was reported as retired or 
unknown for a number of these individuals (43%, n = 25). 
One of the two individuals in Southampton diagnosed with esophagus cancer reported an 
occupation where exposures to PCE or secondhand smoke were unlikely to occur, based on the 
available information.  The occupation for the other individual was reported as retired. 
Among the 37 individuals in Westfield diagnosed with esophagus cancer, an occupation was 
reported for 25 individuals.  None of these 25 individuals reported occupations where exposures 
to PCE or secondhand smoke were likely to have occurred, based on the available information.   
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3. Hodgkin’s Disease 
Hodgkin’s disease (or Hodgkin’s lymphoma) is a form of cancer that involves the lymphatic 
system and can be distinguished from non-Hodgkin’s lymphomas by cancer cell type.  The 
American Cancer Society estimates that there will be approximately 7,800 new cases of this 
disease in the United States in 2006, accounting for less than 1% of all cancer types, and 
approximately 1,490 deaths (ACS 2006).  Because of substantial improvement in effective 
therapy for this disease, mortality rates have decreased approximately 60% since the early 1970s 
(ACS 1999). 
Epidemiologic studies have shown that Hodgkin’s disease is more common among men than 
women and more common among whites than blacks.  People of Jewish descent appear to be at 
higher risk of Hodgkin’s disease compared to people of non-Jewish descent (Mueller 1996).  The 
disease is relatively rare among children.  Two peaks in the age distribution have been observed 
for Hodgkin’s disease.  The first peak occurs in young adults usually between the ages of 15 to 
40 (typically ages 25–30) and the second peak occurs in adults aged 55 years and above.  
The clinical and cellular features of Hodgkin’s disease suggest a chronic infectious process 
(Mueller 1996).  The bimodal age distribution of this disease suggests that two distinct etiologies 
(or causes) for Hodgkin’s disease may be involved for each group.  Researchers have proposed 
that among young adults, Hodgkin’s disease is caused by a biological agent of low infectivity.  
Among individuals of older ages, the cause is probably similar to those of other lymphomas 
(Mueller 1996).  The virus that has been linked most specifically to this disease is the Epstein-
Barr virus (EBV).  EBV, a herpes virus, is common in the general population and causes 
mononucleosis or “mono.”  Approximately 40% to 50% of Hodgkin’s disease cases are 
associated with EBV (Weiss 2000).   
Hodgkin’s disease trends in the young adult population reveal that the disease has become 
increasingly associated with populations both of middle to higher socioeconomic status and 
small family size.  These factors are consistent with susceptibility to late infections with common 
childhood viruses, supporting the theory that Hodgkin’s disease is associated with an infectious 
agent (Mueller 1996).  Occupational exposures to workers in the chemical industry and 
woodworkers have also been suggested in several epidemiologic studies to be associated with the 
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development of Hodgkin’s disease.  However, specific chemical exposures related to the 
development of this disease have not been identified and results of studies investigating 
occupational exposures are inconsistent (Mueller 1996).  Based on an examination of medical 
and scientific literature, the American Cancer Society concludes that although the exact cause 
remains unknown, Hodgkin’s disease does not seem to be caused by genetic, lifestyle (e.g., 
dietary), or environmental factors (ACS 1999). 
a) Age and Gender 
Eleven of the 13 individuals diagnosed with Hodgkin’s disease in Easthampton during 1982–
2000 were between the ages of 15 and 40 or above age 55 at the time of diagnosis.  Three 
individuals were aged 25–30, which is a common age for this cancer type, and there were no 
children under 16 years diagnosed with Hodgkin’s disease.  This is generally consistent with 
what is seen in the general population.  Both males and females were diagnosed slightly above 
the expected rate.   
Twenty-one of the 24 individuals diagnosed with Hodgkin’s disease in Holyoke were between 
the ages of 15 and 40 or above age 55.  Four individuals were aged 25–30, and there were no 
children under 16 years diagnosed with Hodgkin’s disease.  Both females and males were 
diagnosed at a less than expected rate.   
The three individuals diagnosed with Hodgkin’s disease in Southampton were between the ages 
of 30 and 60.  Both males and females were diagnosed at a rate very near the expected rate.   
In Westfield, 17 of the 21 individuals diagnosed with Hodgkin’s disease were between the ages 
of 15 and 40 or above age 55.  Four individuals were aged 25–30, and there were three children 
under age 15 diagnosed with Hodgkin’s disease.  Both males and females were diagnosed at a 
less than expected rate.  In Westfield CT 8125, where there was a statistically significant 
elevation in Hodgkin’s disease among females, the six females were between the ages of 12 and 
33 when diagnosed.    
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b) Occupation 
Of the 13 individuals in Easthampton diagnosed with Hodgkin’s disease, an occupation was 
reported for 10 individuals.  None of these 10 individuals reported occupations that are related to 
the chemical or woodworking industries, based on the available information.   
Of the 24 individuals in Holyoke diagnosed with Hodgkin’s disease, an occupation was reported 
for 17 individuals.  None of these individuals reported occupations that are related to the 
chemical or woodworking industries, based on the available information.   
The three individuals in Southampton diagnosed with Hodgkin’s disease reported occupations 
that are unlikely to be related to the chemical or woodworking industries, based on the available 
information. 
In Westfield, at least one adult might have worked at a job in which occupational exposures 
potentially related to the development of Hodgkin’s disease may have been possible.  However, 
information regarding specific job duties that could help to further define exposure potential for 
these individuals was not available.  Occupations reported for the remaining individuals are not 
likely to be related to an increased risk of this cancer type.  Occupation was reported as retired or 
unknown for some of these adults (33%, n = 6). 
4. Kidney and Renal Pelvis Cancer 
Kidney cancer is twice as common in males as it is in females and the incidence most often 
occurs in the fifth and sixth decades of life (50-70 year age group) (ACS 2001a).  
Epidemiological studies have shown that incidence rates of kidney cancer rise with increasing 
age before reaching a plateau at approximately age 70 (McLaughlin et al. 1996).  The etiology of 
kidney cancer is not fully understood.  However, a number of environmental, hormonal, cellular, 
and genetic factors have been studied as possible causal factors in the development of renal cell 
carcinoma.  Cigarette smoking is the most important known risk factor for renal cell cancer.  
Smoking increases the risk of developing renal cell cancer by 30% to 100% (ACS 2001a).  In 
both males and females, a statistically significant dose-response relationship between smoking 
and this cancer has been observed.  Approximately one-third of renal cell cancers in men and 
one-quarter of those in women may be caused by cigarette smoking (ACS 2001a). 
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Although kidney cancer is not generally considered an occupationally associated cancer, some 
studies have suggested that environmental and occupational factors may be associated with its 
development.  Some studies have shown an increased incidence of this cancer type among 
leather tanners, shoe workers, and workers exposed to asbestos.  In addition, exposure to 
cadmium is associated with an increased incidence of kidney cancer, particularly among men 
who smoke.  Also, workplace exposure to organic solvents, such as TCE, may increase the risk 
of this cancer (ACS 2001a).  More recently, renal cell carcinoma, the most common type of 
kidney cancer, has been suggested to be associated with occupational exposure to petroleum, tar, 
and pitch products.  However, studies of oil refinery workers and petroleum products distribution 
workers have not identified a definitive relationship between exposure to gasoline or other 
petroleum products and kidney cancer (Linehan et al. 1997, McLaughlin et al. 1996). 
a) Age and Gender 
The incidence of kidney cancer in Easthampton generally increased with increasing age.  The 
average age of individuals diagnosed with kidney cancer in the town during 1982–2000 was 63 
years, while the state mean was 64 years.  Eighty-six percent (n = 31) of individuals diagnosed 
were age 50 or older at the time of diagnosis, which is consistent with the literature.  There was 
one diagnosis of kidney cancer in a child aged 0–19 years versus about 0.5 diagnoses expected 
for that age group.  More males (n = 22) than females (n = 14) were diagnosed with kidney 
cancer in Easthampton, which is consistent with state and national trends.   
In Holyoke, the average age of individuals diagnosed with kidney cancer was 65 years.  Eighty-
seven percent (n = 71) of individuals diagnosed were over the age of 50 at the time of diagnosis.  
There were two diagnoses of kidney cancer in children versus about two diagnoses expected in 
children aged 0–19 years.  More males (n = 45) than females (n = 37) were diagnosed with 
kidney cancer in Holyoke.   
In Southampton, the average age of individuals diagnosed with kidney cancer was 59 years.  
Five of the seven individuals were over the age of 50 at the time of diagnosis.  There was one 
diagnosis of kidney cancer in a child aged 0–19 years versus about 0.2 diagnoses expected for 
that age group.  Males were diagnosed at a rate that was less than expected and females were 
diagnosed more often than expected, though the elevation was not statistically significant.  
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In Westfield, the average age of individuals diagnosed with kidney cancer was 66 years.  Eighty-
eight percent (n = 68) of individuals diagnosed were age 50 or older at the time of diagnosis.   
There was one diagnosis of kidney cancer in a child aged 0–19 years versus about 1.3 diagnoses 
expected for that age group.  More males (n = 43) than females (n = 34) were diagnosed with 
kidney cancer in Westfield.   
b) Tobacco Use 
Of the 12,328 individuals diagnosed with kidney cancer from 1982 to 2000 in Massachusetts, 
9,651 reported a smoking status.  Of those individuals with a reported smoking status, 57% were 
current/former smokers and 43% were nonsmokers.  Smoking history was unknown for 2,677 
(22%) individuals. 
Of the 36 individuals diagnosed with kidney cancer in Easthampton during 1982–2000, 29 
individuals reported a smoking status.  Of those 29 individuals with a reported smoking status, 
59% (n = 17) were current/former smokers and 41% (n = 12) were nonsmokers.  Smoking 
history was unknown for seven (19%) individuals.   
In Holyoke, 67 of the 82 individuals diagnosed with kidney cancer reported a smoking status.  Of 
those 67 individuals with a report smoking status, 54% (n = 36) were current/former smokers and 
46% (n = 31) were nonsmokers.  Smoking history was unknown for 15 (18%) individuals. 
In Southampton, six of the seven individuals diagnosed with kidney cancer reported a smoking 
status.  Of those six individuals with a reported smoking status, four were current/former 
smokers and two were nonsmokers.  Smoking status was unknown for one individual. 
In Westfield, 65 of 77 individuals with kidney cancer reported a smoking status.  Of those 65 
individuals with a reported smoking status, 55% (n = 36) were current/former smokers and 45% 
(n = 29) were nonsmokers.  Smoking status was unknown for 12 (16%) individuals. 
In summary, it is likely that smoking played a role in the development of kidney cancer among 
some residents of Easthampton, Holyoke, Southampton, and Westfield.  
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c) Occupation 
Review of occupation for adults diagnosed with kidney cancer in Easthampton revealed that four 
individuals (11%) might have worked a job in which occupational exposures potentially related 
to the development of kidney cancer may have been possible.  However, information regarding 
specific job duties that could help to further define exposure potential for these individuals was 
not available.  Occupations reported for the remaining individuals are not likely to be related to 
an increased risk of this cancer type.  It is important to note that occupation was reported as 
retired or unknown for 29% of these adults (n = 10). 
In Holyoke, at least 12 adults (15%) might have worked at a job in which an occupational 
exposure potentially related to the development of kidney cancer may have been possible.  
Occupation was reported as retired or unknown for 29% of adults diagnosed with kidney cancer 
(n = 23).   
In Southampton, at least one individual might have worked at a job in which an occupational 
exposure potentially related to the development of kidney cancer may have been possible.  
Occupation was reported as retired or unknown for two of the six adults diagnosed with kidney 
cancer.   
In Westfield, at least 12 adults (16%) might have worked at a job in which an occupational 
exposure potentially related to the development of kidney cancer may have been possible.  
Occupation was reported as retired or unknown for 34% of adults diagnosed with kidney cancer 
(n = 26).   
5. Leukemia 
In 2006, leukemia is expected to affect approximately 35,070 individuals (20,000 males and 
15,070 females) in the United States, resulting in 22,280 deaths (ACS 2006).  In Massachusetts, 
approximately 770 individuals will be diagnosed with the disease in 2006, representing more 
than 2% of all cancer diagnoses (ACS 2006).  There are four major types of leukemia: acute 
myeloid leukemia (AML), chronic lymphoid leukemia (CLL), chronic myeloid leukemia (CML), 
and acute lymphoid leukemia (ALL).  There are also several rare types of leukemia (e.g., hairy 
cell leukemia, myelomonocytic leukemia).  In adults, the most common types are AML and 
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CLL.  The average age at diagnosis is 65 years for AML and 70 years for CLL (ACS 2005b, 
2005c).  For CML, the average age at diagnosis is about 50 years (ACS 2005d).  Leukemia is the 
most common type of childhood cancer, accounting for more than 30% of all cancers diagnosed 
in children.  The majority of these cases are of the ALL type (ACS 2003a).  While ALL occurs 
predominantly among children (peaking between ages 2 and 3 years), an elevation in incidence is 
also seen among older individuals.  The increase in incidence among older individuals begins at 
approximately 40-50 years of age, and peaks at about age 85 (Linet and Cartwright 1996).  
Statewide, the average age of all leukemia diagnoses is 59 years.  
The various subtypes of leukemia occur with different frequencies in the population.  For the 
purpose of classification in this evaluation, if the histology (i.e., cell type) of the leukemia 
diagnosis was not otherwise specified or not classified as one of the four main subtypes, then the 
individual case was categorized as “other.”  Available information regarding the expected 
distribution of leukemia by histology types can vary considerably depending on coding methods, 
making comparisons of type-specific incidence rates from different cancer registries difficult 
(Linet and Cartwright 1996).  In the state of Massachusetts during the time period 1982–2000, 
34% of all leukemia cases were AML, 26% were CLL, 13% were ALL, 11% were CML, and 
16% were other histology types. 
Several occupational exposures have been identified as playing a role in the development of 
leukemia.  For example, exposures to particular chemicals are thought to increase the risk of 
developing certain kinds of leukemia.  Exposures to ionizing radiation, chronic, high-dose 
exposure to pesticides, and other chemicals such as benzene, have also been suggested as 
possible risk factors for leukemia (Linet and Cartwright 1996).  Chronic occupational exposure 
to benzene has been established as a cause of AML.  High doses of radiation among survivors of 
atomic bomb blasts or nuclear reactor accidents are associated with an increased incidence of 
AML, CML, and ALL, but no association has been established for lower doses such as those 
used in medical diagnostics. 
a) Age and Gender 
The average age of individuals diagnosed with leukemia in Easthampton was 50 years.  The 
statewide average age for leukemia diagnoses was 59 years.  Sixty-one percent (n = 14) were age 
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50 or older at the time of diagnosis.  Leukemia generally occurred about as expected among 
males and less often than expected among females.  However, five diagnoses occurred in 
children aged 0–19 years, while approximately three diagnoses would have been expected.   
In Holyoke, the average age of individuals diagnosed with leukemia was 63 years, which is 
comparable to the statewide average age for leukemia diagnoses.  Eighty-two percent (n = 80) 
were age 50 or older at the time of diagnosis.  Nine diagnoses occurred in children aged 0–19 
years, while approximately 11 would have been expected.  From 1988 to 1993, when there was a 
statistically significant elevation for males and females combined and females alone, the average 
age for both sexes combined was 59.  Six diagnoses occurred in children, while about three were 
expected during this time period.  In CT 8121, where leukemia in males was statistically 
significantly elevated from 1994 to 2000, the average age among males was 67.  One male aged 
0–19 years was diagnosed in this census tract.   
In Southampton, the average age of individuals diagnosed with leukemia was 61 years.  Six of 
the seven individuals diagnosed were age 50 or older at the time of diagnosis.  No diagnoses 
occurred in children aged 0–19 years, while about one diagnosis would have been expected.  
Leukemia occurred about as expected among both males and females.  
In Westfield, the average age of individuals diagnosed with leukemia was 59 years, which is the 
same as the statewide average age.  Seventy-eight percent (n = 51) were age 50 or older at the 
time of diagnosis.  Eight diagnoses occurred in children aged 0–19 years, which is approximately 
the number expected (7.8 diagnoses).  Leukemia occurred slightly more often among males and 
occurred less than expected among females.  
b) Histology 
The four main leukemia subtypes have different risk factors suspected to be associated with their 
development and generally occur with different frequency among adults and children. Of the 23 
individuals diagnosed with leukemia in Easthampton during 1982–2000, 39% were diagnosed 
with AML subtype, 4% were diagnosed with CLL, 26% were diagnosed with ALL, 13% were 
diagnosed with CML, and 17% were not specified or were diagnosed with other types of 
leukemia.  This distribution is somewhat similar to that seen statewide, except that the relative 
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distribution of CLL was lower and the relative distribution of ALL was higher in Easthampton 
than in the state as a whole.  This difference could have been due to the small number of 
leukemia diagnoses in Easthampton relative to the state.  Three of the five children diagnosed 
with leukemia in Easthampton were diagnosed with the ALL subtype, the most common subtype 
among children.  The remaining two children had two other histology types.  
Of the 97 individuals diagnosed with leukemia in Holyoke, 31% were diagnosed with AML 
subtype, 26% were diagnosed with CLL, 21% were diagnosed with ALL, 7% were diagnosed 
with CML, and 15% were not specified or were diagnosed with other types of leukemia.  Seven 
of the nine children diagnosed with leukemia in Holyoke were diagnosed with ALL, the most 
common subtype among children.  The remaining two children had two other histology types.  
Of the 36 individuals diagnosed with leukemia during 1988–1993, when a statistically significant 
elevation occurred, there were eight cases of AML, six cases of CLL, 10 cases of ALL, two 
cases of CML, and 10 diagnoses of seven other leukemia types.  As previously mentioned, these 
leukemia cell types are different and have varied risk factors.  Four of the six children diagnosed 
during this time period had ALL, the most common subtype in children.  Of the 14 males 
diagnosed with leukemia in CT 8121, when there was a statistically significant elevation among 
males from 1994 to 2000, seven were diagnosed with CLL, three with AML, and three were 
diagnosed with another or non-specified leukemia type.  The child diagnosed in CT 8121 during 
this time period had ALL, the most common type in children.   
Of the seven individuals diagnosed with leukemia in Southampton, two were diagnosed with 
CLL, two were diagnosed with ALL, two were diagnosed with CML, and one was diagnosed 
with another histology type.  There were no children diagnosed with leukemia in Southampton.  
Of the 65 individuals diagnosed with leukemia in Westfield, 31% were diagnosed with AML 
subtype, 22% were diagnosed with CLL, 14% were diagnosed with ALL, 11% were diagnosed 
with CML, and 23% were not specified or were diagnosed with other types of leukemia.  Seven 
of the eight children diagnosed with leukemia in Holyoke were diagnosed with ALL, the most 
common subtype among children.   
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c) Occupation 
Review of occupation for adults diagnosed with leukemia in Easthampton revealed that at least 
one adult may have worked a job in which occupational exposures potentially related to the 
development of leukemia may have been possible.  However, information regarding specific job 
duties that could help to further define exposure potential for these individuals was not available.  
Occupations reported for the remaining adults are not likely to be related to an increased risk of 
this cancer type.  Occupation was reported as retired or unknown for a number of these 
individuals (33%, n = 6). 
In Holyoke, at least one adult might have worked at a job in which occupational exposures 
potentially related to the development of leukemia may have been possible.  Occupation was 
reported as retired or unknown for 15% of adults diagnosed with leukemia (n = 13).   
Among the seven adults in Southampton diagnosed with leukemia, an occupation was reported 
for three individuals.  None of these three individuals reported occupations where exposures to 
the chemicals listed above were likely to have occurred, based on the available information.   
In Westfield, at least two adults might have worked at a job in which occupational exposures 
potentially related to the development of leukemia may have been possible.  Occupation was 
reported as retired or unknown for 46% of adults diagnosed with leukemia (n = 26).   
6. Liver Cancer 
An estimated 18,510 people in the United States (12,600 men and 5,910 women) will be 
diagnosed with liver cancer in 2006, accounting for approximately 1% of all new cancers (ACS 
2006).  Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver, 
accounting for about 75% of all cases.  Men are at least two to three times more likely to develop 
liver cancer than women (Yu et al. 2000).  Although the risk of developing HCC increases with 
increasing age, the disease can occur in persons of any age (London and McGlynn 1996).  
Although chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) is the most 
significant risk factor for developing liver cancer (ACS 2001b), epidemiological and 
environmental evidence indicates that exposure to certain chemicals and toxins can also 
contribute significantly to the development of liver cancer.  For example, vinyl chloride, a 
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known human carcinogen used in the manufacturing of some plastics, and thorium dioxide, used 
in the past for certain x-ray tests, are risk factors for a rare type of liver cancer called 
angiosarcoma (ACS 2001b, London and McGlynn 1996).  These chemicals may also increase 
the risk of HCC, but to a lesser degree.  In addition, arsenic has been associated with an 
increased risk of liver cancer (ATSDR 2001b). 
a) Age and Gender 
The seven individuals diagnosed with liver cancer in Easthampton during 1982–2000 had a mean 
age of 62 years.  This is consistent with the statewide average age of 65.  All of the diagnoses 
were among males.   
In Holyoke, the average age of individuals diagnosed with liver cancer was 70 years.  There was 
one diagnosis of an unspecified type of liver cancer in a child.  Seventy-four percent of liver 
cancer diagnoses were among males.   
There were no diagnoses of liver cancer in Southampton from 1982 to 2000. 
In Westfield, the average age of individuals diagnosed with liver cancer was 65 years.  There 
was one diagnosis of hepatoblastoma in a young child.  Hepatoblastoma is a rare type of liver 
cancer that normally occurs in children under 4 years.  Seventy-six percent of liver cancer 
diagnoses occurred in males.   
b) Occupation 
Of the five individuals who reported an occupation among the seven diagnosed with liver cancer 
in Easthampton, none were employed in an occupation that is likely to be related to an increased 
risk of developing liver cancer.  Occupation was unknown for the remaining two individuals. 
In Holyoke, at least one individual might have worked at a job in which occupational exposures 
potentially related to the development of liver cancer may have been possible.  Occupation was 
reported as retired or unknown for 33% of adults diagnosed with liver cancer (n = 6).   
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In Westfield, at least one individual might have worked at a job in which occupation exposure 
potentially related to the development of liver cancer may have been possible.  Occupation was 
reported as retired or unknown for 20% of adults diagnosed with liver cancer (n = 4).   
7. Non-Hodgkin’s Lymphoma 
NHL can occur at all ages; however, the average age at diagnosis is in the early 60s and the 
incidence of this disease generally increases with age.  NHL occurred about equally among 
males (51%) and females (49%) in Massachusetts from 1982 to 2000.  The American Cancer 
Society estimates that approximately 56,390 Americans will be diagnosed with NHL in 2005, 
making it the sixth most common cancer in the United States among both men and women, 
excluding non-melanoma skin cancers (ACS 2005a).  Although the primary factors related to the 
development of NHL include conditions that suppress the immune system and viral infections, 
certain occupational exposures have been associated with an increased risk of developing NHL, 
such as occupations related to chemicals or agriculture.  Farmers, herbicide and pesticide 
applicators, and grain workers appear to have the most increased risk (Zahm et al. 1990, 1993; 
Tatham et al. 1997).  An elevated risk for NHL development has also been noted among fence 
workers, orchard workers, and meat workers.  High-dose exposure to benzene has been 
associated with NHL (ACS 2003b); however, a recent international cohort study indicated that 
petroleum workers exposed to benzene were not at an increased risk of NHL (Wong and Raabe 
2000). 
a) Age and Gender 
The average age at diagnosis for individuals diagnosed with NHL in Easthampton during 1982–
2000 was 62 years, which is consistent with the average age of 63 years seen statewide.  Fifty-six 
percent (n = 25) of NHL diagnoses occurred in males.  Males comprised 51% of NHL diagnoses 
in Massachusetts during the same time period.  In CT 8223, where there was a statistically 
significant elevation among males from 1994 to 2000, the average age was 57 years.   
In Holyoke, the average age of individuals diagnosed with NHL was 64 years.  There were five 
diagnoses in children aged 0–19 years from 1982 to 2000, while about three diagnoses were 
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expected for this age group.  NHL diagnoses were almost equally split between males (48%) and 
females (52%).   
In Southampton, the average age of individuals diagnosed with NHL was 61 years.  Three of the 
diagnoses occurred in males and four occurred in females.  
In Westfield, the average age of individuals diagnosed with NHL was 63 years.  There were two 
diagnoses in children from 1982 to 2000, while about two diagnoses were expected.  Fifty-four 
percent of NHL diagnoses occurred in males and 46% occurred in females.   
b) Occupation 
Review of occupational information for individuals diagnosed with NHL in Easthampton 
revealed that at least six individuals (13%) might have worked at a job in which occupational 
exposures potentially related to the development of NHL may have been possible.  However, 
information regarding specific job duties that could help to further define exposure potential for 
these individuals was not available, and occupation was reported as retired or unknown for 22% 
of individuals (n = 10).   
In Holyoke, at least eight individuals (6%) diagnosed with NHL might have worked a job in 
which occupational exposures potentially related to the development of NHL may have been 
possible.  Occupation was reported as retired or unknown for 33% of adults diagnosed with NHL 
(n = 44).   
In Southampton, one of the four individuals diagnosed with NHL who reported an occupation 
might have worked a job in which occupational exposures potentially related to the development 
of NHL may have been possible.  Occupation was reported as retired or unknown for three of the 
seven individuals diagnosed with NHL.   
In Westfield, at least five individuals (5%) diagnosed with NHL might have worked a job in 
which occupational exposures potentially related to the development of NHL may have been 
possible.  Occupation was reported as retired or unknown for 39% of adults diagnosed with NHL 
(n = 36).   
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8. Pancreatic Cancer 
The risk of developing pancreatic cancer increases with age, and the majority of cases occur 
between age 60 and 80.  Men are approximately 30% more likely to develop pancreatic cancer 
than are women (ACS 2000b), although women in Massachusetts were diagnosed slightly more 
often than men from 1982 to 2000.  Besides age, the most consistent and only established risk 
factor for pancreatic cancer is cigarette smoking.  According to the American Cancer Society, 
approximately 30% of all pancreatic cancer cases are thought to result directly from cigarette 
smoking (ACS 2000b).  Studies have estimated that the risk of pancreatic cancer is two to six 
times greater in heavy smokers than in non-smokers (Anderson et al. 1996). 
Numerous occupations have been investigated for their potential role in the development of 
pancreatic cancer, but studies have not produced consistent results.  Heavy exposure to certain 
pesticides (including DDT and its derivatives) may increase the risk of pancreatic cancer (ACS 
2000b, Ji et al. 2000, Porta et al. 1999).  Exposure to certain dyes and certain chemicals related 
to gasoline, in addition to asbestos and ionizing radiation, have also been associated with the 
development of pancreatic cancer in some studies, however, other studies have found no link 
between these agents and pancreatic cancer (ACS 2000b, Anderson et al. 1996).  A recent 
evaluation of data from several studies has implicated organic solvents (e.g., chlorinated 
hydrocarbons) and polycyclic aromatic hydrocarbons, nickel compounds, and chromium 
compounds in the development of pancreatic cancer, but further studies are needed to 
corroborate this finding (Ojajarvi et al. 2000). 
a) Age and Gender 
A review of individuals diagnosed with pancreatic cancer in Easthampton from 1982–2000 
revealed that slightly more females (53%) than males (47%) were diagnosed.  Both males and 
females were diagnosed slightly more often than expected, although the elevations were not 
statistically significant.  The mean age at diagnosis was 70 years, which is the same as the 
average age for statewide pancreatic cancer incidence.  Thirty-three of the 34 individuals were 
age 50 or older at the time of diagnosis.  Among the individuals diagnosed from 1994 to 2000, 
when there was a statistically significant elevation townwide for males and females combined, 
the mean age was 70.     
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In Holyoke, most of the individuals diagnosed with pancreatic cancer were female (59%, n = 58).  
Males were diagnosed approximately as expected, and females were diagnosed slightly more 
often than expected, although not statistically significantly.  The average age of individuals 
diagnosed with pancreatic cancer was 71 years.  All but two of the individuals were age 50 or 
older at the time of diagnosis.  In CT 8121, where there was a statically significant elevation 
among females from 1988 to 1993, the average age was also 71.   
In Southampton, males experienced pancreatic cancer less than the rate expected and females 
were diagnosed slightly higher than the expected rate.  There were two males and five females 
diagnosed.  The seven individuals diagnosed with pancreatic cancer in Southampton were all 
over the age of 60.     
In Westfield, the majority of pancreatic cancer diagnoses were male (59%, n = 39).  Pancreatic 
cancer among males occurred slightly higher than the rate expected and less than expected for 
females.  The average age of individuals diagnosed with pancreatic cancer was 68 years.  Most 
of the individuals (92%) were age 50 or older at the time of diagnosis.   
b) Tobacco Use 
Of the 11,549 individuals diagnosed with pancreatic cancer from 1982 to 2000 in Massachusetts, 
8,523 reported a smoking status.  Of those individuals with a reported smoking status, 57% were 
current/former smokers and 43% were nonsmokers.  Smoking history was unknown for 3,026 
(26%) individuals. 
In Easthampton, 22 out of 34 individuals diagnosed with pancreatic cancer during the years 
1982–2000 reported a smoking status.  Of those 22 individuals with a reported smoking status, 
36% (n = 8) were current/former smokers and 64% (n = 14) were nonsmokers.  Smoking history 
was unknown for 12 (35%) individuals.  For the time period 1994–2000, when there was a 
statistically significant elevation townwide, 15 out of 21 individuals reported a smoking status.  
Of those 15 with a reported smoking status, 33% (n = 5) were current/former smokers and 67% 
(n = 10) were nonsmokers.  The townwide elevation from 1994 to 2000 was in part due to a 
statistically significant elevation among males in CT 8224 during that time period.  Of the nine 
males diagnosed with pancreatic cancer in CT 8224 from 1994 to 2000, six reported a smoking 
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status.  Of those six males with a smoking status, four were current/former smokers and two 
were nonsmokers.   
In Holyoke, 81 out of 99 individuals diagnosed with pancreatic cancer reported a smoking status.  
Of those 81 individuals with a reported smoking status, 48% (n = 39) were current/former 
smokers and 52% (n = 42) were nonsmokers.  Smoking history was unknown for 18 (18%) 
individuals.  In CT 8121, where there was a statistically significant elevation among females 
from 1988 to 1993, 10 out of 12 females diagnosed with pancreatic cancer reported a smoking 
status.  Of those 10 individuals with a reported smoking status, 50% (n = 5) were current/former 
smokers and 50% (n = 5) were nonsmokers.     
Of the seven individuals diagnosed with pancreatic cancer in Southampton, six reported a 
smoking status.  Of those six individuals with a reported smoking status, two were 
current/former smokers and four were nonsmokers.   
In Westfield, 49 out of 66 individuals diagnosed with pancreatic cancer reported a smoking 
status.  Of those 49 individuals with a reported smoking status, 53% (n = 26) were current/former 
smokers and 47% (n = 23) were nonsmokers.  Smoking history was unknown for 17 (26%) 
individuals. 
In summary, it is likely that smoking played a role in the development of pancreatic cancer 
among some residents of Easthampton, Holyoke, Southampton, and Westfield.  
c)  Occupation 
Review of occupational information for individuals diagnosed with pancreatic cancer in 
Easthampton revealed that at least two individuals might have worked at a job in which 
occupational exposures potentially related to the development of pancreatic cancer may have 
been possible.  However, information regarding specific job duties that could help to further 
define exposure potential for these individuals was not available, and occupation was reported as 
retired or unknown for 29% of individuals (n = 10).   
In Holyoke, at least 13 individuals (13%) diagnosed with pancreatic cancer might have worked a 
job in which occupational exposures potentially related to the development of pancreatic cancer 
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may have been possible.  Occupation was reported as retired or unknown for 32% of individuals 
diagnosed with pancreatic cancer (n = 32).   
In Southampton, two of the five individuals diagnosed with pancreatic cancer who reported an 
occupation might have worked a job in which occupational exposures potentially related to the 
development of pancreatic cancer may have been possible.  Occupation was reported as retired 
or unknown for two of the seven individuals diagnosed with pancreatic cancer.   
In Westfield, at least seven individuals (11%) diagnosed with pancreatic cancer might have 
worked a job in which occupational exposures potentially related to the development of 
pancreatic cancer may have been possible.  Occupation was reported as retired or unknown for 
38% of individuals diagnosed with pancreatic cancer (n = 25).   
D. Analysis of Geographic Distribution of Cancer Incidence 
In addition to determining incidence rates for each cancer type, a qualitative evaluation of the 
geographic pattern of the residences of individuals diagnosed with the eight cancer types from 
1982 to the present was conducted, particularly as the geographic distribution relates to areas of 
environmental concern.  In particular, the analysis focused on the geographic distribution of 
individuals living in the Plains area of Easthampton, where residents likely received most of their 
drinking water from the Hendrick Street Wellfield and Pines Well, and individuals diagnosed 
within the potential extent of TCE-contaminated groundwater.  The inclusion of individuals 
living within the potential extent of TCE-contaminated groundwater is very conservative and 
may include individuals who did not consume TCE-contaminated drinking water.  In addition to 
the aforementioned individuals, residents who were diagnosed with one of the eight cancer types 
from 2001 to the present and lived in the Plains area of Easthampton or within the potential 
extent of TCE-contaminated groundwater were included in the qualitative evaluation of 
geographic distribution.   
Place of residence at the time of diagnosis was mapped for each individual diagnosed with one of 
the eight cancer types in order to assess any possible geographic concentrations of diagnoses in 
relation to each other or in relation to opportunities for TCE exposure or other potential locations 
of environmental concern (i.e., MassDEP 21E hazardous material and oil releases) located in 
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Easthampton, Holyoke, Southampton, or Westfield.  As previously mentioned, cancer is one 
word that describes many different diseases.  Therefore, for the purposes of this evaluation, the 
geographic distribution of each cancer type was evaluated separately to determine whether an 
atypical pattern of any one type was occurring.  The geographic distributions of some specific 
types of cancer were also evaluated together because they may have similar etiologies (e.g., 
leukemia and NHL in children).   
Based on a review of address at the time of diagnosis for each individual diagnosed with one of 
the eight cancer types, no apparent concentrations of cancer diagnoses (of any type) were 
observed in any one area of Easthampton, Holyoke, Southampton, or Westfield that were not 
associated with areas of higher population density.  For example, many of the males residing in 
Easthampton CT 8223 who were diagnosed with NHL from 1994 to 2000, when there was a 
statistically significant elevation, lived in a densely populated area.  Further evaluation revealed 
that these individuals were diagnosed with histological types of NHL that are consistent with the 
distribution of histologies observed statewide (i.e., most of these males were diagnosed with the 
most common type of NHL diagnosed in the state).  Also, the age distribution of the individuals 
was consistent with the statewide age distribution.   
The geographic distribution was reviewed for all statistically significant elevations in the four 
communities.  To summarize, the statistically significant elevations observed in the four 
communities were as follows:  
 bladder cancer among males in Southampton from 1982 to 2000, 
 bladder cancer among males and females combined and males alone in 
Southampton from 1988 to 1993, 
 bladder cancer among males and females in Westfield CT 8125 from 1982 to 
2000, 
 Hodgkin’s disease among females in Westfield CT 8125 from 1982 to 2000, 
 leukemia among males and females combined and females alone in Holyoke from 
1988 to 1993, 
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 leukemia among males in Holyoke CT 8121 from 1994 to 2000, 
 NHL among males in Easthampton CT 8223 from 1994 to 2000, 
 NHL among males and females combined and females alone in Westfield from 
1982 to 2000, 
 pancreatic cancer among males and females combined who were diagnosed in 
Easthampton from 1994 to 2000, 
 pancreatic cancer among males in Easthampton CT 8224 from 1994 to 2000, and  
 pancreatic cancer among females in Holyoke CT 8121 from 1988 to 1993.   
There were no geographic patterns observed for any of these elevations that were not associated 
with areas of high population density.  
None of the eight cancer types were statistically significantly elevated from 1982 to 2000 in CT 
8224, which includes the Plains area in southern Easthampton.  Because of their proximity to the 
wells, Plains area residents likely received more drinking water from the Easthampton municipal 
wells that were contaminated with TCE, relative to Easthampton residents in other areas of town.  
Seven of the eight cancer types evaluated were diagnosed among Plains area residents.  Of the 
six cancer types that have possible associations with TCE exposure based on the scientific 
literature, there were three diagnoses of bladder cancer, two diagnoses of Hodgkin’s disease, four 
diagnoses of kidney cancer, six diagnoses of leukemia, no diagnoses of liver cancer, and six 
diagnoses of NHL in the Plains area.  No apparent geographic concentrations of individuals 
diagnosed with any of the eight cancer types from 1982 to the present were noted in the Plains 
area.   
No apparent geographic concentrations of individuals diagnosed with any of the eight cancer 
types from 1982 to the present were noted in the areas of Holyoke, Southampton, and Westfield 
that are within the potential extent of TCE-contaminated groundwater.  Most individuals in this 
area who were diagnosed with one of the cancer types were located where population density is 
greatest.  In addition, no unusual geographic patterns were noted in the Dupuis Road 
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neighborhood of Holyoke, where the community expressed concerns that residents in the 1950s 
were exposed to the combustion products of PCBs when wastes were burned at a Dupuis Road 
property.   
No other unusual spatial patterns or concentrations of cases at the neighborhood level that would 
suggest a common factor (environmental or non-environmental) related to cancer diagnoses 
among residents was apparent for any of the eight cancer types evaluated.  Any patterns that 
were observed appeared to be consistent with what would be expected based on the population 
distribution and areas of higher population density.  For example, in each of the four 
communities, the majority of individuals diagnosed with each type of cancer tended to be located 
in areas of the town where population and housing density are greatest.   
Information about which Holyoke, Southampton, and Westfield residences within the potential 
extent of TCE-contaminated groundwater had private wells and which residences were supplied 
with municipal water (both TCE-impacted and those not impacted by environmental 
contaminants) was obtained from the MassDEP and local water departments.  This information 
was compared with available residential history information for the individuals who were 
diagnosed with one of the eight cancer types between 1982 and 2000 in order to determine how 
long the individuals lived at their residence prior to diagnosis.  Information for residential 
histories was obtained from annual resident lists for Holyoke (City of Holyoke 1970–1998) and 
Westfield (City of Westfield 1970–1998) and from the Hampden County and Hampshire County 
registries of deeds (Office of the Secretary of the Commonwealth 2005).  Residential histories 
were constructed for each individual who lived within the potential extent of TCE-contaminated 
groundwater at the time of diagnosis.  Residential histories were also constructed for individuals 
diagnosed while living in the Plains area of southern Easthampton where residents received more 
municipal water from the Hendrick Street Wellfield and Pines Well relative to other 
Easthampton residents.  Although it is not possible to determine what may have caused any one 
person’s diagnosis with cancer, the length of time in which an individual lived in a particular 
residence can help determine the importance that their location might have in terms of exposure 
to a potential environmental source.  The residential history information is discussed in Section 
VIII along with information about the various sources of drinking water for residences within the 
potential extent of TCE-contaminated groundwater.  Available risk factor information for those 
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individuals who were diagnosed with one of the eight cancer types is also included in the 
analysis.   
VIII. DISCUSSION 
This public health assessment provides a review of possible environmental exposures related to 
TCE in the Barnes Aquifer and an evaluation of cancer incidence in Easthampton, Holyoke, 
Southampton, and Westfield in western Massachusetts.  In the 1950s, TCE wastes were released 
at two Holyoke residential properties and the former Southampton Sanitary Engineering in 
Southampton.  PCB wastes were also released at the two residential properties in Holyoke.  The 
MassDEP believes that the wastes originated from the former General Electric facility on 
Jackson Street in Holyoke.  TCE contamination now extends approximately 4.5 miles through 
the Barnes Aquifer from the source properties north to municipal wells in Easthampton.  This 
evaluation was initiated based on community concerns about possible environmental exposure in 
relation to TCE contamination in public and private drinking water wells whose source is the 
Barnes Aquifer and community concerns about cancer.  Community concerns also included 
possible exposures to PCBs in soil, PCBs and benzene in drinking water, and dioxins in air.  
The MDPH evaluated cancer incidence data for Easthampton, Holyoke, Southampton, and 
Westfield and for the census tracts within those communities where some residents were at risk 
of exposure to TCE-contaminated drinking water from the Barnes Aquifer.  Available 
environmental information was reviewed for Barnes Aquifer drinking water and the source 
properties to determine possible pathways of exposure for residents.  In addition, the geographic 
pattern of cancer diagnoses was evaluated at the neighborhood level to identify any unusual 
concentrations of diagnoses, with a particular focus on neighborhoods where residents were at 
risk of exposure to TCE. 
There are completed exposure pathways that occurred in the past related to TCE contamination 
in the Barnes Aquifer.  Exposure to TCE in municipal drinking water from the Hendrick Street 
Wellfield and Pines Well in the past probably occurred for many Easthampton residents from the 
early 1980s to about 1997.  A potential exposure pathway could have occurred from as early as 
the 1960s to the 1980s.  For about 600 residents in western Holyoke who were supplied with 
drinking water from the Pequot Well, there is a potential exposure pathway from 1974 to 1980 
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and a completed exposure pathway from 1980 to 1987.  However, upon considering conservative 
exposure doses for both of these scenarios, adverse health effects or unusually increased cancer 
risk due to exposure to past contamination in municipal drinking water seemed unlikely.  Present 
and future exposure pathways related to TCE in municipal drinking water were eliminated 
because Holyoke Water Works closed the Pequot Well in 1987 and Easthampton installed a 
water treatment plant in 1997.   
Past exposure to TCE in private well water from the contaminated section of the Barnes Aquifer 
occurred for some residents of Holyoke and Southampton (TCE was not detected above the 
drinking water comparison value in private wells in Easthampton and Westfield).  The majority 
of residents with TCE-contaminated private wells are no longer being exposed because they 
accepted bottled water and whole house carbon filters or connected their households to a 
municipal water supply not impacted by environmental contaminants.  However, since a filter 
requires maintenance, there is the potential for present or future exposures if residents do not 
properly maintain them or if they use unfiltered water.  There also exists a potential exposure 
pathway for a small number of residents who declined to have their private wells tested. 
The maximum TCE concentration (34.2 ppb) detected in any drinking water sample (since 1980 
in municipal wells and since 1997 in private wells) was from a private well in Southampton.  
However, based on the contaminant levels detected, the frequency and duration of contact 
assumed, and a review of the scientific literature, it is unlikely that exposures to TCE in Barnes 
Aquifer drinking water resulted in adverse health effects.  
Past exposures to PCBs in surface soil may have been possible for children who lived at two 
Holyoke residential properties where wastes were released and who may have played in surface 
soil there.  However, upon considering conservative exposure dose scenarios, adverse health 
effects or unusually increased cancer risk due to past exposure to PCBs were unlikely.  Since 
PCB-contaminated soil was removed from the two residential properties and replaced with clean 
soil, in addition to the placement of Activity and Use Limitation (AUL) deed restrictions on the 
properties, present and future exposures to PCBs in soil were eliminated as exposure pathways.   
Community members expressed concerns that PCBs and benzene might have migrated via 
groundwater to drinking water wells in the same way that TCE migrated via groundwater to 
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drinking water wells.  Because PCBs and benzene have not been demonstrated to have migrated 
from the source properties via groundwater, exposures to PCBs or benzene in drinking water 
were eliminated as past, present, and future exposure pathways for residents.   
Residents also expressed concerns that individuals living at or near the Dupuis Road property in 
Holyoke in the 1950s were exposed to the combustion products of PCBs in smoke when wastes 
were reportedly burned.  However, air monitoring data were not available for that time.  Also, 
surface soil data were not available for PCB combustion products that could have been deposited 
at neighboring properties from ambient air, which could help to evaluate potential past exposure 
opportunities.  Because no environmental data were available, the likelihood of adverse health 
effects that might result from potential past inhalation exposure to PCB combustion products in 
ambient air could not be evaluated quantitatively.  Instead, the pattern of cancer was evaluated 
for the Dupuis Road neighborhood, and no unusual geographic patterns or concentrations of 
diagnoses were noted.  
Cancer in general has a long period of development or latency period (i.e., the interval between 
first exposure to a disease-causing agent and the appearance of symptoms of the disease [Last 
1995]).  In particular, solid tumors such as bladder, kidney, and liver cancer generally have a 
long latency period that ranges from at least 10 to 20 years and may be as long as 50 years (Levy 
and Wegman 1995).  Because the TCE waste released in Holyoke and Southampton could have 
reached groundwater and affected private wells as early as the 1950s, the community has 
expressed concern that Massachusetts Cancer Registry (MCR) data are not available prior to 
1982, when the MCR first began collecting cancer diagnoses data.  Although earlier data are not 
available, it is still useful to analyze cancer incidence data from 1982 to 2000 due to the long 
latency periods of some of the cancer types evaluated.  In addition, if exposure to TCE resulted 
in a trend in cancer incidence prior to 1982 and TCE exposure continued into more recent years, 
one would expect to observe a trend in the years following 1982.   
Using data from the MCR, the MDPH evaluated the incidence of eight cancer types that were 
selected based on a potential association with TCE and residents’ concerns about particular 
cancer types.  Five census tracts were chosen for evaluation because they include residents who 
were at risk of exposure to TCE in Barnes Aquifer drinking water.  It is important to note that 
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while most residents of Easthampton CT 8223 and CT 8224 were at times at risk of exposure to 
TCE from the Barnes Aquifer prior to 1997, most residents of Holyoke CT 8121, Southampton 
CT 8225, and Westfield CT 8125 were not at risk of exposure (i.e., estimates show that about 
1,900 of the 26,416 residents of the three latter census tracts were at risk of exposure to TCE in 
drinking water from the Barnes Aquifer).   
The time period of the cancer incidence analysis, 1982 to 2000, includes the most recent and 
complete cancer incidence data available from the MCR at the time of this evaluation.  No 
consistent trends in elevations were observed for the eight cancer types evaluated from 1982 to 
2000 for Easthampton, Holyoke, Southampton, and Westfield and for the census tracts where 
some residents were at risk of exposure to TCE in drinking water.  A detailed discussion of some 
cancer types that were statistically significantly elevated in census tracts where some residents 
were at risk of exposure to TCE in Barnes Aquifer drinking water follows.   
From 1994 to 2000, NHL among males in Easthampton CT 8223 was statistically significantly 
elevated (10 diagnoses observed versus 4.3 expected) and pancreatic cancer among females in 
the same census tract was borderline statistically significantly elevated (7 observed vs. 2.8 
expected) (Table 9d).  The geographic pattern of males diagnosed with NHL and females 
diagnosed with pancreatic cancer during this time period closely matched areas of population 
density.  Males diagnosed with NHL had a variety of histological types, which was consistent 
with the distribution of histologies observed statewide.  The average age at the time of diagnosis 
for the males diagnosed with NHL and the women diagnosed with pancreatic cancer was 
consistent with statewide trends.  During the two earlier time periods evaluated (1982–1987 and 
1988–1993), NHL among males and pancreatic cancer among females in CT 8223 occurred 
about as expected or less than expected.   
From 1994 to 2000, pancreatic cancer among males in Easthampton CT 8224 was statistically 
significantly elevated (9 diagnoses observed versus 3.7 expected) (Table 10d).  Based on a 
review of available risk factor information, smoking may have played a role in some individuals’ 
diagnoses.  Easthampton CT 8224 includes the Plains area where residents, because of their 
proximity to contaminated municipal wells and the way Easthampton municipal water is 
distributed, likely received more water from the Hendrick Street Wellfield and Pines Well 
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relative to the rest of Easthampton.  Three of the nine males diagnosed during this time period 
lived in the Plains area.   One of the three individuals likely lived in the area less than 5 years 
prior to diagnosis; therefore, their diagnosis was not likely related to place of residence.  Of the 
two remaining males, one was a current/former smoker, which is the most important risk factor 
for pancreatic cancer.  During the two earlier time periods evaluated (1982–1987 and 1988–
1993), pancreatic cancer among males in CT 8224 occurred less than expected and about as 
expected, respectively.   
A statistically significant elevation in leukemia diagnoses among males occurred in Holyoke CT 
8121 from 1994 to 2000 (14 diagnoses observed versus 7.4 expected) (Table 12d).  Based on the 
location of their residences at the time of diagnosis, none of the 14 individuals were at risk of 
exposure to TCE in Barnes Aquifer drinking water from the Pequot Well, Coronet Homes Well, 
or private wells.  The geographic distribution of leukemia diagnoses corresponded to the 
distribution of population in this census tract.  A variety of leukemia histologies were diagnosed 
among the males, and the average age at diagnosis was 67 years old.  During the two earlier time 
periods evaluated (1982–1987 and 1988–1993), leukemia among males occurred about as 
expected and less than expected.   
Among females in Holyoke CT 8121, a statistically significant elevation for pancreatic cancer 
was observed from 1988 to 1993 (12 diagnoses observed versus 6.2 expected) (Table 12c).  The 
average age at diagnosis was consistent with statewide trends, and five of the 10 women with a 
known smoking history were current/former smokers.  The geographic distribution of residences 
of women diagnosed with pancreatic cancer during this time period corresponded to the 
distribution of the overall population.  Of the 12 females, 11 were not at risk of exposure to TCE 
from the Barnes Aquifer, based on the location of their residences at the time of diagnosis.  It is 
unknown whether the remaining individual, who resided within the potential extent of TCE-
contaminated groundwater, could have been exposed to TCE.  In CT 8121 during the other two 
time periods (1982–1987 and 1994–2000), about one or two more cases of pancreatic cancer 
among women in CT 8121 were observed over the expected number, but neither elevation was 
statistically significant.   
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Bladder cancer among Southampton males was statistically significantly elevated during the 
1982–2000 time period, with the overall elevation attributed to elevations during the two earliest 
time periods (6 diagnoses observed versus 2.8 expected during 1982–1987, and 8 diagnoses 
observed versus 3.0 expected during 1988–1993, the latter of which was statistically significant) 
(Tables 13b–13c).  Bladder cancer occurred slightly less often than expected among males from 
1994 to 2000 (3 diagnoses observed versus 3.8 expected) (Table 13d).  Overall, among the 14 
individuals diagnosed with bladder cancer during the two earliest time periods, eight reported a 
smoking history, and six of these eight were current or former smokers.  The geographic 
distribution of bladder cancer among males in Southampton was generally consistent with 
population density.  Ten of the 14 males diagnosed from 1982 to 1993 were not at risk of 
exposure to TCE from the Barnes Aquifer, based on the location of their residences at the time of 
diagnosis.  It is unknown whether three of the males, who resided at the time of diagnosis within 
the potential extent of TCE-contaminated groundwater, could have been exposed.  The 
remaining individual could have been exposed to TCE; therefore, if exposure did occur, it could 
have played a role in the development of bladder cancer.  Two of the four remaining males 
reported smoking history information and were both current/former smokers.  The average age at 
diagnosis of the four males was 73 years old, which is consistent with statewide trends.  Two of 
the males were likely long-term residents (15+ years), and residential histories were unknown for 
the other two males.   
In Westfield CT 8125, bladder cancer was statistically significantly elevated among males and 
females from 1982 to 2000 (28 diagnoses observed versus 18.1 expected) (Table 15a).  The 
elevation was largely due to elevations among males for each of the three smaller time periods, 
when two to four more males than expected were diagnosed with bladder cancer (Tables 15b–
15d).  None of the elevations among males were statistically significant.  Of the 22 males 
diagnosed from 1982 to 2000 with bladder cancer in CT 8125, 21 were not at risk of exposure to 
TCE from the Barnes Aquifer, based on the location of their residences at the time of diagnosis.  
Most of the males resided in the southern part of the census tract, where population and housing 
density are greatest.  It is unknown whether the remaining individual, who resided within the 
potential extent of TCE-contaminated groundwater, may have been exposed to TCE from Barnes 
Aquifer drinking water.  According to a review of available risk factor information, this 
individual reported being a current/former smoker.  Therefore, smoking may have played a role 
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in the development of bladder cancer for this individual.  Among the 22 males in CT 8125 who 
were diagnosed with bladder cancer from 1982 to 2000, 17 had a known smoking history, and 14 
of the 17 reported being current/former smokers.  Therefore, information on bladder cancer in 
this census tract is consistent with patterns seen elsewhere in the state and in the scientific 
literature. 
Hodgkin’s disease among females in Westfield CT 8125 was statistically significantly elevated 
from 1982 to 2000 (6 diagnoses observed versus 2.1 expected) (Table 15a).  The diagnoses were 
fairly evenly distributed through time, with three, one, and two diagnoses occurring in the first, 
middle, and most recent time periods, respectively (Tables 15b–15d).  Most of the individuals 
lived in the densely populated southern area of the census tract and none were at risk of exposure 
to TCE from the Barnes Aquifer, based on the location of their residences at the time of 
diagnosis.  According to a review of available risk factor information, the individuals were 
diagnosed with Hodgkin’s disease between the ages of 12 and 33, which is consistent with the 
peak in diagnoses that typically occurs among young adults.   
In studies of community exposure to TCE in drinking water, the strongest support for increased 
cancer incidence is for leukemia (Wartenberg et al. 2000).  For the town of Easthampton, where 
most residents were likely at risk of some exposure to TCE-contaminated municipal water in the 
past, there were fewer diagnoses of leukemia than expected from 1982 to 2000, based on the 
state rate of leukemia.  Leukemia diagnoses in CT 8223 occurred less often than expected during 
all time periods.  In CT 8224, which includes the Plains area that received more municipal water 
from TCE-contaminated wells relative to unaffected municipal wells, there was about one 
additional leukemia diagnosis above the expected number from 1982 to 2000.  Leukemia was 
diagnosed at about the expected rate in CT 8224 for each smaller time period.  Therefore, 
although many individuals in Easthampton could have been exposed to some level of TCE in 
municipal drinking water, it does not appear that exposures were of sufficient concentration or 
duration to result in elevated leukemia diagnoses.  In addition, none of the approximately 1,000 
Holyoke residents who lived at a residence supplied by the Pequot Well or Coronet Homes Well, 
municipal wells that were contaminated with TCE, were diagnosed with leukemia from 1982 to 
the present.   
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In summary, analysis of the geographic distribution of residences of individuals diagnosed with 
cancer, available risk factor information, and residential history information did not reveal any 
atypical patterns that would suggest that a common factor is related to the incidence of cancer in 
Easthampton, Holyoke, Southampton, Westfield, or in the census tracts of concern.  That is, no 
unusual concentrations of individuals diagnosed with the eight cancer types evaluated were 
observed among the populations at potential risk of TCE exposure or in any other areas of the 
four communities.  In general, cancer patterns observed in Easthampton, Holyoke, Southampton, 
and Westfield were similar to those seen in the general population and in Massachusetts.  Data 
reviewed suggest that smoking likely played some role in the diagnoses of certain cancers 
(bladder, esophageal, kidney, and pancreatic cancers) among some individuals.  Also, 
occupational exposures may have played a role for some individuals in the development of the 
eight cancer types.  However, it is difficult to fully assess the extent to which these factors 
influenced overall cancer patterns in the four communities due to incomplete information for 
some risk factors (e.g., occupation).   
In all, the information reviewed and analyzed for this public health assessment included available 
environmental data, cancer incidence data, available risk factor information for individuals 
diagnosed with cancer, residential history information, and a review of the relevant scientific 
literature.  Based on this information, it does not appear that a common factor (environmental or 
non-environmental) played a major role in the overall incidence of cancer in the census tracts 
where some residents were at risk of exposure to TCE from the Barnes Aquifer or in 
Easthampton, Holyoke, Southampton, or Westfield as a whole during the 19-year time period, 
1982–2000.  
IX. ATSDR CHILD HEALTH CONSIDERATIONS 
The ATSDR and MDPH recognize that the unique vulnerabilities of infants and children demand 
special emphasis in communities faced with contamination of their environment.  Children are at 
a greater risk than adults from certain kinds of exposure to hazardous substances emitted from 
waste sites.  They are more likely to be exposed because they play outdoors and because they 
often bring food into contaminated areas.  Because of their smaller stature, they might breathe 
dust, soil, and heavy vapors close to the ground.  Children are also smaller, resulting in higher 
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doses of contaminant exposure per body weight.  The developing body systems of children can 
sustain permanent damage if certain toxic exposures occur during critical growth stages.  Most 
importantly, children depend completely on adults for risk identification and management 
decisions, housing decisions, and access to medical care.   
The incidence and patterns of cancer among children in Easthampton, Holyoke, Southampton, 
and Westfield are discussed in Section VII (“Analysis of Cancer Incidence”) of this report.  As 
discussed previously, risk of exposure to TCE in municipal drinking water existed in the past for 
children in Easthampton and some children in west Holyoke prior to treatment and well closures.  
Risk of exposure to TCE in private well water also existed in the past for some children living in 
certain parts of Holyoke, Southampton, and Westfield.  At present, most children are not at risk 
of exposure to TCE in private well water because most residences have whole house filters or are 
now connected to uncontaminated municipal water.  A potential exposure pathway still exists for 
a small number of children living at residences where private well testing was refused or where 
residents use unfiltered water.   
In addition, exposure to contaminants in air and soil may have been possible in the past for 
children living at or near the Holyoke residential properties where wastes were released.  
However, it is unlikely that anyone would have had contact with soil at the properties for a 
sufficient frequency and duration of time to result in health effects.  Present and future exposures 
are not of concern because PCB-contaminated surface soils were removed and Activity and Use 
Limitation deed restrictions were placed on both properties.   
X. LIMITATIONS 
There are several limitations encountered when analyzing environmental data.  As a result, these 
limitations make it impossible to determine the role potential exposures to specific contaminants 
or to environmental media harboring those contaminants may have played in the development of 
an individual’s cancer or other health impact.  That is, due to historical and analytical data gaps 
in the environmental data, this type of evaluation cannot conclude what may have caused any 
one individual’s cancer or other illness, whether the cause is environmental, behavioral, viral, 
genetic, or a combination of these factors. 
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This public health assessment is an investigation that considers descriptive health outcome data 
for cancer to determine whether the pattern or occurrence of selected cancer types is unusual.  
The purpose of this investigation is to evaluate the patterns of cancer in a geographical context in 
relation to available information about factors, including environmental factors, related to cancer 
to see whether further investigation seems warranted.  Information from descriptive analyses, 
which may suggest that a common etiology (or cause) is possible, can serve to identify areas 
where further public health actions may be warranted.  Inherent limitations in this type of 
analysis and the available data make it impossible to determine the precise causal relationships or 
synergistic roles that may have played a part in the development of individual cancers in these 
communities.  Also, this type of analysis cannot determine what may have caused any one 
individual’s cancer.  Cancers in general have a variety of risk factors known or suggested to be 
related to the etiology (cause) of the disease that could not be evaluated in this report.  For 
example, it is believed that many cancers are related largely to behavioral factors such as 
cigarette smoking, diet, and alcohol consumption.  Other factors associated with cancer are 
socioeconomic status, heredity/genetics, race, and geography.  It is beyond the scope of this 
report to determine the causal relationship of these factors and the development of cancer or 
other health outcomes in Easthampton, Holyoke, Southampton, and Westfield.  
XI. CONCLUSIONS 
 In the past, Easthampton residents and some western Holyoke residents were at risk of 
exposure to TCE in municipal drinking water from the Barnes Aquifer.  Some residents 
of western Holyoke and eastern Southampton were at risk of exposure to TCE in Barnes 
Aquifer drinking water from private wells.  Based on the contaminant levels detected 
since 1980 in municipal wells and since 1997 in private wells, the frequency and duration 
of contact assumed, and a review of the scientific literature, it is unlikely that exposures 
resulted in adverse health effects.   
 Holyoke and Southampton residents with TCE-contaminated private well water are not at 
risk of exposure if they properly maintain whole house charcoal filters or connected their 
households to unaffected municipal water.  However, a potential exposure pathway could 
remain if residents do not properly maintain their filters or use unfiltered water.     
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 Children who may have played in surface soil at two Holyoke residential properties may 
have been at risk of exposure to PCBs; however, based on the levels detected and the 
frequency and duration of contact assumed, it is unlikely that potential exposures could 
have resulted in adverse health effects.  The contaminated soils have since been removed.   
 Potential exposures to PCBs in private well water were ruled out because PCBs have not 
been demonstrated to have migrated via groundwater from the release properties.     
 No consistent trends in elevations were observed from 1982 to 2000 for any of the eight 
cancer types [Hodgkin’s disease, leukemia, non-Hodgkin’s lymphoma (NHL), and 
cancers of the bladder, esophagus, kidney, liver, and pancreas] in Easthampton, Holyoke, 
Southampton, Westfield, or the census tracts where some residents were at risk of 
exposure to TCE in drinking water from the Barnes Aquifer.   
 In Easthampton CT 8223, NHL among males was statistically significantly elevated from 
1994 to 2000.  The histological types of NHL were consistent with the statewide 
distribution, and no unusual geographic concentrations of diagnoses were observed.  
There was a statistically significant elevation in pancreatic cancer among males and 
females townwide and males in Easthampton CT 8224 from 1994 to 2000.  Based on 
available risk factor information, smoking may have played a role in some individuals’ 
diagnoses.   
 In Holyoke CT 8121, males were diagnosed with leukemia statistically significantly more 
often than expected from 1994 to 2000.  Based on the location of their residences at the 
time of diagnosis, none of the 14 males were at risk of exposure to TCE in Barnes 
Aquifer drinking water.  Pancreatic cancer was statistically significantly elevated for 
females from 1988 to 1993.  Eleven of the 12 females were not at risk of exposure to 
TCE from the Barnes Aquifer, based on their residences.  It is unknown whether the 
remaining individual could have been exposed to TCE.   
 In Southampton, a statistically significant elevation in bladder cancer among males from 
1982 to 2000 was attributed to elevations during two time periods, 1982–1987 and 1988–
1993.  Ten of the 14 males diagnosed from 1982 to 1993 were not at risk of exposure to 
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TCE from the Barnes Aquifer, based on the location of their residences.  It is unknown 
whether three of the males could have been exposed.  The remaining individual could 
have been exposed to TCE; therefore, if exposure did occur, it could have played a role in 
the development of bladder cancer.  Based on available risk factor information, it is likely 
that smoking played a role in the development of bladder cancer among some males. 
 In Westfield CT 8125, a statistically significantly elevation in bladder cancer for males 
and females from 1982 to 2000 was due to elevations among males during the three 
smaller time periods.  Of the 22 males diagnosed, 21 were not at risk of exposure to TCE 
from the Barnes Aquifer, based on the locations of their residences.  It is unknown 
whether the remaining individual could have been exposed; however, based on available 
risk factor information, it is likely that smoking played a role in the individual’s 
diagnosis.  Based on their residences, none of the six females diagnosed with Hodgkin’s 
disease, which was statistically significantly elevated from 1982 to 2000, were at risk of 
exposure to TCE from the Barnes Aquifer.   
 A review of the geographic distribution of residences of individuals diagnosed with any 
of the eight cancer types in Easthampton, Holyoke, Southampton, and Westfield revealed 
no apparent spatial patterns at the neighborhood level.  Further, no unusual 
concentrations of individuals diagnosed with cancer were observed among residents 
potentially exposed to TCE or in any other area of the four communities.   
 Residents living in the Dupuis Road neighborhood in Holyoke could have been exposed 
to air contaminants when PCB wastes were reportedly burned at a property there.  
Because no environmental data were available for that time, it was not possible to 
quantitatively evaluate the potential for adverse health effects.  However, a qualitative 
review of cancer diagnoses in the Dupuis Road neighborhood revealed no unusual pattern 
or concentration of diagnoses. 
 Based on the information reviewed in this evaluation, it does not appear that a common 
factor (environmental or non-environmental) played a major role in the overall incidence 
of cancer in the census tracts where some residents were at risk of exposure to TCE from 
the Barnes Aquifer or in the communities of Easthampton, Holyoke, Southampton, and 
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Westfield as a whole during the 19-year time period, 1982–2000.  Information reviewed 
included available environmental data, risk factor information for individuals diagnosed 
with cancer, residential history information, and a review of the relevant scientific 
literature. 
The ATSDR requires that one of five conclusion categories be used to summarize findings of 
a public health assessment.  These categories are as follows: (1) Urgent Public Health 
Hazard; (2) Public Health Hazard; (3) Indeterminate Public Health Hazard; (4) No Apparent 
Public Health Hazard; (5) No Public Health Hazard.  A category is selected from site-specific 
conditions such as the degree of public health hazard based on the presence and duration of 
human exposure, contaminant concentration, the nature of toxic effects associated with site-
related contaminants, presence of physical hazards, and community health concerns.  
Therefore, based on the MDPH evaluation of the available environmental data, the exposure 
pathway analysis, and risk factor information related to the cancer types evaluated in this 
analysis, the ATSDR would classify the TCE-contaminated section of the Barnes Aquifer as 
posing an indeterminate public health hazard in the past due to incomplete historical 
sampling data for private wells prior to 1997.  Most exposure opportunities have been 
eliminated through municipal water treatment and well closures, connections to municipal 
water not impacted by contaminants, and whole house charcoal filters; however, for some 
residents with private wells (i.e., residents of a few households that declined testing,  
residents who might not properly maintain their filters, and residents who use unfiltered 
water), the ATSDR would classify the contaminated section of the Barnes Aquifer as posing 
an indeterminate public health hazard at present and in the future.  
XII. RECOMMENDATIONS 
1. Holyoke, Southampton, and Westfield residents who continue to use private wells 
without whole house carbon filters in the vicinity of the contaminated section of the 
Barnes Aquifer, including the small number of Easthampton residents on Fort Hill Road 
that use private wells, should test their wells to ensure that TCE levels remain below the 
U.S. EPA Maximum Contaminant Level (MCL) of 5 ppb.  
 88 
2. If TCE is detected in a private well above the U.S. EPA MCL of 5 ppb, residents should 
properly maintain a whole house carbon filter or connect to municipal water, if possible.  
The MDPH supports the City of Holyoke and the Town of Southampton exploring the 
feasibility of connecting remaining Holyoke homes with TCE-contaminated private wells 
to municipal water.   
3. The Easthampton Board of Health requires private well testing at the time of property 
transfer for all residences with private wells and for newly constructed wells.  The 
MDPH recommends that the City of Holyoke and the Town of Southampton consider a 
similar requirement and/or notification of the existence of a whole house charcoal filter at 
the time of property transfer for residences in the vicinity of the contaminated section of 
the Barnes Aquifer.  The MDPH is available to offer guidance to help determine the 
geographic boundaries of such a requirement.    
4. The MDPH recommends that Holyoke and Southampton evaluate the feasibility of a 
testing and approval process for new private well construction in the vicinity of the TCE-
contaminated section of the Barnes aquifer.  The MDPH is available to offer guidance to 
help determine the geographic boundaries of such a requirement.    
5. In order to address a data gap regarding potential past exposure for residents to air 
contaminants during the reported burning of PCB wastes, the MDPH recommends that 
the MassDEP continue its efforts toward identifying Potentially Responsible Party(s) that 
could conduct or oversee surface soil sampling and analysis for the combustion products 
of PCBs (i.e., chlorinated dibenzodioxins and chlorodibenzofurans) at residential 
properties neighboring the Dupuis Road property in Holyoke where burning occurred.  
The MDPH recommends that sampling be conducted in areas where further study 
suggests that contaminants in ambient air might have been deposited.  The MDPH is 
available to review and comment on any sampling protocol developed for this effort.   
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XIII. PUBLIC HEALTH ACTION PLAN 
The Public Health Action Plan for Easthampton, Holyoke, Southampton, and Westfield, 
Massachusetts, contains recommendations for actions to be taken in the vicinity of the Barnes 
Aquifer.  The purpose of the Public Health Action Plan is to ensure that this health assessment 
not only identifies potential public health hazards, but also provides a plan of action designed to 
mitigate and prevent adverse human health effects resulting from exposure to hazardous 
substances in the environment.  Included is a commitment on the part of the ATSDR and MDPH 
to follow up on this plan to ensure that it is implemented.  The public health actions to be 
implemented by the ATSDR and MDPH are as follows: 
 Upon request, the MDPH will review new environmental data related to Barnes Aquifer 
TCE contamination as it becomes available and will work with other environmental 
agencies to identify and fill in data gaps.   
 If requested, the MDPH will review and comment on any proposed plan for assessing the 
presence of PCB combustion products in surface soil at residential properties neighboring 
the Dupuis Road residence where PCB wastes were reportedly burned in the 1950s.  If 
new soil sampling data are generated, the MDPH will further characterize opportunities 
for exposure upon request.  
 The MDPH/BEH will continue to monitor the incidence of all cancer types in the 
communities of Easthampton, Holyoke, Southampton, and Westfield through city/town 
cancer incidence reports published by the Massachusetts Cancer Registry. 
The ATSDR and MDPH will evaluate and expand the Public Health Action Plan when needed.  
New environmental, toxicological, or health outcome data may determine the need for additional 
actions related to the Barnes Aquifer. 
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Alan W. Yarbrough, M.S. 
Team Lead, CAPEB, DHAC  
Agency for Toxic Substances & Disease Registry 
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MAPPED/NOT 
MAPPED RTN LOCATION AID SITE NAME ADDRESS TOWN  DATE MATERIALS SOURCES
CURRENT 
STATUS
Mapped 1-0000064 GASSTATION EASTHAMPTON EXXON 32 UNION ST EH 1/12/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST DEPNFA
Mapped 1-0000065 MUNICIPAL
EASTHAMPTON LANDFILL 
TOWN OF OLIVER ST EH 1/15/1987 WASTE OIL
LANDFILL, 
UNCONTAIN ADQREG
Not Mapped 1-0000066 EASTHAMPTON LANDFILL LOUDVILLE RD EH 1/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE ADQREG
Mapped 1-0000067 FERRY STREET SITE FERRY ST EH 1/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE DEPNFA
Mapped 1-0000068 COMMERCIAL MAGNAT CO ONEIL ST EH 10/24/1985 UNKNOWN CHEMICAL OF UNKNOWN TYPE SEPTIC TANK WCSPRM
Mapped 1-0000296
INDUSTRIAL, 
MANUFACT NATIONAL FELT CO MECHANIC ST EH 8/14/1987 OIL UST RAO
Mapped 1-0000415 STANLEY HOME PRODUCTS 116 PLEASANT ST EH 7/15/1989 PETROLEUM BASED OIL RAO
Mapped 1-0000504 INDUSTRIAL STONINGTON CORP. 45 FERRY ST EH 10/15/1988 PETROLEUM BASED OIL UST RAO
Mapped 1-0000512 KELLOGG BRUSH ARTHUR ARTHUR ST EH 8/1/1988 UNKNOWN CHEMICAL OF UNKNOWN TYPE PENNFA
Mapped 1-0000513 INDUSTRIAL
KELLOG BRUSH 
MANUFACTURING 122 PLEASANT ST EH 10/15/1988 UNKNOWN CHEMICAL OF TYPE - OIL RAO
Mapped 1-0000514
PLEASANT STREET 
PROPERTY 13-15 PLEASANT ST EH 10/15/1988 UNKNOWN CHEMICAL OF UNKNOWN TYPE PENNFA
Mapped 1-0000608
GASSTATION, 
WETLANDS INLAND CITGO STATION 101-109 PLEASANT ST EH 4/15/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST REMOPS
Not Mapped 1-0000639 MUNICIPAL
PROPERTY OFF HENDRICKS 
ST OFF HENDRICKS ST EH 7/15/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE TIER1A
Mapped 1-0000674 COGASPLANT
EASTHAMPTON AREA WORK 
CENTER 19 LIBERTY ST EH 1/15/1990 UNKNOWN CHEMICAL OF UNKNOWN TYPE TIER1C
Mapped 1-0000689 MANUFACT CATALYTIC PAINT CO ARTHUR ST EH 1/10/1991 UNKNOWN CHEMICAL OF TYPE - OIL UNKNOWN RAO
Mapped 1-0000723 WWTP SLUDGE LAGOON FERRY ST EH 1/15/1990 UNKNOWN CHEMICAL OF UNKNOWN TYPE LSPNFA
Mapped 1-0000728 INDUSTRIAL FMR J P STEVENS 27 PAYSON AVE EH 1/15/1990 WASTE OIL LAGOON RAO
Mapped 1-0000776 GASSTATION COTTAGE STREET MOTORS 47 COTTAGE ST EH 3/12/1990 PETROLEUM BASED OIL UST RAO
Mapped 1-0001020
FORMER, 
GASSTATION
HAMPSHIRE CHRYSLER 
PLYMOUTH 150 NORTHAMPTON ST EH 7/15/1993 WASTE OIL UST RAO
Mapped 1-0001071 INDUSTRIAL EASTHAMPTON TIRE OUTLET 141 NORTHAMPTON ST EH 9/27/1993 WASTE OIL UST INVSUB
Mapped 1-0010035 MUNICIPAL SEWER PUMP STATION NONATUCK PARK EH 10/25/1993 DIESEL FUEL, FUEL OIL #2 UST RAO
Mapped 1-0010201 INDUSTRIAL
FREIGHT ELEVATOR INSIDE 
STANHOME INC 116 PLEASANT ST EH 2/14/1994
PETROLEUM BASED OIL (150 GAL), 
PETROLEUM BASED OIL (53 GAL) PIPE RAONR
Mapped 1-0010339 INDUSTRIAL
KELLOGG BRUSH INJECTION 
MOLDING DEPT FL 122 PLEASANT ST EH 5/16/1994
PETROLEUM BASED OIL (60 GAL), 
PETROLEUM BASED OIL (60 GAL) PIPE RAO
Mapped 1-0010464 COMMERCIAL CITGO STATION 105 PLEASANT ST EH 8/8/1994 DIESEL FUEL, GASOLINE UST REMOPS
Mapped 1-0010486 COMMERCIAL NEAR WEST ST 54 NORTHAMPTON ST EH 8/25/1994 FUEL OIL #2, FUEL OIL #2 (75 PPMV) UST RAO
Mapped 1-0010723 COMMERCIAL GASOLINE STATION 124 NORTHAMPTON ST EH 2/17/1995
GASOLINE, UNKNOWN CHEMICAL OF TYPE 
- OIL UST RAO
Mapped 1-0010866 COMMERCIAL LAZY D FARMS 283 EAST ST EH 5/12/1995
GASOLINE, PETROLEUM BASED OIL (600 
PPMV) UST RAO
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MAPPED RTN LOCATION AID SITE NAME ADDRESS TOWN  DATE MATERIALS SOURCES
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STATUS
Mapped 1-0010892 7/11 STATION 97 UNION ST EH 6/2/1995
GASOLINE (100 PPM), TOTAL PETROLEUM 
HYDROCARBONS (TPH) (100 PPMV) UST RAONR
Mapped 1-0011353 COMMERCIAL
ABANDONED FOOD & FUEL 
GAS STATION 72 UNION ST EH 5/2/1996 GASOLINE UST RAO
Not Mapped 1-0011609 ROADWAY TTU ACCIDENT PARK ST EH 11/26/1996
DIESEL FUEL (40 GAL), UNKNOWN 
CHEMICAL OF UNKNOWN TYPE VEHICLE RAO
Mapped 1-0011629 INDUSTRIAL JPS ELASTOMERICS CORP 412 MAIN ST EH 12/10/1996
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(115 LBS) RAO
Mapped 1-0011636 RESIDNTIAL NO LOCATION AID 17 BROOK ST EH 12/12/1996 FUEL OIL #2 (202 PPMV) UST RAO
Mapped 1-0011887 RESIDNTIAL NO LOCATION AID FORT HILL RD EH 6/21/1997
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(385 GAL) DRUMS RAO
Mapped 1-0012049 COMMERCIAL EASTHAMPTON BP 124 NORTHAMPTON ST EH 10/15/1997 GASOLINE (100 PPM) UST RAO
Mapped 1-0012059 INDUSTRIAL
GARAGE BEHIND NATIONAL 
NONWOVEN 150 PLEASANT ST EH 10/21/1997
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(10 GAL) DRUMS RAO
Mapped 1-0012176 STRONG CORPORATION 40 ONEIL ST EH 1/26/1998 FUEL OIL #2 RAO
Mapped 1-0012406 COMMERCIAL PRIDE STATION 60 UNION ST EH 6/18/1998 GASOLINE (25 GAL) UNKNOWN RAO
Mapped 1-0012489 RESIDNTIAL CIALEK RESIDENCE 17 GROVELAND ST EH 7/30/1998 FUEL OIL #2 (169 PPM) UST RAO
Mapped 1-0012499 MUNICIPAL TOWN LODGING 75 OLIVER ST EH 8/4/1998 FUEL OIL #2 (100 PPM) UST RAO
Mapped 1-0012881 COMMERCIAL
OCONNELL OIL SERVICE 
STATION 19 PARSONS ST EH 4/6/1999 GASOLINE (5700 PPB) UST TIER1C
Mapped 1-0013108 COMMERCIAL AJ KIENLE COAL CO 20 MECHANIC ST EH 9/15/1999 FUEL OIL #2 (150 PPMV) UST RAO
Mapped 1-0000088 ATLAS COPCO HOLYOKE INC
161 LOWER WESTFIELD 
RD HO 7/15/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE DEPNDS
Mapped 1-0000089 ATLAS COPCO HOLYOKE INC 37 APPLETON ST HO 7/15/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE DEPNDS
Mapped 1-0000090 GASSTATION BURGESS GULF 582 SOUTH ST HO 7/24/1986 UNKNOWN CHEMICAL OF UNKNOWN TYPE DEPNFA
Mapped 1-0013515 INDUSTRIAL FRM ZONOLITE PLANT WEMELCO WAY HO 6/30/2000 ASBESTOS HISTORICAL TIERII
Mapped 1-0013516 INDUSTRIAL OCTOBER COMPANY INC 51 FERRY ST HO 6/30/2000 DIESEL FUEL (55 GAL) TANKER RAO
Mapped 1-0013709 STATE OXBOW STATE BOAT RAMP ROUTE 5 HO 12/4/2000
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(26 GAL) DRUMS RAO
Mapped 1-0000091 DOWNING & DOWNING 109 WINTER ST HO 4/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE DEPNDS
Mapped 1-0000092 MANUFACT HAMPDEN PAPERS 100 WATER ST HO 4/8/1986 BENZENE, METHYL- UST DEPNFA
Mapped 1-0000093 INDUSTRIAL HOLYOKE GAS & ELETRIC CABOT ST HO 10/28/1986 PETROLEUM BASED OIL UNKNOWN RAO
Mapped 1-0000094
INTERNATIONAL PAPER CO 
FMR
161 LOWER WESTFIELD 
RD HO 1/15/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE DEPNDS
Mapped 1-0000095 GASSTATION INTERSTATE CHEVRON 181 FRANKLIN ST HO 4/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST RAO
Mapped 1-0000096 MANUFACT JAMES RIVER GRAPHICS BERKSHIRE ST HO 10/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE UNCONTAIN RAO
Mapped 1-0000097 COMMERCIAL MARCOTTE FORD SALES 1025 MAIN ST HO 7/9/1986 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST PENNFA
Mapped 1-0000098
COMMERCIAL, 
INDUSTRIAL, 
MANUFA
BASF POLYMER SYSTEMS 
FMR MOBIL 3 HANOVER ST HO 1/15/1987 PETROLEUM BASED OIL UST REMOPS
Mapped 1-0000099 REMINGTON FORMER 686 MAIN ST HO 1/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE DEPNFA
Mapped 1-0000100 GASSTATION REPUBLIC OIL 330 MAIN ST HO 4/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST REMOPS
Mapped 1-0000101 GASSTATION REPUBLIC OIL
NORTH BRIDGE ST 
CANAL ST HO 4/15/1987 UNKNOWN CHEMICAL OF TYPE - OIL UST DEPNFA
Mapped 1-0000102 SCHWARTZ 118 CABOT ST HO 4/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST TIERII
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Mapped 1-0000103 AUTOREPAIR
SHELDON TRANSFER & 
STORAGE 55 NORTH CANAL ST HO 9/17/1986 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST TIER1D
Mapped 1-0000271 COMMERCIAL PARSONS PAPER 84 SARGEANT ST HO 7/15/1987 UNKNOWN CHEMICAL OF TYPE - OIL UST RAO
Mapped 1-0000359
HOSPITAL, 
MUNICIPAL HOLYOKE HOSPITAL 575 BEECH ST HO 9/4/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST RAO
Mapped 1-0000435 INDUSTRIAL FORMER LUDLOW CORP 111 MOSHER ST HO 10/15/1988 PETROLEUM BASED OIL UST PENNFA
Mapped 1-0000474 MUNICIPAL HOLYOKE DPW 24 COMMERCIAL ST HO 5/11/1988 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST RAO
Mapped 1-0000507
CHESTNUT STREET 
PROPERTY 167 CHESTNUT ST HO 10/15/1988 UNKNOWN CHEMICAL OF UNKNOWN TYPE PENNFA
Mapped 1-0000525 SLABYS SUNOCO 220 SUFFOLK ST HO 4/15/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE RAO
Mapped 1-0000576
NORTHAMPTON STREET 
PROPERTY 1607 NORTHAMPTON ST HO 1/24/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE RAO
Mapped 1-0000614 EARLY AUTO CARE INC 636 MAIN ST HO 7/15/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE RAO
Mapped 1-0000656 INDUSTRIAL XIDEX CORP FACILITY 195 APPLETON ST HO 10/15/1989 UNKNOWN CHEMICAL OF TYPE - OIL UST RAO
Mapped 1-0000670 RESIDNTIAL LINCOLN ST PROPERTY 85 LINCOLN ST HO 1/15/1990 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST DEPNFA
Mapped 1-0000676 INDUSTRIAL CITY PAINT FACTORY 1548 NORTHAMPTON ST HO 1/15/1990 UNKNOWN CHEMICAL OF TYPE - OIL RAO
Mapped 1-0000700 GASSTATION CRABTREES MOBIL 01 JFN 1530 NORTHAMPTON ST HO 1/15/1990 UNKNOWN CHEMICAL OF UNKNOWN TYPE RAO
Mapped 1-0000701 OPENSPACE COMMERCIAL & JACKSON
COMMERCIAL ST 
JACKSON ST HO 1/15/1990
PETROLEUM BASED OIL, UNKNOWN 
CHEMICAL OF TYPE - OIL UST STMRET
Mapped 1-0000704 INDUSTRIAL WINTER ST PARCEL 20 WINTER ST HO 11/22/1989 PETROLEUM BASED OIL UST RAO
Mapped 1-0000711 HOLYOKE WATER POWER BERKSHIRE ST HO 1/15/1990 UNKNOWN CHEMICAL OF UNKNOWN TYPE LSPNFA
Mapped 1-0000790
DRYCLEANER, 
FORMER DOMINOS PIZZA 399-401 HILLSIDE AVE HO 10/15/1990 UNKNOWN CHEMICAL OF TYPE - OIL TIER1D
Mapped 1-0000802 GASSTATION GETTY PETROLEUM STATION 630 DWIGHT ST HO 10/15/1990 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST RAO
Mapped 1-0000816
COGASPLANT, 
FORMER, 
INDUSTRIAL HOLYOKE GAS WORKS FMR 7 NORTH BRIDGE ST HO 10/15/1990 UNKNOWN CHEMICAL OF TYPE - OIL UST TIER1A
Mapped 1-0000907 INDUSTRIAL MT TOM GENERATOR PLANT ROUTE 5 HO 7/15/1991 UNKNOWN CHEMICAL OF UNKNOWN TYPE PIPE, UST REMOPS
Mapped 1-0000966 HOSPITAL HOLYOKE SOLDIERS HOME 110 CHERRY ST HO 4/15/1992 PETROLEUM BASED OIL UST RAO
Mapped 1-0001024
COMMERCIAL, 
GASSTATION
YEORG'S GARAGE & TIRE 
SERVICE 158 CHESTNUT ST HO 7/15/1993 PETROLEUM BASED OIL UST TIERII
Mapped 1-0001046 GASSTATION
GALLAGHERS OLD FASHION 
SER 532 HIGH ST HO 10/1/1993 UNKNOWN CHEMICAL OF TYPE - OIL UST DPS
Mapped 1-0001051 REARDONS GARAGE 1537 NORTHAMPTON ST HO 7/15/1993 UNKNOWN CHEMICAL OF UNKNOWN TYPE DEPNDS
Mapped 1-0001053 INDUSTRIAL AVERY DENNISON 1 CABOT ST HO 8/3/1993 UNKNOWN CHEMICAL OF UNKNOWN TYPE
UNCONTAIN, 
UNKNOWN WCSPRM
Mapped 1-0001055 INDUSTRIAL
HOLYOKE GAS TAR 
DEPOSITS
BELOW HOLYOKE DAM 
COURT RIV HO 7/15/1993 UNKNOWN CHEMICAL OF UNKNOWN TYPE PIPE TIER1A
Mapped 1-0001056 UTILITY
NEW ENGLAND TELEPHONE 
CO 322 MAPLE ST HO 7/9/1993 PETROLEUM BASED OIL UST RAO
Mapped 1-0001069 SKI AREA MOUNT TOM SKI AREA ROUTE 5 HO 9/28/1993 PETROLEUM BASED OIL PIPE RAO
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Mapped 1-0010023 COMMERCIAL OLD STEIGERS BUILDING 253-267 HIGH ST HO 10/19/1993 FUEL OIL #2, FUEL OIL #4 UST RAO
Mapped 1-0010047 INDUSTRIAL ADAMS PAKKAWOOD 191 APPLETON ST HO 10/30/1993
UNKNOWN CHEMICAL OF TYPE - OIL (100 
GAL), UNKNOWN CHEMICAL OF TYPE - OIL 
(450 PPM) TRANSFORM RAO
Not Mapped 1-0010165 ROADWAY NO LOCATION AID SOUTHBOUND I91 HO 1/12/1994 DIESEL FUEL (40 GAL), KEROSENE FUELTANK RAO
Mapped 1-0010168
INDUSTRIAL, 
WATERBODY
HOLYOKE WATER POWER 
HADLEY FALLS STATION GATEHOUSE RD HO 1/14/1994
FUEL OIL #2 (1800 GAL), FUEL OIL #2 (400 
GAL) PIPE, UST REMOPS
Mapped 1-0010176 STATE SOLDIERS HOME 110 CHERRY ST HO 1/20/1994 FUEL OIL #6 (15 GAL) TANKER RAO
Mapped 1-0010212 RESIDNTIAL SPEARS RESIDENCE 29 MEADOW ST HO 2/22/1994
FUEL OIL #2 (100 GAL), PETROLEUM BASED 
OIL (30 GAL) PIPE, UST RAO
Mapped 1-0010218 ROADWAY NORTH OF EXIT 16 MM 15.3
RT 91 SOUTHBOUND 
EXIT 17 HO 2/23/1994 DIESEL FUEL
FUELTANK, 
VEHICLE RAO
Not Mapped 1-0010256 ROADWAY MM17 N RT 91N MM17 HO 3/20/1994 DIESEL FUEL, DIESEL FUEL (100 GAL)
FUELTANK, 
TRACT TANK RAO
Not Mapped 1-0010267 COMMERCIAL FMR DREIKORNS BLDG 322 PARK ST HO 3/24/1994 FUEL OIL #2, FUEL OIL #2 (4 INCH) UST RAO
Mapped 1-0010271 ROADWAY NO LOCATION AID
COR OF MAPLE ST AND 
ESSEX ST HO 3/29/1994 FUEL OIL #2 (10 GAL), FUEL OIL #2 (50 GAL) PIPE, TANKER RAO
Mapped 1-0010318
COMMERCIAL, 
SERVSTATIO
B & D PETROLEUM SALES 
INC 3 BROWN AVE HO 5/2/1994
GASOLINE (300 PPMV), GASOLINE (320 
PPM)
OVERFILL, 
POSSIBLE, 
UST RAO
Mapped 1-0010435 RESIDNTIAL LAFLAMME RESIDENCE
240 WEST MADISON 
AVE HO 7/18/1994 FUEL OIL #2 UST RAO
Mapped 1-0010457 COMMERCIAL FMR MAIN AUTO 600 MAIN ST HO 8/1/1994 WASTE OIL DRUMS RAO
Mapped 1-0010473
COMMERCIAL, 
WATERBODY HADLEY DAM GATEHOUSE RD HO 8/15/1994 FUEL OIL #2, FUEL OIL #2 (20 GAL) UST RAONR
Mapped 1-0010477 COMMERCIAL HAZEN PAPER THIRD LEVEL CANAL HO 8/19/1994
2-BUTANONE, 2-BUTANONE (1 GAL), 
BENZENE, METHYL- (1 GAL) PUMP LEAK RAO
Mapped 1-0010532 INDUSTRIAL MT TOM POWER PLANT RT 5 SMITHS FRY HO 9/26/1994 FUEL OIL #6 (50 GAL) PIPE RAO
Mapped 1-0010533 HOSPITAL HOLYOKE HOSPITAL 575 BEECH ST HO 9/26/1994 FUEL OIL #2 UST RAO
Mapped 1-0010649 INDUSTRIAL MASTEX INDUSTRIES
CABOT AND BIGELOW 
ST HO 12/7/1994
1-METHYL-2-CHLOROBENZENE (27 LBS), 1-
METHYL-2-CHLOROBENZENE (40 LBS) RELEASE RAO
Mapped 1-0010718 COMMERCIAL OLD TAXI GARAGE 118 CABOT ST HO 2/1/1995 FUEL OIL #2 (10 GAL), WASTE OIL
AST, 
UNKNOWN RAONR
Mapped 1-0010765 COMMERCIAL JOHNS SUNOCO 1616 NORTHAMPTON ST HO 3/13/1995 GASOLINE (100 PPMV) UST RAO
Mapped 1-0010782 COMMERCIAL CORNER MAPLE ST 145 HAMPDEN ST HO 3/23/1995 GASOLINE, GASOLINE (100 PPMV) UST RAO
Mapped 1-0010849 INDUSTRIAL HOLYOKE B & M RAILROAD CRESCENT ST HO 5/2/1995 DIESEL FUEL (150 GAL) FUELTANK RAO
Mapped 1-0010878 RESIDNTIAL RESIDENCE 48 LIBERTY ST HO 5/25/1995 FUEL OIL #2 (4000 MG/KG) UST RAO
Mapped 1-0010902 RESIDNTIAL LACASSE APARTMENTS SOUTH CANAL ST HO 6/9/1995 FUEL OIL #2, FUEL OIL #2 (347 PPM) UST RAO
Not Mapped 1-0010915 MM 17 RTE 91 N HO 6/19/1995
DIESEL FUEL (10 GAL), DIESEL FUEL (60 
GAL) FUELTANK RAO
Mapped 1-0010916
COMMERCIAL, 
FUNERALHOM HOLBERT FUNERAL HOME 250 SUFFOLK ST HO 6/19/1995
FUEL OIL #2 (100 PPM), FUEL OIL #2 (150 
PPM), PETROLEUM BASED OIL UST RAO
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Mapped 1-0010919 COMMERCIAL YEORGS GARAGE 158 CHESTNUT ST HO 6/20/1995
UNKNOWN CHEMICAL OF TYPE - OIL, 
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(10.8 INCH) UNKNOWN RAONR
Mapped 1-0010937 INDUSTRIAL HEATING OIL STORAGE DIKE 3 HANOVER ST HO 7/4/1995 OIL (300 GAL) AST RAO
Mapped 1-0010938 INDUSTRIAL LOADING DOCK 20 WATER ST HO 7/7/1995 WASTE OIL DRUMS RAO
Mapped 1-0010975 MUNICIPAL HOLYOKE DPW BEHIND CITY HALL HO 7/27/1995
GASOLINE (2300 PPM), GASOLINE (2500 
PPM) UST RAO
Mapped 1-0010996 MUNICIPAL CITY OF HOLYOKE DPW 63 NORTH CANAL ST HO 8/11/1995 DIESEL FUEL, FUEL OIL #2 (110 PPM) UST RAO
Mapped 1-0010998 MUNICIPAL FIRE DEPT REPAIR YARD 1034 HAPDEN ST HO 8/14/1995 GASOLINE UST RAO
Mapped 1-0011057 RESIDNTIAL SERGEANT WEST APTS 151 WEST ST HO 9/22/1995 FUEL OIL #2 UST RAO
Mapped 1-0011080 RESIDNTIAL NO LOCATION AID 8 WILLIAMS ST HO 10/6/1995 FUEL OIL #2 (9100 PPM) UST TIER1D
Mapped 1-0011086 SCHOOL, STATE HCC 303 HOMESTEAD AVE HO 10/11/1995 GASOLINE (180 PPMV) UST RAO
Mapped 1-0011102
COMMERCIAL, 
INDUSTRIAL, 
WATERB ON CANAL 383 DWIGHT ST HO 10/20/1995 FUEL OIL #6 PIPE RAO
Mapped 1-0011163 MUNICIPAL DPW GARAGE 63 NORTH CANAL ST HO 12/1/1995 PETROLEUM BASED OIL (190 PPM) UST RAONR
Mapped 1-0011232 RESIDNTIAL FRANCISCAN MISSIONARY
1039 NORTHAMPTON 
RD HO 2/1/1996 FUEL OIL #2 UNKNOWN RAO
Mapped 1-0011291 RESIDNTIAL FREDDIE MAC PROPERTY 38 COIT ST HO 3/14/1996 FUEL OIL #2 (101 PPM) UST RAO
Mapped 1-0011312 MUNICIPAL FIRE STATION #3 1579 NORTHAMPTON ST HO 4/3/1996 GASOLINE PIPE RAO
Mapped 1-0011337 OPENSPACE CENTRAL AUTO SALES 1010 MAIN ST HO 4/22/1996
AST, DRUMS, 
TANKER TIER1D
Mapped 1-0011360 INDUSTRIAL CHEMICAL FINISHING INC 110 NORTH BRIDGE ST HO 5/6/1996 UNKNOWN CHEMICAL OF UNKNOWN TYPE DRUMS RAO
Mapped 1-0011380 COMMERCIAL LOG CABIN RESTRAURANT EASTHAMPTON RD HO 5/23/1996
FUEL OIL #2 (125 PPMV), FUEL OIL #2 (31 
PPMV) UST RAO
Mapped 1-0011399
COMMERCIAL, 
RESIDNTIAL SPEAR PROPERTY 693 DWIGHT ST HO 6/6/1996 FUEL OIL #2 (165 PPM) UST RAONR
Mapped 1-0011517
COMMERCIAL, 
INDUSTRIAL HAMPDEN PAPERS 100 WATER ST HO 9/13/1996 DIESEL FUEL (17 GAL) FUELTANK RAO
Mapped 1-0011534 COMMERCIAL OIL TANK 158 CHESTNUT ST HO 9/26/1996 FUEL OIL #2 UST RAONR
Mapped 1-0011549 COMMERCIAL
A.J. VIRGILIO 
CONSTRUCTION CO 115 CHAPIN ST HO 10/10/1996 DIESEL FUEL, FUEL OIL #2, WASTE OIL DRUMS RAO
Mapped 1-0011569
COMMERCIAL, 
RESIDNTIAL NO LOCATION AID
INT RTE 202 
HOMESTEAD AVE HO 10/24/1996
UNKNOWN CHEMICAL OF TYPE - OIL (30 
GAL) TRANSFORM RAO
Mapped 1-0011840 COMMERCIAL REAR OF FOOD MART SOUTH ST HO 5/21/1997
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(30 GAL) DRUMS RAO
Mapped 1-0011868
MEDIAN, 
OPENSPACE, 
ROADWAY MT TOM POWER STACK RTE I-91 S HO 6/12/1997 DIESEL FUEL (50 GAL) VEHICLE RAO
Mapped 1-0011916
MUNICIPAL, 
OPENSPACE SPRINGDALE PARK 827 MAIN ST HO 7/14/1997 WASTE OIL (50 GAL) DRUMS RAO
Mapped 1-0011975 RESIDNTIAL
SISTERS OF PROVIDENCE 
MOTHERHOUSE 5 GAMELIN ST HO 8/22/1997 GASOLINE (155 PPMV) UST RAO
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Mapped 1-0011977 COMMERCIAL ANATEC DWIGHT ST HO 8/25/1997 DIESEL FUEL (25 GAL) SADDLE TANK RAO
Mapped 1-0012055 INDUSTRIAL ANITEC 383 DWIGHT ST HO 10/15/1997 SULFURIC ACID
PIPE, 
SCRUBBER RAO
Mapped 1-0012080 COMMERCIAL BASF CORPORATION HANOVER ST HO 11/6/1997
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(100 GAL) AST RAO
Mapped 1-0012266 AT CANAL STREET CABOT ST HO 3/30/1998 DIESEL FUEL (-70 GAL) VEHICLE RAO
Mapped 1-0012301 INDUSTRIAL
ATLAS COPCO 
COMPRESSORS INC
161 LOWER WESTFIELD 
RD HO 4/22/1998 DIESEL FUEL (-20 GAL) VEHICLE RAO
Mapped 1-0012319 COMMERCIAL F L ROBERTS 679 MAIN ST HO 4/28/1998 GASOLINE (300 PPM) UST RAO
Mapped 1-0012484 COMMERCIAL JC PENNY LOADING DOCK HOLYOKE MALL HO 7/24/1998 GASOLINE (-20 GAL) VEHICLE RAO
Mapped 1-0012611 RESIDNTIAL VACANT LOT 129 TO 133 WALNUT ST HO 9/28/1998
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(-3 GAL) DRUMS TIER1D
Mapped 1-0012759 MUNICIPAL FIRE STATION 206 MAPLE ST HO 12/23/1998 GASOLINE (260 PPM) UST RAO
Mapped 1-0012771 MUNICIPAL FIRE STATION #6 820 HOMESTEAD AVE HO 12/30/1998 GASOLINE (100 PPM) UST RAO
Mapped 1-0012772 MUNICIPAL HOLYOKE DPW 63 CANAL ST HO 12/30/1998 GASOLINE (100 PPM) UST RAO
Mapped 1-0012784 MUNICIPAL HOLYOKE WATER WORKS 20 COMMERCIAL ST HO 1/16/1999 GASOLINE (118 PPMV) UST RAO
Mapped 1-0012833 COMMERCIAL
NEW WALGREEN 
CONSTRUCTION SITE 1588 NORTHAMPTON ST HO 2/22/1999 FUEL OIL #2 (110 PPM) UST RAO
Mapped 1-0012879
INDUSTRIAL, 
WATERBODY
NEXT TO HALLMARK 
BUILDING 526 SOUTH WATER ST HO 4/3/1999 WASTE OIL
DRUMS, 
VEHICLE TIERII
Mapped 1-0012884 RESIDNTIAL NO LOCATION AID 263 ELM ST HO 4/8/1999 FUEL OIL #2 (120 PPM) UST TIER1D
Mapped 1-0012908 MUNICIPAL SULLIVAN SCRAP 107 APPLETON ST HO 4/27/1999 1,1'-BIPHENYL, CHLORO-DERIVS. (500 PPM) TRANSFORM RAO
Mapped 1-0012915 COMMERCIAL
FILENES PARKING LOT 
HOLYOKE MALL MALL RING RD HO 5/1/1999
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(345 GAL) TRANSFORM RAO
Mapped 1-0013089 RESIDNTIAL NO LOCATION AID 75 MOUNTAINVIEW DR HO 9/3/1999 FUEL OIL #2 (100 PPM) UST RAO
Not Mapped 1-0013194
RIGHTOFWAY, 
STATE MM 18 RTE 91 N HO 11/17/1999 DIESEL FUEL (10 GAL) VEHICLE RAO
Mapped 1-0013243 RESIDNTIAL
ABANDONED APARTMENT 
BLDG 1 WORCESTER PL HO 12/16/1999
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL, WASTE OIL DRUMS TIER1D
Mapped 1-0013278 RESIDNTIAL RESIDENCE 92 CHAPIN ST HO 1/18/2000 FUEL OIL #2 (275 GAL) AST RAO
Mapped 1-0013507 RESIDNTIAL NO LOCATION AID 74 MADISON AVE HO 6/26/2000 FUEL OIL #2 (119 PPM) UST RAO
Not Mapped 1-0013551
COMMERCIAL, 
RESIDNTIAL, 
ROADWA UNDERPASS BRIDGE MAIN AND LYMAN ST HO 7/21/2000
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(30 GAL) VEHICLE RAO
Mapped 1-0013568 COMMERCIAL
UNION MART GASOLINE 
STATION 297 APERMONT HWY HO 7/31/2000
BENZENE (1000 PPB), BENZENE, METHYL- 
(1400 PPB), UNKNOWN CHEMICAL OF TYPE 
- HAZARDOUS MATERIAL (1700 PPB) UNKNOWN RAO
Mapped 1-0013592 COMMERCIAL SEALED AIR CORP
2030 LOWER 
HOMESTEAD AVE HO 8/17/2000
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(21 GAL) TRANSFORM RAO
Mapped 1-0013692 RESIDNTIAL RESIDENCE 1873 NORTHAMPTON ST HO 11/17/2000 FUEL OIL #2 (25 GAL) AST, PIPE RAO
Mapped 1-0013699 COMMERCIAL HAROLDS GARAGE INC 19 HOLYOKE ST HO 11/27/2000 DIESEL FUEL (835 GAL) TANKER RAO
Mapped 1-0013735 RESIDNTIAL LUSSIER RESIDENCE 30 DUPUIS RD HO 12/29/2000 1,1'-BIPHENYL, CHLORO-DERIVS. (23 PPM) UNKNOWN TIERII
Mapped 1-0013736 RESIDNTIAL ODABASHEN RESIDENCE 94 APREMONT HWY HO 12/29/2000 1,1'-BIPHENYL, CHLORO-DERIVS. (411 PPM) UNKNOWN RAO  
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Mapped 1-0000264
FORMER, 
REFINISHER FORMER MR STRIPPER 6 COLEMAN RD SH 11/17/1986 UNKNOWN CHEMICAL OF UNKNOWN TYPE BURIED, PIPE DEPNFA
Mapped 1-0010766 COMMERCIAL
MIDTOWN MOTORS N OF 
POMEROY MDW RD 151 COLLEGE HWY SH 3/14/1995 GASOLINE (100 PPMV) UST RAO
Not Mapped 1-0010955
RESIDNTIAL, 
ROADWAY POLE 18 PLEASANT ST SH 7/15/1995
UNKNOWN CHEMICAL OF TYPE - OIL (18 
GAL) TRANSFORM RAO
Mapped 1-0011109
RESIDNTIAL, 
ROADWAY CORNER OF FOMER RD COLLEGE HWY SH 10/28/1995
UNKNOWN CHEMICAL OF TYPE - OIL (10 
GAL), UNKNOWN CHEMICAL OF UNKNOWN 
TYPE (3 GAL)
TRANSFORM, 
VEHICLE RAO
Mapped 1-0013737
COMMERCIAL, 
RESIDNTIAL
4.5 MILE LONG GW 
CONTAMINATION PLUME 82 PEQUOT RD SH 12/20/2000 ETHENE, TRICHLORO- (26 PPB) UNKNOWN TIER1D
Mapped 1-0000227
COMMERCIAL, 
FORMER, JUNKYARD CAMEROTAS AUTO SALVAGE NECK RD PO BOX 537 WF 9/17/1986
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL, UNKNOWN 
CHEMICAL OF TYPE - OIL, UNKNOWN 
CHEMICAL OF TYPE - OIL UNKNOWN RAO
Mapped 1-0000228 MANUFACT DECORATED PROD CO 1 ARCH RD WF 8/14/1986 UNKNOWN CHEMICAL OF UNKNOWN TYPE LAGOON RAO
Mapped 1-0000229 GASSTATION
CENTER CITY SERVICE 
STATION 1 FRANKLIN ST WF 2/13/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST DEPNFA
Mapped 1-0000230 GASSTATION MOBIL GAS 27 SOUTHWICK RD WF 1/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST DEPNFA
Mapped 1-0000232 MANUFACT COLUMBIA MFG CO MTD CYCLE ST WF 1/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE LAGOON DEPNFA
Mapped 1-0000233 MANUFACT PTS ELECTRONICS 300 UNION ST WF 4/15/1987 UNKNOWN CHEMICAL OF TYPE - OIL SEPTIC TANK DEPNFA
Mapped 1-0000234 GASSTATION REPUBLIC OIL 322 EAST MAIN ST WF 4/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST RAO
Mapped 1-0000235 INDUSTRIAL SAVAGE INDUSTRIES SPRINGDALE RD WF 2/12/1987
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL
UNCONTAIN, 
UST RAO
Mapped 1-0000236 MANUFACT TELL TOOL TPKE INDUSTRIAL RD WF 4/15/1987 UNKNOWN CHEMICAL OF TYPE - OIL DRYWELL DEPNFA
Mapped 1-0000237 WALTHAM GRINDING 30 EMERY ST WF 1/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE DEPNFA
Mapped 1-0000238
INDUSTRIAL, 
MANUFACT INTERNATIONAL SALT 163 UNION ST WF 4/15/1987
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL, UNKNOWN 
CHEMICAL OF UNKNOWN TYPE
UNCONTAIN, 
UNKNOWN RAO
Mapped 1-0000288
BARNES AIR NATIONAL 
GUARD
BARNES MUN A P BUCK 
PONDS RD WF 10/15/1987
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(.5 INCH) UNKNOWN TIER1A
Mapped 1-0000315 INDUSTRIAL WESTFIELD COATING 221 UNION ST WF 10/15/1988 UNKNOWN CHEMICAL OF TYPE - OIL LAGOON RAO
Mapped 1-0000326 GASSTATION GETTY POWER TEST 278 ELM ST WF 10/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST RAO
Mapped 1-0000328 WESTFIELD NEWS 64 SCHOOL ST WF 1/15/1988 UNKNOWN CHEMICAL OF UNKNOWN TYPE RAO
Mapped 1-0000343 COMMERCIAL KANTANYS VOLKSWAGON 342 MAIN ST WF 7/7/1988 UNKNOWN CHEMICAL OF UNKNOWN TYPE UNCONTAIN RAONR
Mapped 1-0000356 GASSTATION FIRESTONE 322 EAST MAIN ST WF 1/15/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST DEPNDS
Mapped 1-0000381 TOWNSEND ASSOCIATES 79 MAINLINE DR WF 10/15/1988 UNKNOWN CHEMICAL OF UNKNOWN TYPE LSPNFA
Mapped 1-0000427 LEAKING STORAGE TANK 163 UNION ST WF 1/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE DEPNFA
Mapped 1-0000428
PREFERRED ELECTRONICS 
INC MAIN LINE DR WF 1/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE DEPNFA
Mapped 1-0000429 WESTFIELD FORD 234 EAST MAIN ST WF 1/15/1987 UNKNOWN CHEMICAL OF UNKNOWN TYPE DEPNFA
Mapped 1-0000453 MANUFACT DIGITAL
1111 SOUTHAMPTON 
RD WF 1/15/1989 PETROLEUM BASED OIL UST WCSPRM  
111 
Table 1 (Continued)
MAPPED/NOT 
MAPPED RTN LOCATION AID SITE NAME ADDRESS TOWN  DATE MATERIALS SOURCES
CURRENT 
STATUS
Mapped 1-0000485 GASSTATION BOBS AUTOMOTIVE 97 SOUTH MAPLE ST WF 6/20/1988 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST RAO
Mapped 1-0000489 BP STATION 88 SOUTH MAPLE ST WF 6/21/1988 UNKNOWN CHEMICAL OF UNKNOWN TYPE RAO
Mapped 1-0000510 AXTON CROSS CHEMICAL TPKE INDUSTRIAL RD WF 10/15/1988 UNKNOWN CHEMICAL OF UNKNOWN TYPE DEPNFA
Mapped 1-0000529
COMMERCIAL, 
FORMER, TANK 
FARM ELM STREET PROPERTY 224 ELM ST WF 1/15/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST RAO
Mapped 1-0000540 RICHARDSON SILKSCREEN 798 APREMONT WAY WF 1/15/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE RAO
Mapped 1-0000544
FORMER, FUEL 
DEPOT SCARFO REALTY 30 CLINTON AVE WF 10/31/1988 PETROLEUM BASED OIL UST RAO
Mapped 1-0000559 FILMTECH INC 181 NOTRE DAME ST WF 1/15/1989 PETROLEUM BASED OIL RAO
Mapped 1-0000571 PARKSIDE PARTS INC 17 PARKSIDE AVE WF 1/15/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE WCSPRM
Mapped 1-0000586 MULTIFUELS CORPORATION 136 MEADOW ST WF 4/15/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE RAO
Mapped 1-0000589 WING FARM TIMBERSWAMP RD WF 1/27/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE RAO
Mapped 1-0000601 TANK FARM AGWAY MULTIFUELS ARCH RD WF 4/15/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE PIPE RAO
Mapped 1-0000602 RYANS PACKAGE STORE 11 FRANKLIN ST WF 3/23/1989 PETROLEUM BASED OIL UST DEPNDS
Mapped 1-0000604 PEER BROTHERS TRUCKING 253 UNION ST WF 4/15/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE RAO
Mapped 1-0000626 NATIONAL GUARD ARMORY 137 FRANKLIN ST WF 4/27/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE RAO
Mapped 1-0000633 PREFERRED ELECTRONICS 2 53 MAINLINE DR WF 1/15/1990 UNKNOWN CHEMICAL OF UNKNOWN TYPE DEPNFA
Mapped 1-0000650 FOWLER FARMS SOUTHWICK RD WF 1/15/1990 UNKNOWN CHEMICAL OF UNKNOWN TYPE PENNFA
Mapped 1-0000665 GASSTATION E MAIN MOBIL 01 PL6 460 EAST MAIN ST WF 10/15/1989 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST RAO
Mapped 1-0000707 COMMERCIAL AFM CORP ELISE ST WF 12/15/1989 WASTE OIL DRYWELL RAO
Mapped 1-0000734 COMMERCIAL PLAZA MALL 288 SOUTHAMPTON RD WF 4/15/1990 UNKNOWN CHEMICAL OF UNKNOWN TYPE LSPNFA
Mapped 1-0000758 INDUSTRIAL N E CONCRETE & PIPE 69 NECK RD WF 2/16/1990 PETROLEUM BASED OIL UST RAO
Mapped 1-0000767
COMMERCIAL, 
MUNICIPAL SACKETT STREET 30 SACKETT ST WF 10/15/1990 UNKNOWN CHEMICAL OF UNKNOWN TYPE TIER1A
Mapped 1-0000836 GASSTATION
MURRAYS MOBIL STATION 01 
FKM 162 SOUTHAMPTON RD WF 10/15/1990 UNKNOWN CHEMICAL OF TYPE - OIL UST RAO
Mapped 1-0000840
COMMERCIAL, 
FORMER, 
GASSTATION TERRYS AUTO FMR 235 ELM WF 10/15/1990 PETROLEUM BASED OIL UST RAO
Mapped 1-0000851 GASSTATION PVRR PARCEL ADJACENT 235 ELM ST WF 1/15/1991 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST RAO
Mapped 1-0000860 FMR POST OFFICE 25 RAILROAD AVE WF 10/1/1993 UNKNOWN CHEMICAL OF UNKNOWN TYPE DEPNFA
Mapped 1-0000868 GASSTATION SHELL OIL STATION 259 NORTH ELM ST WF 1/9/1991 UNKNOWN CHEMICAL OF UNKNOWN TYPE UNKNOWN DPS
Mapped 1-0000869 GASSTATION LECRENSKIS MOBIL 33 MAIN ST WF 1/9/1991 UNKNOWN CHEMICAL OF UNKNOWN TYPE PIPE, UST RAO
Mapped 1-0000875 GASSTATION J J MOBIL MART 01 FMO 181 ELM ST WF 4/15/1991 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST RAO
Mapped 1-0000888 MANUFACT ANDERSON & SONS 214 NORTH ELM ST WF 4/15/1991 UNKNOWN CHEMICAL OF UNKNOWN TYPE REMOPS
Mapped 1-0000910 MERIT STATION 310 EAST MAIN ST WF 7/15/1993 UNKNOWN CHEMICAL OF UNKNOWN TYPE RAO
Mapped 1-0000918 INDUSTRIAL DAY LUMBER COMPANY
SOUTH BROAD ST PO 
BOX 9 WF 7/15/1993 WASTE OIL UST RAO
Mapped 1-0000924 INDUSTRIAL ATLANTIC VALVE COMPANY TPKE INDUSTRIAL PARK WF 10/15/1991 UNKNOWN CHEMICAL OF UNKNOWN TYPE
DRYWELL, 
UST RAO
Mapped 1-0000955 INDUSTRIAL
PROP LEASED FROM JSLANE 
CO
UNION ST SPRINGDALE 
RD WF 4/15/1992 WASTE OIL PENNFA  
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Mapped 1-0000962 COMMERCIAL WESTFIELD SAVINGS BANK 280 LOCKHOUSE RD WF 7/15/1993 PETROLEUM BASED OIL VEHICLE WCSPRM
Mapped 1-0000987
FORMER, 
GASSTATION STERLING RADIATOR 260 NORTH ELM ST WF 10/30/1992 UNKNOWN CHEMICAL OF UNKNOWN TYPE RAO
Mapped 1-0001012 STATE POLICE BARRACKS
MASSACHUSETTS TPKE 
MM 414 WF 4/20/1993 PETROLEUM BASED OIL UST RAO
Mapped 1-0001052 COLLEGE WESTFIELD STATE COLLEGE 577 WESTERN AVE WF 6/25/1993 FUEL OIL #6 UST REMOPS
Mapped 1-0001073 GASSTATION DEGRAYS SERVICE CENTER 163 MEADOW ST WF 9/28/1993 UNKNOWN CHEMICAL OF UNKNOWN TYPE PIPE RAO
Mapped 1-0001080 TANK FARM WESTERN MASS HOSPITAL 91 EAST MOUNTAIN RD WF 9/29/1993 UNKNOWN CHEMICAL OF UNKNOWN TYPE UST RAO
Mapped 1-0010097 STATE
WESTFIELD MHD MAINT 
DEPOT RT 20 (EAST MAIN ST) WF 12/3/1993 DIESEL FUEL UST RAO
Mapped 1-0010141 AIR BASE, FEDERAL
BUILDING 028 UST/BARNES 
ANG BASE
1 TANK DESTROYER 
BLVD WF 9/29/1994
FUEL OIL #2 (55 PPMV), TOTAL 
PETROLEUM HYDROCARBONS (TPH) (54.9 
PPM) TANKER, UST RAONR
Mapped 1-0010144 AIR BASE, FEDERAL BUILDING 051 UST
1 TANK DESTROYER 
BLVD WF 12/23/1993
FUEL OIL #2 (73 PPMV), TOTAL 
PETROLEUM HYDROCARBONS (TPH) (73.2 
PPM) TANKER, UST RAONR
Mapped 1-0010161 AIR BASE, FEDERAL
BARNES ANG 
BASE/BUILDING 027 UST
1 TANK DESTROYER 
BLVD WF 1/7/1994
UNKNOWN CHEMICAL OF TYPE - OIL (483 
PPMV), WASTE OIL (138 PPM), WASTE OIL 
(483 PPM) UST RAONR
Mapped 1-0010198
INDUSTRIAL, 
MUNICIPAL, 
WATERBO
HYDROPOWER GENERATING 
STATION 1717 GRANVILLE RD WF 2/7/1994
MINERAL OIL (1000 GAL), MINERAL OIL 
(1475 GAL) TRANSFORM RAO
Mapped 1-0010202 RESIDNTIAL
RESIDENTIAL RT 10 TO 
CITYVIEW TO SACKETT 256 SACKETT RD WF 2/14/1994 FUEL OIL #2 (30 GAL), FUEL OIL #2 (45 GAL) PIPE RAO
Mapped 1-0010298 INDUSTRIAL
CONSTRUCTION SERVICE 
PLANT 140 UNION ST WF 4/15/1994
FUEL OIL #2 (200 GAL), FUEL OIL #2 (60 
PPMV) PIPE STMRET
Mapped 1-0010333 AIR BASE, FEDERAL ADJACENT TO BLDG 006 BARNES ANG BASE WF 5/9/1994 OIL (500 PPMV) UST RAONR
Mapped 1-0010389 INDUSTRIAL WESTFIELD COATINGS CORP 221 UNION ST WF 6/20/1994
ETHANOL, 2-BUTOXY- (1000 GAL), 
ETHANOL, 2-BUTOXY- (1000 GAL) PIPE RAONR
Mapped 1-0010392 COMMERCIAL FMR TERRYS AUTO SALES 235 ELM ST WF 6/22/1994 GASOLINE (100 PPMV) UST RAO
Mapped 1-0010463 WESTFIELD COATINGS CORP 221 UNION ST WF 8/8/1994
DIESEL FUEL (10 GAL), DIESEL FUEL (334 
GAL) AST RAO
Mapped 1-0010475 SCHOOL, STATE
WESTFIELD STATE COLLEGE 
BOILER HOUSE 577 WESTERN AVE WF 8/16/1994
FUEL OIL #6 (2 INCH), TOTAL PETROLEUM 
HYDROCARBONS (TPH) (39700 PPM), 
TOTAL PETROLEUM HYDROCARBONS 
(TPH) (4.3 PPM) UST RAONR
Mapped 1-0010505 RESIDNTIAL
FMR FOWLER FARMS 
PROPERTY 37 SOUTH MEADOW RD WF 9/8/1994
1,3-BENZENEDICARBONITRILE, 2,4,5,6-
TETRACHLORO- (520000 ), 6,9-METHANO-
2,4,3-BENZODIOXATHIEPIN,6,7,8,9,10,10-H... 
(25000 ), PETROLEUM BASED OIL (25300 
MG/KG), TOTAL PETROLEUM 
HYDROCARBONS (TPH) PEST APPL RAO
Mapped 1-0010545 WATERBODY
SPRINGFIELD WATER 
SUPPLY PARISH FILTERS 1515 GRANVILLE RD WF 10/5/1994 FUEL OIL #2 UST RAO  
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Mapped 1-0010573 SCHOOL
HEADSTART OF WESTFIELD 
SO SIDE OF BLDG 390 SOUTHAMPTON RD WF 10/24/1994 FUEL OIL #2, FUEL OIL #2 (10 GAL) UST RAO
Mapped 1-0010583
OPENSPACE, 
RESIDNTIAL FMR RAYS EQUIPMENT
133 PROSPECT STREET 
EXT WF 10/31/1994 WASTE OIL (100 GAL) DRUMS RAO
Mapped 1-0010595
AIRPORT, 
COMMERCIAL KC AVIATION 33 ELISE ST WF 11/3/1994 JET FUEL (150 PPMV), JET FUEL (50 PPMV) UST RAO
Mapped 1-0010623 COMMERCIAL LECRENSKIS MOBIL 33 MAIN ST WF 11/18/1994 GASOLINE (22.8 INCH), GASOLINE (9 GAL) TANKER RAO
Mapped 1-0010638
MUNICIPAL, 
WATSUP FAC WEST PARISH FILTERS GRANVILLE RD WF 11/30/1994 FUEL OIL #2 (60 GAL) PIPE, UST RAO
Mapped 1-0010640 RESIDNTIAL
OAKS MOBILE HOME PARK 
LOT #21 404 SOUTHWICK RD WF 12/2/1994 FUEL OIL #2, FUEL OIL #2 (200 GAL) AST RAO
Mapped 1-0010663 INDUSTRIAL
NEW ENGLAND CONCRETE 
PIPE 69 NECK RD WF 12/19/1994 FUEL OIL #6, FUEL OIL #6 (1.5 INCH) UST RAONR
Not Mapped 1-0010776 COMMERCIAL PRIDE GAS STATION 97 SOUTH MAIN ST WF 3/20/1995
GASOLINE (846952 PPMV), GASOLINE (952 
PPMV) UST RAONR
Mapped 1-0010788 COMMERCIAL BAYBANK 30 ELM ST WF 3/28/1995 FUEL OIL #2, FUEL OIL #2 (1000 PPMV) UST REMOPS
Mapped 1-0010794 GASSTATION
MERIT STATION KMART 
PLAZA 310 EAST MAIN ST WF 3/30/1995
BENZENE, 1,2-DIMETHYL, BENZENE, ETHYL- 
(38 MG/L), BTEX (2.6 PPM), UNKNOWN 
CHEMICAL OF TYPE - HAZARDOUS 
MATERIAL (7.8 PPM), UNKNOWN CHEMICAL 
OF TYPE - HAZARDOUS MATERIAL (96 
MG/L)
FMR REMOV, 
UST TIERII
Mapped 1-0011028 STATE WESTFIELD DEPOT FACILITY EAST MAIN ST WF 9/1/1995
TOTAL PETROLEUM HYDROCARBONS 
(TPH) (947 PPM) UNKNOWN RAO
Mapped 1-0011040 COMMERCIAL GENESIS SPIRITUAL CENTER 53 MILL ST WF 10/5/1995 FUEL OIL #2 (100 PPM) UST RAO
Mapped 1-0011055
COMMERCIAL, 
RESIDNTIAL BAKER RESIDENCE 342 WEST RD WF 9/22/1995 PETROLEUM BASED OIL (125 PPM) UST RAO
Mapped 1-0011126 RESIDNTIAL
C & S WHOLESALE 
GROCERS INC BENNETT RD WF 11/8/1995 FUEL OIL #2 AST RAO
Mapped 1-0011165 STATE WESTERN MASS HOSPITAL 91 EAST MOUNTAIN RD WF 12/5/1995 FUEL OIL #2 (1000 PPMV) UST RAO
Mapped 1-0011354 COMMERCIAL FOOD & FUEL STATION 1400 RUSSELL RD WF 5/2/1996 GASOLINE UST RAO
Mapped 1-0011449 INDUSTRIAL COLUMBIA MFG CO CYCLE ST WF 7/19/1996 FUEL OIL #4
AST, 
UNKNOWN ADQREG
Mapped 1-0011503 RESIDNTIAL JOYNER PROPERTY 78 WESTERN AVE WF 9/3/1996 FUEL OIL #2 (100 GAL) UST RAO
Mapped 1-0011520 COMMERCIAL
COMMERCIAL 
DISTRUBUTING CO 46 SOUTH BROAD ST WF 9/16/1996 GASOLINE UST RAO
Mapped 1-0011687 RESIDNTIAL MOBILE HOME 6 CLIFTON ST WF 1/29/1997 FUEL OIL #2 (275 GAL) TIER1D
Not Mapped 1-0011698 COMMERCIAL REAR OF WAREHOUSE
SERVISTAR INDUSTRIAL 
WAY WF 2/4/1997 FUEL OIL #2 (100 GAL) PIPE, UST RAO
Mapped 1-0011881 RESIDNTIAL
TERRANCE FLAHIVE 
RESIDENCE 34 TEKOA TER WF 6/16/1997 FUEL OIL #2 (580 PPMV) UST RAO
Mapped 1-0011950 RESIDNTIAL RESIDENTIAL FORECLOSURE 56 WESTERN AVE WF 8/9/1997 FUEL OIL #2 (1000 PPMV) UST RAO
Mapped 1-0012001 COMMERCIAL US LINE CO 14 UNION ST WF 9/12/1997 FUEL OIL #2 UST RAO
Mapped 1-0012037 COMMERCIAL PRIDE GAS STATION 322 EAST MAIN ST WF 10/8/1997 GASOLINE PIPE RAONR
Mapped 1-0012267 RESIDNTIAL SAMEL RESIDENCE 179 SACKETT RD WF 3/30/1998 FUEL OIL #2 (-80 GAL) AST TIER1D  
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Mapped 1-0012277 MUNICIPAL FIRE STATION 34 BROAD ST WF 4/6/1998 PETROLEUM BASED OIL UST TIERII
Mapped 1-0012292 RESIDNTIAL SERENDIPITY GIFTS
1375 SOUTHAMPTON 
RD WF 4/16/1998 GASOLINE (100 PPM) UST RAO
Mapped 1-0012355 RESIDNTIAL NO LOCATION AID 5 TO 7 HIGH ST WF 5/21/1998 FUEL OIL #2 UST RAO
Mapped 1-0012385 POWDERMILL VILLAGE 126 UNION ST WF 6/5/1998 FUEL OIL #2 UST RAO
Mapped 1-0012414
OPENSPACE, 
RESIDNTIAL LOT BETWEEN #11 AND #17 CROWN ST WF 6/23/1998 ARSENIC (108 MG/KG) UNKNOWN TIER1D
Mapped 1-0012417 COMMERCIAL NO LOCATION AID 110 AIRPORT RD WF 6/25/1998
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(100 PPM) UST RAO
Not Mapped 1-0012565 ROADWAY INTERCHANGE 3 RTE 90 WF 9/8/1998 PETROLEUM BASED OIL (-50 GAL)
HOSE, 
VEHICLE RAO
Mapped 1-0012619 ROADWAY C & S FACILITY 53 SUMMIT LOCK RD WF 10/1/1998 DIESEL FUEL (20 GAL) VEHICLE RAO
Mapped 1-0012768 COMMERCIAL BEMBEN NURSERIES 17 BROOKLINE AVE WF 12/29/1998 FUEL OIL #2 (125 PPM) UST RAO
Mapped 1-0012779 INDUSTRIAL
CALDOR DISTRIBUTION 
CENTER
1111 SOUTHAMPTON 
RD WF 1/10/1999 FUEL OIL #4 (2000 GAL) PIPE RAO
Mapped 1-0012870 MUNICIPAL
SPRINGFIELD WATER 
WORKS 1515 GRANVILLE RD WF 3/22/1999 GASOLINE (188 PPM) UST RAO
Mapped 1-0012983 STATE WMASS HOSPITAL 91 EAST MOUNTAIN RD WF 6/21/1999 GASOLINE (759 PPM) UST TIER1C
Mapped 1-0013160 RESIDNTIAL DRIVEWAY 47 PINE RIDGE DR WF 10/20/1999 FUEL OIL #2 (15 GAL) PIPE RAO
Mapped 1-0013182 RESIDNTIAL RESIDENCE 148 NORTHWEST RD WF 11/12/1999 FUEL OIL #2 (100 PPM) UST RAO
Not Mapped 1-0013224 ROADWAY MILE MARKER 43.5 MASSACHUSETTS TPKE WF 12/2/1999 DIESEL FUEL (20 GAL), WASTE OIL TANKER RAO
Mapped 1-0013341 RESIDNTIAL ARBOR TRAILOR PARK 16 KLONDIKE AVE WF 3/10/2000 KEROSENE (200 GAL) AST RAO
Mapped 1-0013417 SCHOOL
CROSS STREET 
PLAYGROUND 22 ASHLEY ST WF 4/29/2000 DIESEL FUEL (10 GAL) UNKNOWN RAO
Mapped 1-0013432 INDUSTRIAL COLUMBIA MANUFACTURING SOUTH MEADOW RD WF 5/10/2000
UNKNOWN CHEMICAL OF TYPE - OIL (100 
GAL) TRANSFORM ADQREG
Mapped 1-0013436 RESIDNTIAL RESIDENCE 1259 WESTERN AVE WF 5/11/2000 FUEL OIL #2 (100 PPM) UST RAO
Mapped 1-0013528
COMMERCIAL, 
RESIDNTIAL BUILDING 5 126 UNION ST WF 7/11/2000
NAPHTHALENE (5.9 PPM), UNKNOWN 
CHEMICAL OF UNKNOWN TYPE (4500 PPM) UST RAO
Mapped 1-0013531
COMMERCIAL, 
RESIDNTIAL BUILDING 4 126 UNION ST WF 7/12/2000
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(1800 PPM) UST RAO
Mapped 1-0013538
COMMERCIAL, 
RESIDNTIAL BUILDING 6 126 UNION ST WF 7/13/2000
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(4700 PPM) UST RAO
Mapped 1-0013542
COMMERCIAL, 
RESIDNTIAL BUILDING 3 126 UNION ST WF 7/14/2000
UNKNOWN CHEMICAL OF UNKNOWN TYPE 
(970 PPM) UST RAO
Mapped 1-0013550
COMMERCIAL, 
RESIDNTIAL BUILDING 7 126 UNION ST WF 7/21/2000
NAPHTHALENE (15.2 PPM), UNKNOWN 
CHEMICAL OF UNKNOWN TYPE (67000 
PPM) UST RAO  
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Source: Massachusetts Department of Environmental Protection, Bureau of Waste Site Cleanup, 4/25/2005. Downloadable Site Lists. 
http://www.state.ma.us/dep/bwsc/sites/sdown.htm
Notes:
RTN - Release Tracking Number. Unique ID assigned to releases not remediated by October 1993 and to those occuring October 1993-present.
Location Aid - Place name of release
Address - Street location of release
Town - EH (Easthampton), HO (Holyoke), SH (Southampton), WF (Westfield)
Date - Official release notification date of release
Materials - Chemical(s) in release
Sources - Origin(s) of release contamination
Current Status - Remediation status of release.  Definitions: ADQREG Adequately Regulated; DEFT1B Default  T ier 1B; DEPMOU DEP Memorandum of Understanding; 
DEPNDS Not a Disposal Site (DEP); DEPNFA No Further Action (DEP Determined); DPS Downgradient Property Status; DPSTRM Downgradient Property Status 
Terminated; INVSUB Submittal Invalidated by DEP; LSPNFA LSP No Further Action; PENNDS Pending Not a Disposal Site; PENNFA Pending No Further Action; 
RAO Release Action Outcome; RAONR Response Action Outcome Not Required; REMOPS Remedy Operation Status; SPECPR Special Project; STMRET Response 
Action Outcome Statement Retracted; TCLASS Tier Classification; TIER1A Tier 1A; TIER1B Tier 1B; TIER1C Tier 1C; TIERII T ier II; UNCLSS Unclassified; 
WCSPRM Waiver Completion Statement Permanent.
UST - Underground Storage Tank
AST - Aboveground Storage Tank
GAL - Gallon 
PPMV - Parts per million by volume
PPM - Parts per million
PPB - Parts per billion
LBS - Pounds
MG/KG - Milligrams per kilogram
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Location
Maximum 
concentration (ppb)
Date of sample
Drinking water 
comparison value 
(ppb)
Number of 
samples above 
comparison value
ppb = parts per billion
Data sources:
Holyoke Water Works. Data sheets concerning tests of Pequot Well and Coronet Homes Well. Holyoke, Massachusetts. 2002.
Massachusetts Department of Environmental Protection (MassDEP). Drinking Water Program, Water Quality Assurance Program. Statewide Purgeable Organic Testing 
Program data. Boston, Massachusetts. 1988. 
Comparison value (source organization, reference):
MassDEP MMCL = Massachusetts Maxiumum Contaminant Level for drinking water (MassDEP, MassDEP 2004c)
Frequency of 
detection
Table 2
Maximum concentration of trichloroethylene (TCE) detected in groundwater samples from the Pequot Well
(samples taken from 1980–1992)
Holyoke, Massachusetts
MassDEP MMCL = 5 6Pequot Wells 7 / 8 15 October 1984
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Location
Maximum 
concentration (ppb)
Date of sample
Drinking water comparison 
value (ppb)
Number of samples 
above comparision 
value
Coronet Homes Wells 4 / 6 1.7 October 1984 MassDEP MMCL = 5 0
ppb = parts per billion
Data sources:
Holyoke Water Works. Data sheets concerning tests of Pequot Well and Coronet Homes Well. Holyoke, Massachusetts. 2002.
Massachusetts Department of Environmental Protection (MassDEP). Drinking Water Program, Water Quality Assurance Program. Statewide Purgeable Organic Testing 
Program data. Boston, Massachusetts. 1988. 
Comparison value (source organization, reference):
MassDEP MMCL = Massachusetts Maxiumum Contaminant Level for drinking water (MassDEP, MassDEP 2004c)
Table 3
Maximum concentration of trichloroethylene (TCE) detected in groundwater samples from Coronet Homes Well
(samples taken from 1980–1988)
Holyoke, Massachusetts
Frequency of 
detection
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Location
Maximum 
concentration (ppb)
Date of sample
Drinking water 
comparison value 
(ppb)
Number of samples above 
comparison value
Hendrick Street Wellfield 105 / 127 12.0 December 1991 89
Hendrick Street/Pines Well 
Treatment Plant effluent
1 / 22 0.5 March 2000 0
Pines Well 70 / 72 9.5 March 2001 50
ppb = parts per billion
Data sources:
Easthampton Water Works. Data sheets concerning TCE testing of municipal water. Easthampton, Massachusetts. 2002.
Massachusetts Department of Environmental Protection (MassDEP). Drinking Water Program, Water Quality Assurance Program. Statewide Purgeable Organic Testing Program   
data. Boston, Massachusetts. 1988.
Massachusetts Department of Environmental Protection (MassDEP). Drinking Water Program, Water Quality Assurance Program. Statewide Purgeable Organic Testing Program   
data. Boston, Massachusetts. 2004.
Comparison value (source organization, reference):
MassDEP MMCL = Massachusetts Maxiumum Contaminant Level for drinking water (MassDEP, MassDEP 2004c)
MassDEP MMCL = 5
Frequency of 
detection
Table 4
Maximum concentration of trichloroethylene (TCE) detected in groundwater samples from Easthampton Water Works wells
 (samples taken from 1980–2003)
Easthampton, Massachusetts
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Location
Maximum 
concentration (ppb)
Date of sample
Drinking water 
comparison value (ppb)
Number of samples above 
comparison value
Group Well #1 0 / 9 -- -- 0
Group Well #2 0 / 45 -- -- 0
Group Well #7 0 / 50 -- -- 0
Group Well #8 2 / 47 2.9 November 1993 0
ppb = parts per billion
Data sources:
Massachusetts Department of Environmental Protection (MassDEP). Drinking Water Program, Water Quality Assurance Program. Statewide Purgeable Organic Testing Program   
data. Boston, Massachusetts. 1988.
Massachusetts Department of Environmental Protection (MassDEP). Drinking Water Program, Water Quality Assurance Program. Statewide Purgeable Organic Testing Program   
data. Boston, Massachusetts. 2004.
Comparison value (source organization, reference):
MassDEP MMCL = Massachusetts Maxiumum Contaminant Level for drinking water (MassDEP, MassDEP 2004c)
MassDEP MMCL = 5
Frequency of 
detection
Table 5
Maximum concentration of trichloroethylene (TCE) detected in groundwater samples from Westfield Water Department wells that 
draw from the Barnes Aquifer (samples taken from 1986–2004)
Westfield, Massachusetts
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Chronic EMEG (child) = 100 0
Chronic EMEG (adult) = 400 0
MassDEP MMCL = 70 0
Int. EMEG (child) = 700 0
Int. EMEG (adult) = 2,000 0
MassDEP MMCL = 5 0
Chronic EMEG (child) = 90 0
Chronic EMEG (adult) = 300 0
RMEG (child) = 500 0
RMEG (adult) = 2,000 0
MassDEP MMCL = 7 0
Int. EMEG (child) = 3,000 0
Int. EMEG (adult) = 10,000 0
MassDEP MMCL = 70 0
Int. EMEG (child) = 2,000 0
Int. EMEG (adult) = 7,000 0
RMEG (child) = 200 0
RMEG (adult) = 700 0
MassDEP MMCL = 100 0
Int. EMEG (child) = 3,000 0
Int. EMEG (adult) = 10,000 0
MassDEP MMCL = 70 1
Int. EMEG (child) = 6,000 0
Int. EMEG (adult) = 20,000 0
RMEG (child) = 200 0
RMEG (adult) = 700 0
MassDEP MMCL = 140 0
RMEG (child) = 100 0
RMEG (adult) = 400 0
MassDEP MMCL = 5 0
0.0181,1-Dichloroethene 1 541/
1.9
Methyl-tert-butyl-ether (MTBE) 17 /
Contaminant
Table 6
Maximum concentrations of contaminants detected in 541 groundwater samples, 1997-2005, from 452 private wells
in Easthampton, Holyoke, Southampton, and Westfield, Massachusetts
Frequency of 
Detection
a
Maximum 
concentration (ppb)
Drinking water comparison 
value (ppb)
Number of samples 
above comparison 
values
24
1,4-Dichlorobenzene 1 / 541 3.1
Chloroform 13 / 541
541 74
1,2-Dichloroethene, cis- 4 / 541
5.4Naphthalene 2 / 541
Tetrachloroethylene (PCE) 29 / 541
0.131,2-Dichloroethene, trans- 5412 /
4.3
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Table 6 (continued)
Int. EMEG (child) = 200 0
Int. EMEG (adult) = 700 0
RMEG (child) = 2,000 0
RMEG (adult) = 7,000 0
MassDEP MMCL = 1,000 0
Int. EMEG (child) = 200,000 0
Int. EMEG (adult) = 700,000 0
MassDEP MMCL = 200 0
Trichloroethylene (TCE) 107 / 541 34.2 MassDEP MMCL = 5 19
a
Effluent samples not included
ppb = parts per billion
Data sources:
Massachusetts Department of Environmental Protection (MassDEP). Bureau of Waste Site Cleanup, Site Discovery Program. Private well data, 1997-2000, from   
Hendrick St. Wellfield/Barnes Aquifer TCE investigation. Springfield, Massachusetts. 2002.
Comparison value (source organization, reference):
CREG = Cancer Risk Evaluation Guide for 1 x 10
-6
 excess cancer risk (ATSDR, ATSDR 2005a)
Chronic EMEG (adult/child) = Environmental Media Evaluation Guide (i.e., for adult or childhood exposures greater than 1 year) (ATSDR 2005a)
Intermediate EMEG (adult) = Environmental Media Evaluation Guide for adults (i.e., for exposures between 14 days and 1 year) (ATSDR, ATSDR 2005a)
EPA RBC = EPA Region 3 Risk Based Concentration for tap water (U.S. EPA, U.S. EPA 2004)
MassDEP MMCL = Massachusetts Maxiumum Contaminant Level for drinking water (MassDEP, MassDEP 2004c)
Massachusetts Department of Environmental Protection (MassDEP). Bureau of Waste Site Cleanup, Site Discovery Program. Data sheets concerning private well data, 2001-2005, from 
Hendrick St. Wellfield/Barnes Aquifer TCE investigation. Springfield, Massachusetts. 2005b. 
Number of samples 
above comparison 
values
Contaminant
Frequency of 
Detection
a
Maximum 
concentration (ppb)
Drinking water comparison 
value (ppb)
2.21,1,1-Trichloroethane 3 / 541
/ 541 0.66
Intermediate EMEG (child) = Environmental Media Evaluation Guide for children (i.e., for exposures between 14 days and 1 year and considers vulnerabilities of children when it comes to 
environmental exposures). (ATSDR, ATSDR 2003a)
RMEG (adult/child) = Reference Dose Media Evaluation Guides (an estimate of a daily exposure to the general public, including sensitive subgroups, that is likely to be without 
appreciable risk of deleterious effects during a specified duration of exposure). (ATSDR 2003a)
Toluene 1
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Table 7 
Summary of Possible Exposure Pathways Related to Barnes Aquifer Contamination  
Easthampton, Holyoke, Southampton, and Westfield, Massachusetts 
 
Environmental 
Medium 
Exposure 
Pathway 
Contaminant(s)  
Point of 
Exposure 
Route of 
Exposure 
Receptor 
Populations 
Time 
Frame 
Type of 
Pathway 
Notes 
Groundwater 
Groundwater 
contamination 
Trichloroethylene 
(TCE) and other 
volatile organic 
compounds (VOCs) 
Offsite  
municipal 
water 
Ingestion/ 
Inhalation/ 
Dermal contact 
Residents Past Completed 
Historical concentrations are 
unknown.  
Groundwater 
contamination 
TCE and other VOCs 
Offsite private 
well water 
Ingestion/ 
Inhalation/ 
Dermal contact 
Residents Past Completed 
Exposure eliminated in 
present/future for residents who 
connected to municipal water or 
use whole house charcoal filters. 
Groundwater 
contamination 
TCE and other VOCs 
Offsite private 
well water 
Ingestion/ 
Inhalation/ 
Dermal contact 
Residents 
Past, 
Present, 
Future 
Completed/
Potential 
Small number of residents who 
refused testing, might not 
properly maintain filters, or use 
unfiltered water.  
Soil Soil/dust 
Polychlorinated 
biphenyls (PCBs) 
Apremont 
Highway site, 
Dupuis Road 
site, nearby 
residences 
Incidental 
Ingestion 
Residents Past Potential 
Sites have been remediated.  
Estimated past exposures to 
surface soil unlikely to result in 
adverse health effects.   
Ambient Air 
Combustion of 
PCBs 
PCBs, dioxins, 
polychlorinated 
dibenzofurans 
Dupuis Road 
site and nearby 
residences 
Inhalation Residents Past Potential 
Historical ambient air 
concentrations are unknown.   
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 47 52.8 89 65 -- 118 35 38.7 91 63 -- 126 12 14.1 85 44 -- 149
Esophageal 15 16.3 92 51 -- 151 13 12.0 108 58 -- 185 2 4.3 NC NC -- NC
Hodgkin's Disease 13 11.1 118 62 -- 201 7 6.1 115 46 -- 237 6 5.0 120 44 -- 262
Kidney 36 32.1 112 79 -- 155 22 19.8 111 70 -- 169 14 12.3 114 62 -- 191
Leukemia 23 27.8 83 52 -- 124 16 15.8 101 58 -- 165 7 12.0 58 23 -- 120
Liver 7 7.9 89 36 -- 183 7 5.8 121 49 -- 250 0 2.1 NC NC -- NC
NHL 45 49.3 91 67 -- 122 25 26.1 96 62 -- 141 20 23.0 86 53 -- 133
Pancreatic 34 29.7 115 79 -- 160 16 14.4 111 64 -- 181 18 15.3 118 70 -- 186
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 8a
Cancer Incidence
Easthampton, Massachusetts
1982-2000
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 15 17.0 88 49 -- 146 9 12.5 72 33 -- 137 6 4.5 133 49 -- 289
Esophageal 4 4.4 NC NC -- NC 4 3.2 NC NC -- NC 0 1.3 NC NC -- NC
Hodgkin's Disease 5 3.5 144 46 -- 337 2 1.9 NC NC -- NC 3 1.6 NC NC -- NC
Kidney 11 7.6 145 72 -- 260 5 4.5 110 36 -- 258 6 3.0 197 72 -- 429
Leukemia 6 7.7 78 29 -- 170 4 4.3 NC NC -- NC 2 3.3 NC NC -- NC
Liver 0 1.6 NC NC -- NC 0 1.1 NC NC -- NC 0 0.5 NC NC -- NC
NHL 13 12.0 108 58 -- 185 9 6.2 144 66 -- 274 4 5.8 NC NC -- NC
Pancreatic 8 8.5 94 40 -- 185 3 4.1 NC NC -- NC 5 4.4 114 37 -- 266
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 8b
Cancer Incidence
Easthampton, Massachusetts
1982-1987
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 14 16.5 85 46 -- 143 11 12.1 91 45 -- 162 3 4.3 NC NC -- NC
Esophageal 3 4.9 NC NC -- NC 2 3.5 NC NC -- NC 1 1.4 NC NC -- NC
Hodgkin's Disease 4 3.7 NC NC -- NC 3 2.0 NC NC -- NC 1 1.7 NC NC -- NC
Kidney 11 10.5 104 52 -- 187 8 6.6 121 52 -- 239 3 3.9 NC NC -- NC
Leukemia 7 7.9 89 36 -- 183 6 4.6 131 48 -- 285 1 3.3 NC NC -- NC
Liver 4 2.2 NC NC -- NC 4 1.6 NC NC -- NC 0 0.6 NC NC -- NC
NHL 9 15.3 59 27 -- 111 2 8.2 NC NC -- NC 7 7.1 98 39 -- 202
Pancreatic 5 8.8 57 18 -- 133 2 4.3 NC NC -- NC 3 4.5 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 8c
Cancer Incidence
Easthampton, Massachusetts
1988-1993
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 18 19.5 92 55 -- 146 15 14.0 107 60 -- 177 3 5.5 NC NC -- NC
Esophageal 8 7.0 114 49 -- 225 7 5.3 133 53 -- 275 1 1.8 NC NC -- NC
Hodgkin's Disease 4 4.0 NC NC -- NC 2 2.2 NC NC -- NC 2 1.8 NC NC -- NC
Kidney 14 14.1 99 54 -- 166 9 8.6 104 48 -- 198 5 5.5 91 29 -- 212
Leukemia 10 12.5 80 38 -- 148 6 6.8 88 32 -- 191 4 5.6 NC NC -- NC
Liver 3 4.0 NC NC -- NC 3 3.0 NC NC -- NC 0 1.1 NC NC -- NC
NHL 23 22.4 103 65 -- 154 14 11.7 120 65 -- 201 9 10.7 84 38 -- 160
Pancreatic 21 12.6 167* 103 -- 255 11 5.9 186 93 -- 332 10 6.6 151 72 -- 277
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 8d
Cancer Incidence
Easthampton, Massachusetts
1994-2000
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 22 22.9 96 60 -- 146 18 16.5 109 65 -- 173 4 6.4 NC NC -- NC
Esophageal 10 6.9 145 69 -- 266 9 4.9 183 83 -- 347 1 2.0 NC NC -- NC
Hodgkin's Disease 4 3.7 NC NC -- NC 4 2.0 NC NC -- NC 0 1.7 NC NC -- NC
Kidney 10 13.2 76 36 -- 140 6 7.9 76 28 -- 165 4 5.3 NC NC -- NC
Leukemia 5 11.2 45 14 -- 104 3 6.2 NC NC -- NC 2 5.0 NC NC -- NC
Liver 1 3.3 NC NC -- NC 1 2.3 NC NC -- NC 0 0.9 NC NC -- NC
NHL 22 20.1 109 68 -- 165 14 10.1 138 75 -- 232 8 10.0 80 34 -- 158
Pancreatic 12 13.0 92 48 -- 161 4 6.0 NC NC -- NC 8 7.0 114 49 -- 225
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9a
Cancer Incidence
Easthampton, Massachusetts
1982-2000
Census Tract 8223
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 9 7.7 117 53 -- 222 7 5.6 126 51 -- 260 2 2.1 NC NC -- NC
Esophageal 2 2.0 NC NC -- NC 2 1.4 NC NC -- NC 0 0.6 NC NC -- NC
Hodgkin's Disease 2 1.2 NC NC -- NC 2 0.7 NC NC -- NC 0 0.6 NC NC -- NC
Kidney 3 3.3 NC NC -- NC 1 1.9 NC NC -- NC 2 1.4 NC NC -- NC
Leukemia 1 3.2 NC NC -- NC 1 1.8 NC NC -- NC 0 1.5 NC NC -- NC
Liver 0 0.7 NC NC -- NC 0 0.5 NC NC -- NC 0 0.2 NC NC -- NC
NHL 4 5.2 NC NC -- NC 3 2.6 NC NC -- NC 1 2.6 NC NC -- NC
Pancreatic 3 3.9 NC NC -- NC 2 1.8 NC NC -- NC 1 2.1 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9b
Cancer Incidence
Easthampton, Massachusetts
1982-1987
Census Tract 8223
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 6 7.2 83 30 -- 181 5 5.2 95 31 -- 222 1 2.0 NC NC -- NC
Esophageal 2 2.1 NC NC -- NC 2 1.5 NC NC -- NC 0 0.6 NC NC -- NC
Hodgkin's Disease 1 1.2 NC NC -- NC 1 0.7 NC NC -- NC 0 0.6 NC NC -- NC
Kidney 4 4.4 NC NC -- NC 3 2.7 NC NC -- NC 1 1.7 NC NC -- NC
Leukemia 2 3.2 NC NC -- NC 1 1.8 NC NC -- NC 1 1.4 NC NC -- NC
Liver 0 0.9 NC NC -- NC 0 0.7 NC NC -- NC 0 0.3 NC NC -- NC
NHL 4 6.3 NC NC -- NC 1 3.2 NC NC -- NC 3 3.1 NC NC -- NC
Pancreatic 0 3.9 NC NC -- NC 0 1.8 NC NC -- NC 0 2.1 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9c
Cancer Incidence
Easthampton, Massachusetts
1988-1993
Census Tract 8223
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 7 7.9 89 36 -- 183 6 5.6 108 39 -- 235 1 2.3 NC NC -- NC
Esophageal 6 2.7 221 81 -- 481 5 2.0 254 82 -- 592 1 0.7 NC NC -- NC
Hodgkin's Disease 1 1.4 NC NC -- NC 1 0.7 NC NC -- NC 0 0.6 NC NC -- NC
Kidney 3 5.4 NC NC -- NC 2 3.2 NC NC -- NC 1 2.2 NC NC -- NC
Leukemia 2 4.8 NC NC -- NC 1 2.5 NC NC -- NC 1 2.2 NC NC -- NC
Liver 1 1.5 NC NC -- NC 1 1.1 NC NC -- NC 0 0.4 NC NC -- NC
NHL 14 8.6 163 89 -- 274 10 4.3 233* 111 -- 428 4 4.3 NC NC -- NC
Pancreatic 9 5.1 177 81 -- 336 2 2.3 NC NC -- NC 7 2.8 249 100 -- 513
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9d
Cancer Incidence
Easthampton, Massachusetts
1994-2000
Census Tract 8223
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 23 30.0 77 49 -- 115 16 22.3 72 41 -- 117 7 7.7 91 36 -- 187
Esophageal 5 9.5 53 17 -- 123 4 7.1 NC NC -- NC 1 2.4 NC NC -- NC
Hodgkin's Disease 8 7.3 109 47 -- 215 3 4.1 NC NC -- NC 5 3.3 153 49 -- 357
Kidney 25 18.9 132 85 -- 195 15 11.9 126 71 -- 208 10 7.1 142 68 -- 261
Leukemia 18 16.6 108 64 -- 171 13 9.6 135 72 -- 231 5 7.0 71 23 -- 166
Liver 6 4.6 130 47 -- 282 6 3.4 175 64 -- 380 0 1.2 NC NC -- NC
NHL 21 29.2 72 44 -- 110 10 16.0 63 30 -- 115 11 13.2 83 41 -- 149
Pancreatic 22 16.7 132 83 -- 199 12 8.4 142 74 -- 249 10 8.3 121 58 -- 222
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 10a
Cancer Incidence
Easthampton, Massachusetts
1982-2000
Census Tract 8224
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 6 9.3 65 24 -- 141 2 6.9 NC NC -- NC 4 2.4 NC NC -- NC
Esophageal 2 2.4 NC NC -- NC 2 1.8 NC NC -- NC 0 0.7 NC NC -- NC
Hodgkin's Disease 2 2.3 NC NC -- NC 0 1.2 NC NC -- NC 2 1.0 NC NC -- NC
Kidney 8 4.2 189 81 -- 372 4 2.6 NC NC -- NC 4 1.7 NC NC -- NC
Leukemia 5 4.4 113 36 -- 263 3 2.6 NC NC -- NC 2 1.9 NC NC -- NC
Liver 0 0.9 NC NC -- NC 0 0.6 NC NC -- NC 0 0.3 NC NC -- NC
NHL 8 6.8 118 51 -- 233 5 3.6 138 44 -- 321 3 3.1 NC NC -- NC
Pancreatic 5 4.6 110 35 -- 256 1 2.3 NC NC -- NC 4 2.3 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 10b
Cancer Incidence
Easthampton, Massachusetts
1982-1987
Census Tract 8224
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 7 9.2 76 30 -- 156 5 6.9 73 23 -- 170 2 2.4 NC NC -- NC
Esophageal 1 2.8 NC NC -- NC 0 2.1 NC NC -- NC 1 0.7 NC NC -- NC
Hodgkin's Disease 3 2.4 NC NC -- NC 2 1.3 NC NC -- NC 1 1.1 NC NC -- NC
Kidney 6 6.1 98 36 -- 213 4 3.9 NC NC -- NC 2 2.2 NC NC -- NC
Leukemia 5 4.7 106 34 -- 248 5 2.8 180 58 -- 421 0 1.9 NC NC -- NC
Liver 4 1.3 NC NC -- NC 4 1.0 NC NC -- NC 0 0.3 NC NC -- NC
NHL 5 9.0 55 18 -- 129 1 5.0 NC NC -- NC 4 4.0 NC NC -- NC
Pancreatic 5 4.9 102 33 -- 238 2 2.5 NC NC -- NC 3 2.4 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 10c
Cancer Incidence
Easthampton, Massachusetts
1988-1993
Census Tract 8224
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 10 11.6 86 41 -- 158 9 8.5 106 48 -- 202 1 3.2 NC NC -- NC
Esophageal 2 4.3 NC NC -- NC 2 3.3 NC NC -- NC 0 1.0 NC NC -- NC
Hodgkin's Disease 3 2.7 NC NC -- NC 1 1.5 NC NC -- NC 2 1.2 NC NC -- NC
Kidney 11 8.8 125 62 -- 224 7 5.5 128 51 -- 264 4 3.3 NC NC -- NC
Leukemia 8 7.7 104 45 -- 205 5 4.3 117 38 -- 272 3 3.4 NC NC -- NC
Liver 2 2.5 NC NC -- NC 2 1.9 NC NC -- NC 0 0.6 NC NC -- NC
NHL 8 13.8 58 25 -- 114 4 7.4 NC NC -- NC 4 6.4 NC NC -- NC
Pancreatic 12 7.5 160 83 -- 280 9 3.7 246* 112 -- 466 3 3.8 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 10d
Cancer Incidence
Easthampton, Massachusetts
1994-2000
Census Tract 8224
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 149 163.7 91 77 -- 107 99 113.2 87 71 -- 106 50 50.5 99 74 -- 131
Esophageal 58 49.0 118 90 -- 153 37 33.5 111 78 -- 152 21 15.5 135 84 -- 207
Hodgkin's Disease 24 28.9 83 53 -- 124 13 14.8 88 47 -- 151 11 14.1 78 39 -- 139
Kidney 82 93.5 88 70 -- 109 45 54.0 83 61 -- 112 37 39.5 94 66 -- 129
Leukemia 97 86.7 112 91 -- 136 51 45.2 113 84 -- 148 46 41.5 111 81 -- 148
Liver 19 23.1 82 49 -- 128 14 15.9 88 48 -- 148 5 7.3 69 22 -- 161
NHL 140 147.4 95 80 -- 112 67 70.3 95 74 -- 121 73 77.1 95 74 -- 119
Pancreatic 99 95.1 104 85 -- 127 41 40.9 100 72 -- 136 58 54.2 107 81 -- 138
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 11a
Cancer Incidence
Holyoke, Massachusetts
1982-2000
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 61 60.8 100 77 -- 129 40 42.1 95 68 -- 130 21 18.7 112 69 -- 171
Esophageal 15 15.3 98 55 -- 162 9 10.2 88 40 -- 168 6 5.1 117 43 -- 256
Hodgkin's Disease 7 9.4 74 30 -- 153 5 4.9 103 33 -- 240 2 4.6 NC NC -- NC
Kidney 22 25.5 86 54 -- 130 10 14.2 71 34 -- 130 12 11.4 106 55 -- 185
Leukemia 29 26.8 108 72 -- 155 15 14.0 107 60 -- 176 14 12.8 109 60 -- 183
Liver 5 5.6 89 29 -- 207 3 3.7 NC NC -- NC 2 2.0 NC NC -- NC
NHL 37 41.2 90 63 -- 124 19 19.2 99 60 -- 155 18 22.0 82 48 -- 129
Pancreatic 33 31.6 104 72 -- 147 13 13.6 96 51 -- 164 20 18.0 111 68 -- 171
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 11b
Cancer Incidence
Holyoke, Massachusetts
1982-1987
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 33 51.6 64* 44 -- 90 21 36.0 58* 36 -- 89 12 15.7 77 40 -- 134
Esophageal 18 15.1 119 71 -- 188 11 10.0 110 55 -- 197 7 5.1 137 55 -- 282
Hodgkin's Disease 9 9.7 93 42 -- 176 4 4.9 NC NC -- NC 5 4.8 104 34 -- 243
Kidney 29 31.2 93 62 -- 134 17 18.4 93 54 -- 148 12 12.8 94 48 -- 164
Leukemia 36 24.8 145* 102 -- 201 16 13.3 121 69 -- 196 20 11.5 173* 106 -- 268
Liver 7 6.6 106 42 -- 218 6 4.6 130 47 -- 283 1 2.0 NC NC -- NC
NHL 44 46.5 95 69 -- 127 24 22.1 109 70 -- 162 20 24.4 82 50 -- 127
Pancreatic 27 28.5 95 62 -- 138 11 12.3 89 45 -- 160 16 16.2 99 56 -- 160
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 11c
Cancer Incidence
Holyoke, Massachusetts
1988-1993
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 55 53.8 102 77 -- 133 38 37.4 102 72 -- 140 17 16.4 103 60 -- 166
Esophageal 25 18.6 134 87 -- 198 17 13.3 128 74 -- 204 8 5.3 151 65 -- 298
Hodgkin's Disease 8 9.7 82 35 -- 162 4 5.0 NC NC -- NC 4 4.7 NC NC -- NC
Kidney 31 36.3 85 58 -- 121 18 21.3 85 50 -- 134 13 15.0 87 46 -- 148
Leukemia 32 34.2 93 64 -- 132 20 17.7 113 69 -- 174 12 16.5 73 38 -- 127
Liver 7 10.4 67 27 -- 138 5 7.3 69 22 -- 160 2 3.1 NC NC -- NC
NHL 59 58.6 101 77 -- 130 24 28.8 83 53 -- 124 35 29.8 117 82 -- 163
Pancreatic 39 35.1 111 79 -- 152 17 15.3 111 65 -- 178 22 19.8 111 70 -- 168
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 11d
Cancer Incidence
Holyoke, Massachusetts
1994-2000
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 57 68.0 84 64 -- 109 41 48.4 85 61 -- 115 16 19.5 82 47 -- 133
Esophageal 22 20.0 110 69 -- 166 11 14.0 78 39 -- 140 11 6.0 183 91 -- 328
Hodgkin's Disease 7 9.7 72 29 -- 149 3 5.2 NC NC -- NC 4 4.5 NC NC -- NC
Kidney 34 37.1 92 64 -- 128 18 22.2 81 48 -- 128 16 14.9 107 61 -- 175
Leukemia 39 32.7 119 85 -- 163 24 17.7 136 87 -- 202 15 15.0 100 56 -- 165
Liver 11 9.3 119 59 -- 212 9 6.5 138 63 -- 261 2 2.7 NC NC -- NC
NHL 56 57.6 97 73 -- 126 26 28.5 91 59 -- 133 30 29.1 103 70 -- 147
Pancreatic 43 38.2 113 82 -- 152 14 17.3 81 44 -- 136 29 20.9 139 93 -- 199
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 12a
Cancer Incidence
Holyoke, Massachusetts
1982-2000
Census Tract 8121
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 16 22.0 73 42 -- 118 14 15.7 89 49 -- 150 2 6.3 NC NC -- NC
Esophageal 4 5.4 NC NC -- NC 1 3.8 NC NC -- NC 3 1.7 NC NC -- NC
Hodgkin's Disease 1 3.0 NC NC -- NC 1 1.6 NC NC -- NC 0 1.4 NC NC -- NC
Kidney 6 8.9 68 25 -- 147 1 5.2 NC NC -- NC 5 3.7 135 43 -- 315
Leukemia 10 9.1 110 53 -- 203 6 4.9 122 44 -- 265 4 4.1 NC NC -- NC
Liver 4 2.0 NC NC -- NC 2 1.3 NC NC -- NC 2 0.7 NC NC -- NC
NHL 21 14.2 148 91 -- 226 11 7.0 158 79 -- 282 10 7.3 138 66 -- 254
Pancreatic 12 11.0 109 56 -- 191 5 5.0 99 32 -- 232 7 6.0 118 47 -- 242
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 12b
Cancer Incidence
Holyoke, Massachusetts
1982-1987
Census Tract 8121
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 15 21.2 71 40 -- 117 8 15.2 53 23 -- 104 7 6.0 117 47 -- 241
Esophageal 8 6.1 131 56 -- 257 4 4.2 NC NC -- NC 4 2.0 NC NC -- NC
Hodgkin's Disease 3 3.2 NC NC -- NC 2 1.7 NC NC -- NC 1 1.5 NC NC -- NC
Kidney 9 12.3 73 33 -- 139 5 7.5 67 22 -- 156 4 4.8 NC NC -- NC
Leukemia 10 9.2 108 52 -- 200 4 5.1 NC NC -- NC 6 4.1 146 53 -- 317
Liver 5 2.6 NC NC -- NC 5 1.9 265 85 -- 617 0 0.7 NC NC -- NC
NHL 14 18.0 78 43 -- 131 6 8.8 68 25 -- 148 8 9.2 87 38 -- 172
Pancreatic 17 11.3 150 87 -- 241 5 5.2 97 31 -- 226 12 6.2 195* 101 -- 340
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 12c
Cancer Incidence
Holyoke, Massachusetts
1988-1993
Census Tract 8121
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 26 23.9 109 71 -- 159 19 17.2 111 67 -- 173 7 6.7 104 42 -- 215
Esophageal 10 8.0 125 60 -- 230 6 5.8 103 38 -- 224 4 2.2 NC NC -- NC
Hodgkin's Disease 3 3.4 NC NC -- NC 0 1.8 NC NC -- NC 3 1.6 NC NC -- NC
Kidney 19 15.1 126 76 -- 197 12 9.1 131 68 -- 229 7 5.9 118 47 -- 243
Leukemia 19 13.7 139 83 -- 216 14 7.4 190* 104 -- 318 5 6.3 79 25 -- 184
Liver 2 4.4 NC NC -- NC 2 3.1 NC NC -- NC 0 1.2 NC NC -- NC
NHL 21 24.2 87 54 -- 133 9 12.4 73 33 -- 138 12 11.8 102 52 -- 177
Pancreatic 14 15.0 94 51 -- 157 4 6.8 NC NC -- NC 10 8.1 123 59 -- 227
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 12d
Cancer Incidence
Holyoke, Massachusetts
1994-2000
Census Tract 8121
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 20 12.8 156 95 -- 241 17 9.8 173* 101 -- 277 3 3.0 NC NC -- NC
Esophageal 2 4.1 NC NC -- NC 1 3.2 NC NC -- NC 1 0.9 NC NC -- NC
Hodgkin's Disease 3 3.1 NC NC -- NC 2 1.7 NC NC -- NC 1 1.3 NC NC -- NC
Kidney 7 8.3 84 34 -- 173 1 5.4 NC NC -- NC 6 2.9 206 75 -- 448
Leukemia 7 7.1 98 39 -- 202 4 4.3 NC NC -- NC 3 2.9 NC NC -- NC
Liver 0 2.0 NC NC -- NC 0 1.6 NC NC -- NC 0 0.5 NC NC -- NC
NHL 7 12.5 56 22 -- 115 3 7.2 NC NC -- NC 4 5.3 NC NC -- NC
Pancreatic 7 7.0 101 40 -- 207 2 3.8 NC NC -- NC 5 3.2 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 13a
Cancer Incidence
Southampton, Massachusetts
1982-2000
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 8 3.6 220 95 -- 433 6 2.8 216 79 -- 470 2 0.9 NC NC -- NC
Esophageal 0 1.0 NC NC -- NC 0 0.7 NC NC -- NC 0 0.2 NC NC -- NC
Hodgkin's Disease 0 0.9 NC NC -- NC 0 0.5 NC NC -- NC 0 0.4 NC NC -- NC
Kidney 1 1.7 NC NC -- NC 1 1.1 NC NC -- NC 0 0.6 NC NC -- NC
Leukemia 2 1.7 NC NC -- NC 0 1.0 NC NC -- NC 2 0.7 NC NC -- NC
Liver 0 0.4 NC NC -- NC 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC
NHL 1 2.7 NC NC -- NC 0 1.5 NC NC -- NC 1 1.2 NC NC -- NC
Pancreatic 1 1.7 NC NC -- NC 1 0.9 NC NC -- NC 0 0.8 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 13b
Cancer Incidence
Southampton, Massachusetts
1982-1987
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 9 3.9 230* 105 -- 436 8 3.0 266* 114 -- 524 1 0.9 NC NC -- NC
Esophageal 1 1.2 NC NC -- NC 0 0.9 NC NC -- NC 1 0.3 NC NC -- NC
Hodgkin's Disease 1 1.0 NC NC -- NC 0 0.6 NC NC -- NC 1 0.4 NC NC -- NC
Kidney 2 2.7 NC NC -- NC 0 1.8 NC NC -- NC 2 0.9 NC NC -- NC
Leukemia 2 2.0 NC NC -- NC 1 1.2 NC NC -- NC 1 0.8 NC NC -- NC
Liver 0 0.6 NC NC -- NC 0 0.4 NC NC -- NC 0 0.1 NC NC -- NC
NHL 3 3.8 NC NC -- NC 2 2.2 NC NC -- NC 1 1.6 NC NC -- NC
Pancreatic 5 2.0 248 80 -- 579 1 1.1 NC NC -- NC 4 0.9 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 13c
Cancer Incidence
Southampton, Massachusetts
1988-1993
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 3 5.2 NC NC -- NC 3 3.8 NC NC -- NC 0 1.3 NC NC -- NC
Esophageal 1 2.0 NC NC -- NC 1 1.6 NC NC -- NC 0 0.4 NC NC -- NC
Hodgkin's Disease 2 1.2 NC NC -- NC 2 0.7 NC NC -- NC 0 0.5 NC NC -- NC
Kidney 4 4.1 NC NC -- NC 0 2.6 NC NC -- NC 4 1.5 NC NC -- NC
Leukemia 3 3.5 NC NC -- NC 3 2.0 NC NC -- NC 0 1.5 NC NC -- NC
Liver 0 1.2 NC NC -- NC 0 0.9 NC NC -- NC 0 0.3 NC NC -- NC
NHL 3 6.3 NC NC -- NC 1 3.5 NC NC -- NC 2 2.8 NC NC -- NC
Pancreatic 1 3.3 NC NC -- NC 0 1.7 NC NC -- NC 1 1.6 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 13d
Cancer Incidence
Southampton, Massachusetts
1994-2000
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 147 128.9 114 96 -- 134 110 92.5 119 98 -- 143 37 36.3 102 72 -- 140
Esophageal 37 39.8 93 65 -- 128 29 28.6 101 68 -- 145 8 11.2 72 31 -- 141
Hodgkin's Disease 21 27.2 77 48 -- 118 8 14.4 56 24 -- 110 13 12.8 102 54 -- 174
Kidney 77 77.7 99 78 -- 124 43 46.8 92 66 -- 124 34 30.8 110 76 -- 154
Leukemia 65 68.8 95 73 -- 120 40 37.8 106 76 -- 144 25 31.0 81 52 -- 119
Liver 21 19.1 110 68 -- 168 16 13.7 117 67 -- 190 5 5.4 93 30 -- 217
NHL 94 120.2 78* 63 -- 96 51 61.6 83 62 -- 109 43 58.6 73* 53 -- 99
Pancreatic 66 73.4 90 70 -- 114 39 34.3 114 81 -- 155 27 39.1 69 45 -- 100
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 14a
Cancer Incidence
Westfield, Massachusetts
1982-2000
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 45 40.7 111 81 -- 148 33 29.4 113 77 -- 158 12 11.3 106 55 -- 185
Esophageal 8 10.6 76 33 -- 149 5 7.5 67 22 -- 156 3 3.1 NC NC -- NC
Hodgkin's Disease 6 8.2 73 27 -- 158 2 4.4 NC NC -- NC 4 3.9 NC NC -- NC
Kidney 21 18.0 117 72 -- 178 11 10.6 104 52 -- 186 10 7.4 135 65 -- 249
Leukemia 17 18.5 92 54 -- 148 10 10.2 98 47 -- 179 7 8.2 85 34 -- 176
Liver 1 3.9 NC NC -- NC 1 2.7 NC NC -- NC 0 1.2 NC NC -- NC
NHL 19 28.6 66 40 -- 104 10 14.5 69 33 -- 126 9 14.1 64 29 -- 121
Pancreatic 14 20.6 68 37 -- 114 9 9.7 93 42 -- 176 5 10.9 46 15 -- 107
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 14b
Cancer Incidence
Westfield, Massachsuetts
1982-1987
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 49 40.2 122 90 -- 161 37 29.0 128 90 -- 176 12 11.2 107 55 -- 187
Esophageal 11 12.0 91 46 -- 164 8 8.4 95 41 -- 187 3 3.6 NC NC -- NC
Hodgkin's Disease 6 9.0 67 24 -- 146 4 4.7 NC NC -- NC 2 4.3 NC NC -- NC
Kidney 20 25.5 78 48 -- 121 12 15.6 77 40 -- 134 8 9.9 81 35 -- 160
Leukemia 19 19.5 97 59 -- 152 12 10.9 110 57 -- 192 7 8.6 82 33 -- 168
Liver 7 5.4 131 52 -- 269 5 3.9 129 42 -- 202 2 1.5 NC NC -- NC
NHL 27 37.4 72 48 -- 105 13 19.2 68 36 -- 116 14 18.2 77 42 -- 129
Pancreatic 23 21.7 106 67 -- 159 14 10.2 137 75 -- 230 9 11.5 78 36 -- 148
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 14c
Cancer Incidence
Westfield, Massachusetts
1988-1993
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 53 47.1 113 84 -- 147 40 34.0 118 85 -- 161 13 13.3 97 52 -- 167
Esophageal 18 16.9 106 63 -- 168 16 12.6 127 72 -- 206 2 4.3 NC NC -- NC
Hodgkin's Disease 9 9.9 91 42 -- 173 2 5.3 NC NC -- NC 7 4.6 153 61 -- 316
Kidney 36 33.7 107 75 -- 148 20 20.5 98 60 -- 151 16 13.2 121 69 -- 196
Leukemia 29 30.3 96 64 -- 137 18 16.5 109 65 -- 173 11 13.8 79 40 -- 142
Liver 13 9.7 134 71 -- 230 10 7.1 142 68 -- 261 3 2.6 NC NC -- NC
NHL 48 53.4 90 66 -- 119 28 27.8 101 67 -- 146 20 25.7 78 48 -- 120
Pancreatic 29 30.4 95 64 -- 137 16 14.2 112 64 -- 182 13 16.2 80 43 -- 137
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 14d
Cancer Incidence
Westfield, Massachusetts
1994-2000
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 28 18.1 155* 103 -- 223 22 13.8 160 100 -- 242 6 4.4 137 50 -- 299
Esophageal 6 5.8 103 38 -- 224 5 4.5 111 36 -- 260 1 1.3 NC NC -- NC
Hodgkin's Disease 8 4.6 174 75 -- 342 2 2.5 NC NC -- NC 6 2.1 287* 105 -- 624
Kidney 9 11.7 77 35 -- 146 6 7.5 80 29 -- 175 3 4.3 NC NC -- NC
Leukemia 15 10.3 146 82 -- 241 9 6.0 150 68 -- 284 6 4.2 141 52 -- 308
Liver 2 2.9 NC NC -- NC 1 2.2 NC NC -- NC 1 0.7 NC NC -- NC
NHL 12 17.6 68 35 -- 119 3 9.9 NC NC -- NC 9 7.8 116 53 -- 220
Pancreatic 9 9.9 91 41 -- 172 8 5.2 152 66 -- 300 1 4.7 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 15a
Cancer Incidence
Westfield, Massachusetts
1982-2000
Census Tract 8125
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 10 5.6 179 86 -- 329 8 4.3 187 81 -- 369 2 1.3 NC NC -- NC
Esophageal 0 1.5 NC NC -- NC 0 1.1 NC NC -- NC 0 0.4 NC NC -- NC
Hodgkin's Disease 3 1.4 NC NC -- NC 0 0.8 NC NC -- NC 3 0.7 NC NC -- NC
Kidney 2 2.6 NC NC -- NC 1 1.6 NC NC -- NC 1 1.0 NC NC -- NC
Leukemia 4 2.7 NC NC -- NC 2 1.6 NC NC -- NC 2 1.1 NC NC -- NC
Liver 0 0.6 NC NC -- NC 0 0.4 NC NC -- NC 0 0.2 NC NC -- NC
NHL 5 4.1 123 40 -- 287 1 2.3 NC NC -- NC 4 1.8 NC NC -- NC
Pancreatic 0 2.7 NC NC -- NC 0 1.4 NC NC -- NC 0 1.2 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 15b
Cancer Incidence
Westfield, Massachusetts
1982-1987
Census Tract 8125
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 9 5.6 161 73 -- 305 7 4.3 164 66 -- 339 2 1.3 NC NC -- NC
Esophageal 3 1.7 NC NC -- NC 2 1.3 NC NC -- NC 1 0.4 NC NC -- NC
Hodgkin's Disease 2 1.5 NC NC -- NC 1 0.8 NC NC -- NC 1 0.7 NC NC -- NC
Kidney 2 3.8 NC NC -- NC 1 2.5 NC NC -- NC 1 1.4 NC NC -- NC
Leukemia 2 2.9 NC NC -- NC 1 1.7 NC NC -- NC 1 1.2 NC NC -- NC
Liver 0 0.8 NC NC -- NC 0 0.6 NC NC -- NC 0 0.2 NC NC -- NC
NHL 3 5.4 NC NC -- NC 1 3.1 NC NC -- NC 2 2.4 NC NC -- NC
Pancreatic 5 2.9 172 55 -- 400 4 1.6 NC NC -- NC 1 1.4 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 15c
Cancer Incidence
Westfield, Massachusetts
1988-1993
Census Tract 8125
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 9 7.0 128 59 -- 243 7 5.2 133 53 -- 275 2 1.8 NC NC -- NC
Esophageal 3 2.7 NC NC -- NC 3 2.1 NC NC -- NC 0 0.6 NC NC -- NC
Hodgkin's Disease 3 1.7 NC NC -- NC 1 0.9 NC NC -- NC 2 0.8 NC NC -- NC
Kidney 5 5.4 92 30 -- 214 4 3.4 NC NC -- NC 1 2.0 NC NC -- NC
Leukemia 9 4.8 186 85 -- 353 6 2.7 218 80 -- 475 3 2.1 NC NC -- NC
Liver 2 1.6 NC NC -- NC 1 1.2 NC NC -- NC 1 0.4 NC NC -- NC
NHL 4 8.4 NC NC -- NC 1 4.6 NC NC -- NC 3 3.8 NC NC -- NC
Pancreatic 4 4.5 NC NC -- NC 4 2.3 NC NC -- NC 0 2.2 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 15d
Cancer Incidence
Westfield, Massachusetts
1994-2000
Census Tract 8125
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Appendix A:  
Coding Definitions of Cancer Site/Type* 
 
  ICD-O-1 and Other  
Pre-ICD-O-2 Codes 
ICD-O-2 Codes ICD-O-3 Codes 
Cancer Site / Type Site code Histology code Site code Histology code Site code Histology code 
Bladder 188.0-188.9 except 9590-
9980 
C67.0-C67.9 except 9590-
9989 
C67.0-C67.9 except 9590-9989 
Esophagus 150.0-150.9 except 9590-
9980 
C15.0-C15.9 except 9590-
9989 
C15.0-C15.9 except 9590-9989 
Hodgkin’s Disease 140.0-199.9 includes O9650-
O9667, P9653-
P9683, B9653-
B9658 
C00.00-C80.9 includes 9650-
9667 
C00.00-C80.9 includes 9650-
9667 
Kidney &  
Renal Pelvis 
189.0, 189.1 except 9590-
9980 
C64.9, C65.9 
 
except 9590-
9989 
C64.9, C65.9 
 
except 9590-9989 
Leukemia 
 
 
 
 
140.0-199.9 
 
includes O9800-
O9943, O9951, 
P9803-P9943, 
B9803-B9943 
1. C00.0-
C80.9 
 
AND 
2. C42.0, 
C42.1, C42.4 
1. includes 9800-
9822, 9824-
9826, 9828-9941 
 
2. includes 9823, 
9827 
1. C00.0-
C80.9 
 
AND 
2. C42.0, 
C42.1, C42.4 
1. includes 9733, 
9742, 9800-9820, 
9826, 9831-9948, 
9963-9964 
2. includes 9823, 
9827 
Liver 
 
155.0 except 9590-
9980 
C22.0 
 
except 9590-
9989 
C22.0 
 
except 9590-9989 
Non-Hodgkin's 
Lymphoma (NHL) 
 
 
 
 
 
140.0-199.9 
 
includes O9590-
O9642, O9670-
O9710, O9750, 
P9593-P9643, 
P9693-P9713, 
P9753, B9593-
B9643, B9703 
1. C00.0-
C80.9 
 
AND 
2. All sites 
except C42.0, 
C42.1, C42.4 
1. includes 9590-
9595, 9670-9717 
 
2. includes 9823, 
9827 
1. C00.0-
C80.9 
 
AND 
2. All sites 
except C42.0, 
C42.1, C42.4 
1. includes 9590-
9596, 9670-9729 
 
2. includes 9823, 
9827 
Pancreas 157.0-157.9 except 9590-
9980 
C25.0-C25.9 except 9590-
9989 
C25.0-C25.9 except 9590-9989 
*Note:  Includes invasive tumors only, selected by excluding in situ stages J0, S0, TTISNXM0, TTANXMX, TTANXM0, TTAN0MX, TTISN0M0, TTISNXMX, TTISN0MX, TTISN0M0, TTIN0M0, 
TTIN0MX, TTINXM0, and TTINXMX (1982-1994 data) or by specifying behavior code (1995-present data). 
ICD-O = International Classification of Diseases for Oncology 
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Bladder Cancer 
 
The American Cancer Society estimates that bladder cancer will affect 61,420 people in the U.S. in 2006, 
accounting for 6% of all cancers diagnosed in the United States among men and 2% among women.  In 
Massachusetts, bladder cancer accounts for approximately 5% of all cancers diagnosed among males and 
females combined (ACS 2006a).  Males are four times more likely to develop bladder cancer than 
females and whites are two times more likely to develop this disease than blacks.  The risk of bladder 
cancer increases with age and nearly 90% of people with this cancer are over the age of 55 at the time of 
diagnosis (ACS 2006b). 
 
The greatest risk factor for bladder cancer is cigarette smoking.  Smokers are more than twice as likely to 
develop bladder cancer compared to nonsmokers (ACS 2006a).  The risk of developing bladder cancer 
increases with the number of packs smoked per day and with duration of smoking.  Further, the risk of 
bladder cancer may be higher in women than in men who smoke comparable numbers of cigarettes 
(Castelao et al. 2001).  Approximately 25-60% of all bladder cancers can be attributed to tobacco use 
(Johansson and Cohen 1997).  Smoking cessation has been found to reduce the risk of developing bladder 
cancer by 30% to 60% (Silverman et al. 1996). 
 
Studies have also revealed a number of occupations that are associated with bladder cancer.  In fact, 
exposures to chemicals in the workplace account for an estimated 20-25% of all bladder cancers 
diagnosed among men in the U.S. (Johansson and Cohen 1997).  Occupational exposure to aromatic 
amines, such as benzidine and beta-naphthylamine, increases the risk of bladder cancer (ACS 2006b).  
These chemicals were common in the dye industry in the past.  A higher risk of bladder cancer has also 
been observed among aromatic amine manufacturing workers as well as among workers in the rubber, 
leather, textiles, printing, and paint products industries (ACS 2006a, Silverman et al. 1996).  The 
development of new chemicals, changed worker exposures, and the elimination of many known bladder 
carcinogens in the workplace have caused shifts in those occupations considered to be high risk.  For 
example, risks among dye, rubber, and leather workers have declined over time, while other occupations 
such as motor vehicle operation (e.g., drivers of trucks, buses, and taxis) and the aluminum industry have 
emerged as potential high-risk occupations (Silverman et al. 1996).  However, specific occupational 
exposures in these occupations have not been confirmed and study findings are not consistent.  Further, 
the risk of bladder cancer from occupational exposures may be increased among smokers (ACS 2006b). 
 
Dietary factors such as consumption of fried foods as well as foods high in fat and cholesterol have been 
found to be associated with increased bladder cancer risk (Silverman et al. 1996).  Use of some anti-
cancer drugs (e.g., cyclophosphamide and chlornaphazine), use of phenacetin, and infection with 
Shistosoma haematobium (a parasite found in Africa) are thought to be associated with the development 
of bladder cancer.  However, not all epidemiological studies have produced convincing findings 
(Silverman et al. 1996). 
 
Other risk factors for bladder cancer include a personal history of bladder cancer, certain rare birth defects 
involving the bladder, and exposure to ionizing radiation (ACS 2006b, Silverman et al. 1996).  Exposure 
to chlorinated by-products in drinking water has also been suggested to increase bladder cancer risk.  
However, a recent population-based study found that an association was present only among smokers 
(Cantor et al. 1998). 
 
References 
 
American Cancer Society. 2006a. Cancer Facts & Figures 2006.  Atlanta: American Cancer Society, Inc. 
 
American Cancer Society (ACS). 2006b. Detailed Guide: Bladder Cancer. Available at: http://www.cancer.org.   
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES 
Source: Community Assessment Program, Bureau of Environmental Health, Massachusetts Department of Public Health 
March 2006 
159 
 
Cantor KP, Lynch CF, Hildesheim ME, et al. 1998. Drinking water source and chlorination by-products I. Risk of 
bladder cancer. Epidemiology 9(1):21-28. 
 
Castelao JE, Yuan JM, Skipper PL, et al. 2001. Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 
93(7):538-45. 
 
Johansson SL, Cohen SM. 1997. Epidemiology and etiology of bladder cancer. Semin Surg Oncol 13:291-298. 
 
Silverman D, Morrison A, Devesa S. 1996. Bladder Cancer. In: Cancer Epidemiology and Prevention. 2
nd
 Ed, edited 
by Schottenfeld D, Fraumeni. JF. New York:  Oxford University Press. 
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES 
Source: Community Assessment Program, Bureau of Environmental Health, Massachusetts Department of Public Health 
March 2006 
160 
Hodgkin’s disease 
 
Hodgkin’s disease (or Hodgkin’s lymphoma) is a form of cancer that involves the lymphatic system and 
can be distinguished from non-Hodgkin’s lymphomas by cancer cell type.  The American Cancer Society 
estimates that there will be approximately 7,800 new cases of this disease in the U.S. in 2006, accounting 
for less than 1% of all cancer types, and approximately 1,490 deaths (ACS 2006).  Because of substantial 
improvement in effective therapy for this disease, mortality rates have decreased approximately 60% 
since the early 1970s (ACS 2006). 
 
Epidemiologic studies have shown that Hodgkin’s disease is more common among men than women and 
more common among whites than blacks.  People of Jewish descent appear to be at higher risk of 
Hodgkin’s disease compared to people of non-Jewish descent (Mueller 1996).  Although the disease is 
relatively rare among children, two peaks in the age distribution have been observed for this cancer type.  
The first peak occurs in young adults usually between the ages of 15 to 40 (typically ages 25-30) and the 
second peak occurs in adults aged 55 years and above (ACS 2006).   
 
Scientists have identified a few risk factors that may make a person more likely to develop Hodgkin’s 
disease.  The bimodal age distribution of this disease suggests that two distinct etiologies (or causes) for 
Hodgkin’s disease may be involved for each group.  A four times higher rate of Hodgkin’s disease has 
been observed in individuals who have had infectious mononucleosis, an infection that is caused by the 
Epstein-Barr virus (EBV).  The virus is present in the lymph nodes of approximately half of the 
individuals diagnosed with Hodgkin’s disease the other half have no evidence of EBV in their Hodgkin 
cells (ACS 2006).  The absence of EBV infection in about half the cases and the high prevalence of EBV 
in the general population suggest that EBV may be only one of several factors in the development of this 
cancer.  Although cytomegalovirus (CMV) and the more recently identified human herpesvirus type 6 
have been considered as possible factors in the development of Hodgkin’s disease, results of antibody 
studies are inconsistent; these viruses do not appear to be related to the risk of Hodgkin’s disease (Mueller 
1996). 
 
Slightly higher rates of Hodgkin’s disease occur among people with reduced immunity, such as those 
with AIDS, people with congenital immune deficiencies, and individuals on immunosuppressant 
medication following organ transplants.  However, Hodgkin’s disease occurs at a much lower rate than 
non-Hodgkin’s lymphomas among this group of individuals (ACS 2006). 
 
Hodgkin’s disease trends in the young adult population reveal that the disease has become increasingly 
associated with populations both of middle to higher socioeconomic status and small family size.  These 
factors are consistent with susceptibility to late infections with common childhood viruses, supporting the 
theory that Hodgkin’s disease is associated with an infectious agent (Mueller 1996).  Occupational 
exposures to workers in the chemical industry and woodworkers have also been suggested in several 
epidemiologic studies to be associated with the development of Hodgkin’s disease.  However, specific 
chemical exposures related to the development of this disease have not been identified and results of 
studies investigating occupational exposures are inconsistent (Mueller 1996).  Based on an examination of 
medical and scientific literature, the American Cancer Society concludes that although the exact cause 
remains unknown, Hodgkin’s disease does not seem to be caused by lifestyle (e.g., dietary), or 
environmental factors (ACS 2006). 
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Kidney cancer 
 
Kidney cancer involves a number of tumor types located in various areas of the kidney and renal system.  
Renal cell cancer (which affects the main area of the kidney) accounts for over 90% of all malignant 
kidney tumors (ACS 2006a).  The American Cancer Society estimates that there will be approximately 
38,890 cases of kidney and upper urinary tract cancer, resulting in more than 12,840 deaths in 2006 (ACS 
2006a).  Kidney cancer is twice as common in males as it is in females and the incidence most often 
occurs in individuals between 55 and 84 years of age (ACS 2006a).  The gender distribution of this 
disease may be attributed to the fact that men are more likely to smoke and are more likely to be exposed 
to potentially carcinogenic chemicals at work. 
 
Since 1970, U.S. incidence rates for renal cell cancer have risen between 2% and 4% annually among the 
four major race and gender groups (i.e., white males, white females, black males, and black females) (Chow 
et al. 1999, McLaughlin et al. 1996).  Rapid increases in incidence among blacks as compared to among 
whites have resulted in an excess of the disease among blacks; age-adjusted incidence rates between 1975 
and 1995 for white men, white women, black men, and black women were 9.6, 4.4, 11.1, and 4.9 per 100,000 
person-years, respectively (Chow et al. 1999).  Rising incidence rates may be partially due to the increased 
availability of screening for kidney cancer. 
 
The etiology of kidney cancer is not fully understood.  However, a number of environmental, cellular, and 
genetic factors have been studied as possible causal factors in the development of renal cell carcinoma.  
Cigarette smoking is the most important known risk factor for renal cell cancer.  Smoking increases the risk 
of developing renal cell cancer by about 40% (ACS 2006a).  In both males and females, a statistically 
significant dose-response relationship between smoking and this cancer has been observed (Yuan et al. 1998).  
 
Virtually every study that has examined body weight and renal cell cancer has observed a positive 
association.  Some studies suggest that obesity is a factor in 20% of people who develop kidney cancer (ACS 
2006a).  A diet high in protein (meat, animal fats, milk products, margarine and oils) has been implicated in 
epidemiological studies as a risk factor for renal cell carcinoma (McLaughlin et al. 1996).  Consumption of 
adequate amounts of fruits and vegetables lowers the risk of renal cell cancer.  In addition, use of diuretics 
and antihypertensive medications are associated with increased risk of renal cell carcinoma.  However, 
hypertension has also been linked to kidney cancer and it is not clear whether the disease or the medications 
used to treat them is the cause (ACS 2000).  Long-term use of pain relievers such as phenacetin (and possibly 
acetaminophen and aspirin) increases the risk for cancer of the renal pelvis and renal cell carcinoma 
(McLaughlin et al. 1996). 
 
Certain medical conditions that affect the kidneys have also been shown to increase kidney cancer risk.  
There is an increased incidence of renal carcinoma in patients with end-stage renal disease who develop 
acquired cystic disease of the kidney.  This phenomenon is seen among patients on long-term dialysis for 
renal failure (Linehan et al. 1997).  In addition, an association has been established between the incidence 
of von Hippel-Lindau disease and certain other inherited conditions in families and renal cell carcinoma, 
suggesting that genetic and hereditary risk factors may be important in the development of kidney cancer 
(ACS 2006a, McLaughlin et al. 1996).
 
 
Environmental and occupational factors have also been associated with the development of kidney cancer.  
Some studies have shown an increased incidence of this cancer type among leather tanners, shoe workers, 
and workers exposed to asbestos.  Exposure to cadmium is associated with an increased incidence of kidney 
cancer, particularly in men who smoke (ACS 2006a, Linehan et al. 1997).   In addition, workplace exposure 
to organic solvents, particularly trichloroethylene, may increase the risk of this cancer (ACS 2006a).  
Although occupational exposure to petroleum, tar, and pitch products has been implicated in the development 
of kidney cancer, most studies of oil refinery workers and petroleum products distribution workers have not 
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identified a definitive relationship between gasoline exposure and renal cancer (Linehan et al. 1997; 
McLaughlin et al. 1996).
 
 
Wilms’ tumor is the most common type of kidney cancer affecting children and accounts for approximately 
5% to 6% of all kidney cancers and about 6% of all childhood cancers.  This cancer is more common among 
African Americans than other races and among females than males.  Wilms’ tumor most often occurs in 
children under the age of 7 years.  The causes of Wilms’ tumor are not known, but certain birth defect 
syndromes and other genetic risk factors (such as family history or genetic mutations) are connected with this 
cancer.  However, most children who develop Wilms’ tumor do not have any known birth defects or inherited 
gene changes.  No environmental risk factors, either before or after a child’s birth, have been shown to be 
associated with the development of Wilms’ tumor (ACS 2006b). 
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Leukemia 
 
Leukemia is the general term that includes a group of different cancers that occur in the blood forming 
organs and result in the formation of abnormal amounts and types of white blood cells in the blood and 
bone marrow.  Individuals with leukemia generally maintain abnormally high amounts of leukocytes or 
white blood cells in their blood.  This condition results in an individual’s inability to maintain certain 
body functions, particularly a person’s ability to combat infection. 
 
In 2005, leukemia is expected to affect approximately 34,810 individuals (19,640 males and 15,420 
females) in the United States, resulting in 22,570 deaths.  In Massachusetts, approximately 770 
individuals will be diagnosed with the disease in 2005, representing more than 2% of all cancer 
diagnoses.  There are four major types of leukemia: acute lymphoid leukemia (ALL), acute myeloid 
leukemia (AML), chronic lymphoid leukemia (CLL), and chronic myeloid leukemia (CML).  There are 
also a few rare types, such as hairy cell leukemia.  In adults, the most common types are AML and CLL.  
Leukemia is the most common type of childhood cancer, accounting for about 30% of all cancers 
diagnosed in children.  The majority of these cases are of the ALL type (ACS 2005). 
 
While ALL occurs predominantly among children (peaking between ages 2 and 3 years), an elevation in 
incidence is also seen among older individuals.  The increase in incidence among older individuals begins 
at approximately 40-50 years of age, peaking at about age 85 (Linet and Cartwright 1996).  ALL is more 
common among whites than African Americans and among males than females (Weinstein and Tarbell 
1997).  Exposure to high-dose radiation (e.g., by survivors of atomic bomb blasts or nuclear reactor 
accidents) is a known environmental risk factor associated with the development of ALL (Scheinberg et 
al. 1997).  Significant radiation exposure (e.g., diagnostic x-rays) before birth may carry up to a 5-fold 
increased risk of developing ALL (ACS 2000b).  However, few studies report an increased risk of 
leukemia associated with residing in proximity to nuclear plants or occupational exposure to low-dose 
radiation (Linet and Cartwright 1996, Scheinberg et al. 1997).  It is unclear whether exposure to 
electromagnetic fields (EMF) plays a role in the development of ALL; however, most studies to date have 
found little or no risk (ACS 2000b). 
 
Few other risk factors for ALL have been identified.  There is evidence that genetics may play an 
important role in the development of this leukemia type.  Studies indicate that siblings of twins who 
develop leukemia are at an increased risk of developing the disease.  Children with Down’s syndrome are 
10 to 20 times more likely to develop acute leukemia (Weinstein and Tarbell 1997).  In addition, other 
genetic diseases, such as Li-Fraumeni syndrome and Klinefelter’s syndrome, are associated with an 
increased risk of developing leukemia.  Patients receiving medication that suppresses the immune system 
(e.g., organ transplant patients) may be more likely to develop ALL (ACS 2000b).  ALL has not been 
definitively linked to chemical exposure, however, childhood ALL may be associated with maternal 
occupational exposure to pesticides during pregnancy (Infante-Rivard et al. 1999).  Certain rare types of 
adult ALL are caused by human T-cell leukemia/lymphoma virus-I (HTLV-I) (ACS 2000a).  Some 
reports have linked other viruses with various types of leukemia, including Epstein-Barr virus and 
hepatitis B virus.  Still others propose that leukemia may develop as a response to viral infection.  
However, no specific virus has been identified as related to ALL (Linet and Cartwright 1996).  Recent 
reports also suggest an infectious etiology for some childhood ALL cases, although a specific viral agent 
has not been identified and findings from studies exploring contact among children in day-care do not 
support this hypothesis (Greaves 1997, Kinlen and Balkwill 2001, Rosenbaum et al. 2000). 
 
Although AML can occur in children (usually during the first 2 years of life), AML is the most common 
leukemia among adults, with an average age at diagnosis of 65 years (ACS 2000a, 2000b).  This type of 
leukemia is more common among males than among females but affects African Americans and whites at 
similar rates (Scheinberg et al. 1997).  High-dose radiation exposure (e.g., by survivors of atomic bomb 
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blasts or nuclear reactor accidents), long-term occupational exposure to benzene, and exposure to certain 
chemotherapy drugs, especially alkylating agents (e.g., mechlorethamine, cyclophosphamide), have been 
associated with an increased risk of developing AML among both children and adults (ACS 2000a, ACS 
2000b, Linet and Cartwright 1996).  The development of childhood AML is suspected to be related to 
parental exposure to pesticides and other chemicals, although findings are inconsistent (Linet and 
Cartwright 1996).  Recent studies have suggested a link between electromagnetic field (EMF) exposure 
(e.g., from power lines) and leukemia (Minder and Pfluger 2001, Schuz et al. 2001).  However, there is 
conflicting evidence regarding EMF exposure and leukemia and it is clear that most cases are not related 
to EMF (ACS 2000a, Kleinerman et al. 2000). 
 
Other possible risk factors related to the development of AML include cigarette smoking and genetic 
disorders.  It is estimated that approximately one-fifth of cases of AML are caused by smoking 
(Scheinberg et al. 1997).  Also, a small number of AML cases can be attributed to rare inherited disorders.  
These include Down’s syndrome in children, Fanconi’s anemia, Wiskott-Aldrich syndrome, Bloom’s 
syndrome, Li-Fraumeni syndrome, and ataxia telangiectasia (ACS 2000a, 2000b).  Recently, scientists 
have suggested that a mutation in a gene responsible for the deactivation of certain toxic metabolites may 
have the ability to increase the risk of acute myeloid leukemia in adults.  However, further research is 
necessary in order to confirm the findings of this study (Smith et al. 2001).  
 
CLL is chiefly an adult disease; the average age at diagnosis is about 70 years (ACS 1999).  Twice as 
many men as women are affected by this type of leukemia (Deisseroth et al. 1997).  While genetics and 
diseases of the immune system have been suggested as playing a role in the development of CLL, high-
dose radiation and benzene exposure have not (ACS 1999, Weinstein and Tarbell 1997).  It is thought that 
individuals with a family history of CLL are two to four times as likely to develop the disease.  Some 
studies have identified an increased risk of developing CLL (as well as ALL, AML, and CML) among 
farmers due to long-term exposure to herbicides and/or pesticides (Linet and Cartwright 1996).  In 
addition, many researchers believe that cigarette smoking plays a role in some chronic leukemias.  The 
role of EMF in the development of chronic leukemia remains controversial (ACS 1999).  Although 
viruses have been implicated in the etiology of other leukemias, there is no evidence that viruses cause 
CLL (Deisseroth et al. 1997). 
 
Of all the leukemias, CML is among the least understood.  While this disease can occur at any age, CML 
is extremely rare in children (about 2% of leukemias in children) and the average age of diagnosis is 40 to 
50 years (ACS 1999).  Incidence rates are higher in males than in females, but unlike the other leukemia 
types, rates are higher in blacks than in whites in the U.S. (Linet and Cartwright 1996).  High-dose 
radiation exposure may increase the risk of developing CML (ACS 1999).  Finally, CML has been 
associated with chromosome abnormalities such as the Philadelphia chromosome (Weinstein and Tarbell 
1997). 
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Liver Cancer 
 
An estimated 18,510 people in the U.S. (12,600 men and 5,910 women) will be diagnosed with liver and 
intrahepatic bile duct cancer in 2006, accounting for approximately 1% of all new cancers (ACS 2006a).  
Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver and accounts for about 
75% of all cases.  Rarer forms of malignant liver cancer include the fibrolamellar subtype of HCC, 
cholangiocarcinoma, and angiosarcomain adults and hepatoblastoma in children.  Cholangriocarcinomas 
account for approximately 10% to 20% of all primary liver cancers and people with gallstones, gall 
bladder inflammation, chronic ulcerative colitis (long-standing inflammation of the large bowel) or 
chronic infection with certain types of parasitic worms are at an increased risk for developing this cancer.  
Hepatoblastoma is a rare cancer that forms usually in children under age 4 and has a 90% survival rate 
with early detection (ACS 2006b). 
 
In some developing countries, HCC is most common type of cancer diagnosed particularly in East Asia 
and Africa.   Incidence in the United States had been increasing up to 1999.  Recently, the rate has 
become more stable (ACS 2006b).  Rates of HCC in the U.S. had increased by 70% during the 1980s and 
1990s (Yu et al. 2000).  Similar trends were observed in Canada and Western Europe.  The primary 
reason for the higher rates observed during those years was the increase in hepatitis C virus infection, an 
important factor related to liver cancer (El-Serag 2001, El-Serag and Mason 2000).   
 
Men are at least three times more likely to develop HCC than women.  Much of this is likely due to 
differences in lifestyle factors which increase a person’s risk for developing liver cancer (ACS 2006b).  
Although 85% of individuals diagnosed with liver cancer are between 45 and 85 years of age, the disease 
can occur in persons of any age (ACS 2006b). 
 
Several important risk factors for liver cancer have been identified.  Chronic infection with hepatitis B 
virus (HBV) and hepatitis C virus (HCV) are the most significant risk factors for developing liver cancer 
(ACS 2006b).  It is estimated that 80% of HCC cases worldwide can be attributed to HBV infection (Yu 
et al. 2000).  In the United States, HBV accounts for less than a quarter of the cases and infection with 
HCV plays a much larger role in the incidence of this cancer.  HBV and HCV can be spread through 
intravenous drug use (e.g., the sharing of contaminated needles), unprotected sexual intercourse, and 
transfusion of and contact with unscreened blood and blood products.  In addition, mothers who are 
infected with these viruses can pass them on to their children at birth or in early infancy (ACS 2006b). 
 
Cirrhosis is also a major risk factor for the development of liver cancer.  Cirrhosis is a progressive disease 
that is the result of scar tissue formation on the liver, which can lead to cancer.  Researchers estimate that 
60% to 80% of HCC cases are associated with cirrhosis.  However, it is unclear if cirrhosis itself causes 
liver cancer or if the underlying causes of cirrhosis contribute to the development of this disease (Garr et 
al. 1997).  Most liver cirrhosis in the U.S. occurs as a result of chronic alcohol abuse, but HBV and HCV 
are also major causes of cirrhosis (ACS 2006b).  In addition, certain inherited metabolic diseases, such as 
hemochromatosis, which causes excess iron accumulation in the body, can lead to cirrhosis (ACS 2006b).  
Some studies have shown that people with hemochromatosis are at an increased risk of developing liver 
cancer (Fracanzani et al. 2001). 
 
Epidemiological and environmental evidence indicates that exposure to certain chemicals and toxins can 
also contribute significantly to the development of liver cancer.  For example, chronic consumption of 
alcoholic beverages has been associated with liver cancer (Wogan 2000).  As noted above, it is unclear if 
alcohol itself causes HCC or if underlying cirrhosis is the cause (London and McGlynn 1996).  However, 
it is clear that alcohol abuse can accelerate liver disease and may act as a co-carcinogen in the 
development of liver cancer (Ince and Wands 1999).  Long-term exposure to aflatoxin can also cause 
liver cancer.  Aflatoxins are carcinogenic agents produced by a fungus found in tropical and subtropical 
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regions.  Individuals may be exposed to aflatoxins if they consume contaminated peanuts and other foods 
that have been stored under hot, humid conditions (Wogan 2000).  Vinyl chloride, a known human 
carcinogen used in the manufacturing of some plastics, and thorium dioxide, used in the past for certain x-
ray tests, are risk factors for a rare type of liver cancer called angiosarcoma (ACS 2006b, London and 
McGlynn 1996).  These chemicals may also increase the risk of cholangiocarcinoma and HCC, but to a 
lesser degree.  The impact of both thorium dioxide and vinyl chloride on the incidence of liver cancer was 
much greater in the past, since thorium dioxide has not been used for decades and exposure of workers to 
vinyl chloride is now strictly regulated in the U.S. (ACS 2006b).  Drinking water contaminated with 
arsenic may increase the risk of liver cancer in some parts of the world (ACS 2006b, ATSDR 2001). 
 
The use of oral contraceptives by women may also be a risk factor in the development of liver cancer.  
However, most of the studies linking oral contraceptives and HCC involved types of oral contraceptives 
that are no longer used.  There is some indication that the increased risk may be confined to oral 
contraceptives containing mestranol.  It is not known if the newer oral contraceptives, which contain 
different types and doses of estrogen and different combinations of estrogen with other hormones, 
significantly increase the risk of HCC (ACS 2006b, London and McGlynn 1996).  Long-term anabolic 
steroid use may slightly increase the risk of HCC (ACS 2006b).  Although many researchers believe that 
cigarette smoking plays a role in the development of liver cancer, the evidence for this is still inconclusive 
(Mizoue et al. 2000, London and McGlynn 1996). 
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Non-Hodgkin’s Lymphoma 
 
Lymphomas are cancers involving the cells of the lymphatic system.  The majority of lymphomas involve 
the lymph nodes and spleen but the disease may also affect other areas within the body.  Non-Hodgkin’s 
lymphoma (NHL) is a classification of all lymphomas except Hodgkin’s disease.  Thus NHL is a mixed 
group of diseases that is characterized by the malignant increase in specific cells of the immune system (B 
or T lymphocytes).  B-cell lymphomas are more common than T-cell lymphomas, accounting for about 
85% of all cases of NHL (ACS 2003).  The various types of NHL are thought to represent different 
diseases with different causes (Scherr and Mueller 1996).  NHL can occur at all ages; however, the 
average age at diagnosis is in the early 60s and the incidence of this disease generally increases with age.  
This disease is more common in men than in women and affects whites more often than African 
Americans or Asian Americans (ACS 2003).  The American Cancer Society estimates that approximately 
56,390 Americans will be diagnosed with NHL in 2005, making it the fifth most common cancer in the 
U.S. among women and the sixth most common cancer among men, excluding non-melanoma skin 
cancers (ACS 2005). 
 
Overall, between 1973 and 1997, the incidence of NHL in the U.S. grew 81% (Garber 2001), although 
during the 1990s, the rate of increase appears to have stabilized (ACS 2005).  In Massachusetts, the 
incidence of NHL increased 50% during 1982-1997 from 10.5 cases per 100,000 to 15.7 cases per 
100,000 (MCR 1997, 2000).  The increase in NHL incidence has been attributed to better diagnosis, 
greater exposure to causative agents, and, to a lesser extent, the increasing incidence of AIDS-related 
lymphomas (Devesa and Fears, 1992, Scherr and Mueller, 1996).  Although the primary factors related to 
the development of NHL include conditions that suppress the immune system, viral infections, and certain 
occupational exposures, these factors are thought to account for only a portion of the increase observed in 
this cancer type (Scherr and Mueller 1996).  The observation that the rate of increase is declining for 
NHL may be attributed in part to increased use of antiretroviral therapy to slow HIV progression (Wingo 
et al. 1998). 
 
NHL is more common among people who have abnormal or compromised immune systems, such as those 
with inherited diseases that suppress the immune system, individuals with autoimmune disorders, and people 
taking immunosuppressant drugs following organ transplants.  Genetic predisposition (e.g., inherited immune 
deficiencies) only accounts for a small proportion of NHL cases (Scherr and Mueller 1996).  AIDS patients 
have a 100- to 300-fold higher risk for NHL than the general population (again, these cases account for only a 
minor part of overall NHL incidence) (Garber 2001).  NHL has also been reported to occur more frequently 
among individuals with conditions that require medical treatment resulting in suppression of the immune 
system, such as cancer chemotherapy.  However, current evidence suggests that the development of NHL is 
related to suppression of the individual’s immune system as a result of treatment, rather than the treatment 
itself (Scherr and Mueller 1996). 
 
Several viruses have been shown to play a role in the development of NHL.  Among organ transplant 
recipients, suppression of the immune system required for acceptance of the transplant leads to a loss of 
control or the reactivation of viruses that have been dormant in the body (e.g., Epstein-Barr Virus [EBV] and 
herpesvirus infections).  In addition, because cancer-causing viruses are known to cause lymphomas in 
various animals, it has been proposed that these types of viruses may also be associated with the development 
of NHL among humans without compromised immune systems.  Infection with the human T-cell 
leukemia/lymphoma virus (HTLV-I) is known to cause T-cell lymphoma among adults.  However, this is a 
relatively rare infection and most likely contributes only a small amount to the total incidence of NHL 
(Scherr and Mueller 1996).  EBV infection is common among the general population and has been shown to 
play a role in the development of most cases of transplant and AIDS related NHL.  The combination of 
immune system deficiencies and EBV infection may cause some people to develop NHL (ACS 2003).  
Although viruses are causal factors for some subtypes of NHL, to date, studies have shown that the role of 
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EBV in the development of NHL in the general population may not be large (Scherr and Mueller 1996).  
Moreover, the high prevalence of EBV in the general population suggests that EBV may be only one of 
several factors in the development of this cancer. 
 
Recent studies have found that a type of bacteria, Helicobacter pylori, a common cause of stomach ulcers, 
can also cause some lymphomas of the stomach (ACS 2003).  An important implication of this finding is that 
treatment with antibiotics could prevent some NHL of the stomach. 
 
Some occupations have been associated with an increased risk of developing NHL, such as occupations 
related to chemicals or agriculture.  Farmers, herbicide and pesticide applicators, and grain workers appear to 
have the most increased risk (Zahm 1990, 1993; Tatham et al. 1997).  Studies conducted among agricultural 
workers have demonstrated increases in NHL among those using herbicides for more than 20 days per year 
and individuals who mix or apply herbicides.  A greater incidence of NHL appears to be related specifically 
to exposure to the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) and organophosphate insecticides (Wigle 
et al. 1990, Zahm et al. 1990, Zahm et al. 1993).  Further studies of exposure to these chemicals and NHL 
incidence have shown that the increased risk is attributed to a specific impurity, 2,3,7,8-tetrachlorodibenzo-p-
dioxin or 2,3,7,8-TCDD, present in these herbicides.  However, reports of accidental industrial exposures to 
TCDD alone have not demonstrated an increased risk of NHL (Scherr and Mueller 1996).  An elevated risk 
for NHL development has also been noted among fence workers, orchard workers, and meat workers.  High-
dose exposure to benzene has been associated with NHL (ACS 2003); however, a recent international cohort 
study indicated that petroleum workers exposed to benzene were not at an increased risk of NHL (Wong and 
Raabe 2000). 
 
In addition, epidemiological studies of long-term users of permanent hair coloring products have 
suggested an increased incidence of NHL (Zahm et al. 1992, Scherr and Mueller 1996).  However, a 
recent population based study found no association between the use of hair color products and an 
increased risk of developing NHL.  The researchers further stated that results from this study and previous 
studies, including experimental animal studies, provide little convincing evidence linking NHL with 
normal use of hair dye (Holly et al. 1998). 
 
Although radiation (e.g., nuclear explosions or radioactive fallout from reactor accidents) has been implicated 
in the development of some cancers, including NHL (ACS 2003), there is little evidence for an increased risk 
of lymphoma due to radiation (Scherr and Mueller 1996). 
 
Recent studies have suggested that contamination of drinking water with nitrate may be associated with an 
increased risk of NHL (Ward et al. 1996).  Nitrate forms N-nitroso compounds which are known carcinogens 
and can be found in smoked or salt-dried fish, bacon, sausages, other cured meats, beer, pickled vegetables, 
and mushrooms. 
 
Smoking has also been suggested to increase the risk of NHL.  A study that evaluated the history of tobacco 
use and deaths from NHL determined that people who had ever smoked had a two-fold increase of dying 
from NHL as compared to those who never smoked.  Further, a four-fold increase was found among the 
heaviest smokers (Linet et al. 1992).  In addition, a more recent study that primarily examined occupation and 
NHL risk found a significant association with high levels of cigarette smoking and all NHL types (Tatham et 
al. 1997).  However, a recent review of five cohort studies and 14 case-control studies concludes that results 
of epidemiological studies have been inconsistent and that smoking has not been determined to be a definitive 
risk factor in the development of NHL (Peach and Barnett 2000). 
 
A recent Danish study has linked the use of tricyclic and tetracyclic antidepressants to NHL; however, more 
research is needed on this possible association (Dalton et al. 2000). 
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Although NHL is associated with a number of risk factors, the causes of this disease remain unknown.  Most 
patients with NHL do not have any known risk factors (ACS 2003). 
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Pancreatic Cancer 
 
The American Cancer Society estimates that approximately 32,180 people in the U.S. (16,100 men and 
16,080 women) will develop pancreatic cancer in 2005.  This disease accounts for approximately 2% of 
all new cases of cancer in both men and women, but between 5% and 6% of all cancer deaths (ACS 
2005).  This discrepancy has been attributed to detection of pancreatic cancer at an advanced stage and 
the short median survival time for this cancer of approximately three months.  Between 1920 and 1965, 
mortality from this disease increased nearly 200% from 2.9 to 8.2 per 100,000 people.  These increases 
are believed to be due, in part, to improved diagnosis during this time period (Anderson et al. 1996).  
However, over the past 25 years, incidence rates have declined slowly but consistently in men and a slight 
decline in rates among women has been observed since the mid-1980s.  Further, since about 1975, men 
have experienced a slight decrease in mortality from pancreatic cancer, although rates among women 
have not dropped (ACS 2005).  The risk of developing pancreatic cancer increases with age and the 
majority of cases occur between age 60 and 80.  Men are approximately 30% more likely to develop 
pancreatic cancer than are women (ACS 2000). 
 
Very little is known about what causes pancreatic cancer and how to prevent it.  However, a number of 
risk factors have been identified.  Besides age, the most consistent and only established risk factor for 
pancreatic cancer is cigarette smoking.  According to the American Cancer Society, approximately 30% 
of all pancreatic cancer cases are thought to result directly from cigarette smoking (ACS 2000).  Studies 
have estimated that the risk of pancreatic cancer is two to six times greater in heavy smokers than in non-
smokers (Anderson et al. 1996). 
 
Certain medical conditions, such as chronic pancreatitis, diabetes mellitus, and cirrhosis, have been 
associated with pancreatic cancer, but the reasons for these associations are largely unknown (ACS 2000).  
More recently, a possible role for the bacteria Helicobacter pylori, which causes ulcers and some gastric 
cancers, has been suggested in the development of pancreatic cancer (Stolzenberg-Solomon et al. 2001). 
 
There is also some evidence to suggest that certain dietary factors may be related to the development of 
pancreatic cancer.  Increased risks of pancreatic cancer may be associated with animal protein and fat 
consumption as evidenced by higher rates of this cancer in countries whose populations eat a diet high in 
fat (ACS 2005).  Decreased risks for the disease are usually associated with fruit and vegetable 
consumption (ACS 2000).  Obesity is also a risk factor for pancreatic cancer (ACS 2000).  Although older 
studies suggested that coffee and alcohol consumption may be risk factors, more recent studies do not 
support this association (Michaud et al. 2001).  
 
Numerous occupations have been investigated for their potential role in the development of pancreatic 
cancer, but studies have not produced consistent results.  Heavy exposure to certain pesticides (including 
DDT and its derivatives) may increase the risk of pancreatic cancer (ACS 2000, Ji et al. 2001, Porta et al. 
1999).  Exposure to certain dyes and certain chemicals related to gasoline, in addition to asbestos and 
ionizing radiation, have also been associated with the development of pancreatic cancer in some studies; 
however, other studies have found no link between these agents and pancreatic cancer (ACS 2000, 
Anderson et al. 1996).  A recent evaluation of data from several studies has implicated organic solvents 
(e.g., chlorinated hydrocarbons and polycyclic aromatic hydrocarbons), nickel compounds, and chromium 
compounds in the development of pancreatic cancer, but further studies are needed to corroborate this 
claim (Ojajarvi et al. 2000).  Although occupational exposures may have played a role in the incidence of 
this cancer in the past, currently most newly diagnosed patients with pancreatic cancer do not have 
evidence of a specific chemical exposure or relevant occupational history (Evans et al. 1997). 
 
Finally, pancreatic cancer seems to run in some families.  According to the American Cancer Society, an 
inherited tendency to develop pancreatic cancer may account for approximately 5% to 10% of cases (ACS 
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2000).  Pancreatic cancer has been observed in both familial clusterings among siblings as well as in 
individuals of consecutive generations (Anderson et al. 1996). 
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ATSDR Glossary of Terms 
 
The Agency for Toxic Substances and Disease Registry (ATSDR) is a federal public health 
agency with headquarters in Atlanta, Georgia, and 10 regional offices in the United States. 
ATSDR's mission is to serve the public by using the best science, taking responsive public health 
actions, and providing trusted health information to prevent harmful exposures and diseases 
related to toxic substances. ATSDR is not a regulatory agency, unlike the U.S. Environmental 
Protection Agency (EPA), which is the federal agency that develops and enforces environmental 
laws to protect the environment and human health. This glossary defines words used by ATSDR 
in communications with the public. It is not a complete dictionary of environmental health terms. 
If you have questions or comments, call ATSDR's toll-free telephone number, 1-888-42-ATSDR 
(1-888-422-8737). 
 
 
 
General Terms 
 
Absorption  
The process of taking in. For a person or an animal, absorption is the process of a substance 
getting into the body through the eyes, skin, stomach, intestines, or lungs.  
 
Acute  
Occurring over a short time [compare with chronic].  
 
Acute exposure  
Contact with a substance that occurs once or for only a short time (up to 14 days) [compare with 
intermediate duration exposure and chronic exposure].  
 
Additive effect  
A biologic response to exposure to multiple substances that equals the sum of responses of all the 
individual substances added together [compare with antagonistic effect and synergistic effect].  
 
Adverse health effect  
A change in body function or cell structure that might lead to disease or health problems  
 
Aerobic  
Requiring oxygen [compare with anaerobic].  
 
Ambient  
Surrounding (for example, ambient air).  
 
Anaerobic  
Requiring the absence of oxygen [compare with aerobic].  
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Analyte  
A substance measured in the laboratory. A chemical for which a sample (such as water, air, or 
blood) is tested in a laboratory. For example, if the analyte is mercury, the laboratory test will 
determine the amount of mercury in the sample.  
 
Analytic epidemiologic study  
A study that evaluates the association between exposure to hazardous substances and disease by 
testing scientific hypotheses.  
 
Antagonistic effect  
A biologic response to exposure to multiple substances that is less than would be expected if the 
known effects of the individual substances were added together [compare with additive effect 
and synergistic effect].  
 
Background level  
An average or expected amount of a substance or radioactive material in a specific environment, 
or typical amounts of substances that occur naturally in an environment.  
 
Biodegradation  
Decomposition or breakdown of a substance through the action of microorganisms (such as 
bacteria or fungi) or other natural physical processes (such as sunlight).  
 
Biologic indicators of exposure study  
A study that uses (a) biomedical testing or (b) the measurement of a substance [an analyte], its 
metabolite, or another marker of exposure in human body fluids or tissues to confirm human 
exposure to a hazardous substance [also see exposure investigation].  
 
Biologic monitoring  
Measuring hazardous substances in biologic materials (such as blood, hair, urine, or breath) to 
determine whether exposure has occurred. A blood test for lead is an example of biologic 
monitoring.  
 
Biologic uptake  
The transfer of substances from the environment to plants, animals, and humans.  
 
Biomedical testing  
Testing of persons to find out whether a change in a body function might have occurred because 
of exposure to a hazardous substance.  
 
Biota  
Plants and animals in an environment. Some of these plants and animals might be sources of 
food, clothing, or medicines for people.  
 
Body burden  
The total amount of a substance in the body. Some substances build up in the body because they 
are stored in fat or bone or because they leave the body very slowly.  
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CAP [see Community Assistance Panel.]  
 
Cancer  
Any one of a group of diseases that occur when cells in the body become abnormal and grow or 
multiply out of control.  
 
Cancer risk  
A theoretical risk for getting cancer if exposed to a substance every day for 70 years (a lifetime 
exposure). The true risk might be lower.  
 
Carcinogen  
A substance that causes cancer.  
 
Case study  
A medical or epidemiologic evaluation of one person or a small group of people to gather 
information about specific health conditions and past exposures.  
 
Case-control study  
A study that compares exposures of people who have a disease or condition (cases) with people 
who do not have the disease or condition (controls). Exposures that are more common among the 
cases may be considered as possible risk factors for the disease.  
 
CAS registry number  
A unique number assigned to a substance or mixture by the American Chemical Society 
Abstracts Service. 
 
Central nervous system  
The part of the nervous system that consists of the brain and the spinal cord.  
 
CERCLA [see Comprehensive Environmental Response, Compensation, and Liability Act of 
1980]  
 
Chronic  
Occurring over a long time [compare with acute].  
 
Chronic exposure  
Contact with a substance that occurs over a long time (more than 1 year) [compare with acute 
exposure and intermediate duration exposure]  
 
Cluster investigation 
A review of an unusual number, real or perceived, of health events (for example, reports of 
cancer) grouped together in time and location. Cluster investigations are designed to confirm 
case reports; determine whether they represent an unusual disease occurrence; and, if possible, 
explore possible causes and contributing environmental factors.  
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Community Assistance Panel (CAP)  
A group of people from a community and from health and environmental agencies who work 
with ATSDR to resolve issues and problems related to hazardous substances in the community. 
CAP members work with ATSDR to gather and review community health concerns, provide 
information on how people might have been or might now be exposed to hazardous substances, 
and inform ATSDR on ways to involve the community in its activities.  
 
Comparison value (CV)  
Calculated concentration of a substance in air, water, food, or soil that is unlikely to cause 
harmful (adverse) health effects in exposed people. The CV is used as a screening level during 
the public health assessment process. Substances found in amounts greater than their CVs might 
be selected for further evaluation in the public health assessment process.  
 
Completed exposure pathway [see exposure pathway].  
 
Comprehensive Environmental Response, Compensation, and Liability Act of 1980 
(CERCLA)  
CERCLA, also known as Superfund, is the federal law that concerns the removal or cleanup of 
hazardous substances in the environment and at hazardous waste sites. ATSDR, which was 
created by CERCLA, is responsible for assessing health issues and supporting public health 
activities related to hazardous waste sites or other environmental releases of hazardous 
substances. This law was later amended by the Superfund Amendments and Reauthorization Act 
(SARA). 
 
Concentration  
The amount of a substance present in a certain amount of soil, water, air, food, blood, hair, urine, 
breath, or any other media.  
 
Contaminant  
A substance that is either present in an environment where it does not belong or is present at 
levels that might cause harmful (adverse) health effects.  
 
Delayed health effect  
A disease or an injury that happens as a result of exposures that might have occurred in the past.  
 
Dermal  
Referring to the skin. For example, dermal absorption means passing through the skin.  
 
Dermal contact  
Contact with (touching) the skin [see route of exposure].  
 
Descriptive epidemiology  
The study of the amount and distribution of a disease in a specified population by person, place, 
and time.  
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Detection limit  
The lowest concentration of a chemical that can reliably be distinguished from a zero 
concentration.  
 
Disease prevention  
Measures used to prevent a disease or reduce its severity.  
 
Disease registry  
A system of ongoing registration of all cases of a particular disease or health condition in a 
defined population.  
 
DOD  
United States Department of Defense.  
 
DOE  
United States Department of Energy.  
 
Dose (for chemicals that are not radioactive)  
The amount of a substance to which a person is exposed over some time period. Dose is a 
measurement of exposure. Dose is often expressed as milligram (amount) per kilogram (a 
measure of body weight) per day (a measure of time) when people eat or drink contaminated 
water, food, or soil. In general, the greater the dose, the greater the likelihood of an effect. An 
"exposure dose" is how much of a substance is encountered in the environment. An "absorbed 
dose" is the amount of a substance that actually got into the body through the eyes, skin, 
stomach, intestines, or lungs.  
 
Dose (for radioactive chemicals)  
The radiation dose is the amount of energy from radiation that is actually absorbed by the body. 
This is not the same as measurements of the amount of radiation in the environment.  
 
Dose-response relationship  
The relationship between the amount of exposure [dose] to a substance and the resulting changes 
in body function or health (response).  
 
Environmental media  
Soil, water, air, biota (plants and animals), or any other parts of the environment that can contain 
contaminants.  
 
Environmental media and transport mechanism  
Environmental media include water, air, soil, and biota (plants and animals). Transport 
mechanisms move contaminants from the source to points where human exposure can occur. The 
environmental media and transport mechanism is the second part of an exposure pathway.  
 
EPA  
United States Environmental Protection Agency.  
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Epidemiologic surveillance [see Public health surveillance]. 
 
Epidemiology  
The study of the distribution and determinants of disease or health status in a population; the 
study of the occurrence and causes of health effects in humans.  
 
Exposure  
Contact with a substance by swallowing, breathing, or touching the skin or eyes. Exposure may 
be short-term [acute exposure], of intermediate duration, or long-term [chronic exposure].  
 
Exposure assessment  
The process of finding out how people come into contact with a hazardous substance, how often 
and for how long they are in contact with the substance, and how much of the substance they are 
in contact with.  
 
Exposure-dose reconstruction  
A method of estimating the amount of people's past exposure to hazardous substances. Computer 
and approximation methods are used when past information is limited, not available, or missing.  
 
Exposure investigation  
The collection and analysis of site-specific information and biologic tests (when appropriate) to 
determine whether people have been exposed to hazardous substances.  
 
Exposure pathway  
The route a substance takes from its source (where it began) to its end point (where it ends), and 
how people can come into contact with (or get exposed to) it. An exposure pathway has five 
parts: a source of contamination (such as an abandoned business); an environmental media and 
transport mechanism (such as movement through groundwater); a point of exposure (such as a 
private well); a route of exposure (eating, drinking, breathing, or touching), and a receptor 
population (people potentially or actually exposed). When all five parts are present, the exposure 
pathway is termed a completed exposure pathway.  
 
Exposure registry  
A system of ongoing followup of people who have had documented environmental exposures.  
 
Feasibility study  
A study by EPA to determine the best way to clean up environmental contamination. A number 
of factors are considered, including health risk, costs, and what methods will work well.  
 
Geographic information system (GIS)  
A mapping system that uses computers to collect, store, manipulate, analyze, and display data. 
For example, GIS can show the concentration of a contaminant within a community in relation to 
points of reference such as streets and homes.  
 
Grand rounds  
Training sessions for physicians and other health care providers about health topics.  
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Groundwater  
Water beneath the earth's surface in the spaces between soil particles and between rock surfaces 
[compare with surface water].  
 
Half-life (t½)  
The time it takes for half the original amount of a substance to disappear. In the environment, the 
half-life is the time it takes for half the original amount of a substance to disappear when it is 
changed to another chemical by bacteria, fungi, sunlight, or other chemical processes. In the 
human body, the half-life is the time it takes for half the original amount of the substance to 
disappear, either by being changed to another substance or by leaving the body. In the case of 
radioactive material, the half life is the amount of time necessary for one half the initial number 
of radioactive atoms to change or transform into another atom (that is normally not radioactive). 
After two half lives, 25% of the original number of radioactive atoms remain.  
 
Hazard  
A source of potential harm from past, current, or future exposures.  
 
Hazardous Substance Release and Health Effects Database (HazDat)  
The scientific and administrative database system developed by ATSDR to manage data 
collection, retrieval, and analysis of site-specific information on hazardous substances, 
community health concerns, and public health activities.  
 
Hazardous waste  
Potentially harmful substances that have been released or discarded into the environment.  
 
Health consultation  
A review of available information or collection of new data to respond to a specific health 
question or request for information about a potential environmental hazard. Health consultations 
are focused on a specific exposure issue. Health consultations are therefore more limited than a 
public health assessment, which reviews the exposure potential of each pathway and chemical 
[compare with public health assessment].  
 
Health education  
Programs designed with a community to help it know about health risks and how to reduce these 
risks.  
 
Health investigation  
The collection and evaluation of information about the health of community residents. This 
information is used to describe or count the occurrence of a disease, symptom, or clinical 
measure and to evaluate the possible association between the occurrence and exposure to 
hazardous substances.  
 
Health promotion  
The process of enabling people to increase control over, and to improve, their health.  
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Health statistics review  
The analysis of existing health information (i.e., from death certificates, birth defects registries, 
and cancer registries) to determine if there is excess disease in a specific population, geographic 
area, and time period. A health statistics review is a descriptive epidemiologic study.  
 
Indeterminate public health hazard  
The category used in ATSDR's public health assessment documents when a professional 
judgment about the level of health hazard cannot be made because information critical to such a 
decision is lacking.  
 
Incidence  
The number of new cases of disease in a defined population over a specific time period [contrast 
with prevalence].  
 
Ingestion  
The act of swallowing something through eating, drinking, or mouthing objects. A hazardous 
substance can enter the body this way [see route of exposure].  
 
Inhalation  
The act of breathing. A hazardous substance can enter the body this way [see route of exposure].  
 
Intermediate duration exposure  
Contact with a substance that occurs for more than 14 days and less than a year [compare with 
acute exposure and chronic exposure].  
 
In vitro  
In an artificial environment outside a living organism or body. For example, some toxicity 
testing is done on cell cultures or slices of tissue grown in the laboratory, rather than on a living 
animal [compare with in vivo].  
 
In vivo  
Within a living organism or body. For example, some toxicity testing is done on whole animals, 
such as rats or mice [compare with in vitro].  
 
Lowest-observed-adverse-effect level (LOAEL)  
The lowest tested dose of a substance that has been reported to cause harmful (adverse) health 
effects in people or animals.  
 
Medical monitoring  
A set of medical tests and physical exams specifically designed to evaluate whether an 
individual's exposure could negatively affect that person's health.  
 
Metabolism  
The conversion or breakdown of a substance from one form to another by a living organism.  
 
 185 
Metabolite  
Any product of metabolism.  
 
mg/kg  
Milligram per kilogram.  
 
mg/cm2  
Milligram per square centimeter (of a surface).  
 
mg/m3  
Milligram per cubic meter; a measure of the concentration of a chemical in a known volume (a 
cubic meter) of air, soil, or water.  
 
Migration  
Moving from one location to another.  
 
Minimal risk level (MRL)  
An ATSDR estimate of daily human exposure to a hazardous substance at or below which that 
substance is unlikely to pose a measurable risk of harmful (adverse), noncancerous effects. 
MRLs are calculated for a route of exposure (inhalation or oral) over a specified time period 
(acute, intermediate, or chronic). MRLs should not be used as predictors of harmful (adverse) 
health effects [see reference dose].  
 
Morbidity  
State of being ill or diseased. Morbidity is the occurrence of a disease or condition that alters 
health and quality of life.  
 
Mortality  
Death. Usually the cause (a specific disease, a condition, or an injury) is stated.  
 
Mutagen  
A substance that causes mutations (genetic damage).  
 
Mutation  
A change (damage) to the DNA, genes, or chromosomes of living organisms.  
 
National Priorities List for Uncontrolled Hazardous Waste Sites (National Priorities List or 
NPL)  
EPA's list of the most serious uncontrolled or abandoned hazardous waste sites in the United 
States. The NPL is updated on a regular basis. 
 
National Toxicology Program (NTP) 
Part of the Department of Health and Human Services. NTP develops and carries out tests to 
predict whether a chemical will cause harm to humans.  
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No apparent public health hazard  
A category used in ATSDR's public health assessments for sites where human exposure to 
contaminated media might be occurring, might have occurred in the past, or might occur in the 
future, but where the exposure is not expected to cause any harmful health effects.  
 
No-observed-adverse-effect level (NOAEL)  
The highest tested dose of a substance that has been reported to have no harmful (adverse) health 
effects on people or animals.  
 
No public health hazard  
A category used in ATSDR's public health assessment documents for sites where people have 
never and will never come into contact with harmful amounts of site-related substances.  
 
NPL [see National Priorities List for Uncontrolled Hazardous Waste Sites] 
 
Physiologically based pharmacokinetic model (PBPK model)  
A computer model that describes what happens to a chemical in the body. This model describes 
how the chemical gets into the body, where it goes in the body, how it is changed by the body, 
and how it leaves the body.  
 
Pica  
A craving to eat nonfood items, such as dirt, paint chips, and clay. Some children exhibit pica-
related behavior.  
 
Plume  
A volume of a substance that moves from its source to places farther away from the source. 
Plumes can be described by the volume of air or water they occupy and the direction they move. 
For example, a plume can be a column of smoke from a chimney or a substance moving with 
groundwater.  
 
Point of exposure  
The place where someone can come into contact with a substance present in the environment 
[see exposure pathway].  
 
Population  
A group or number of people living within a specified area or sharing similar characteristics 
(such as occupation or age).  
 
Potentially responsible party (PRP)  
A company, government, or person legally responsible for cleaning up the pollution at a 
hazardous waste site under Superfund. There may be more than one PRP for a particular site.  
 
ppb  
Parts per billion.  
 
 187 
ppm  
Parts per million.  
 
Prevalence  
The number of existing disease cases in a defined population during a specific time period 
[contrast with incidence].  
 
Prevalence survey  
The measure of the current level of disease(s) or symptoms and exposures through a 
questionnaire that collects self-reported information from a defined population.  
 
Prevention  
Actions that reduce exposure or other risks, keep people from getting sick, or keep disease from 
getting worse.  
 
Public availability session  
An informal, drop-by meeting at which community members can meet one-on-one with ATSDR 
staff members to discuss health and site-related concerns. 
 
Public comment period  
An opportunity for the public to comment on agency findings or proposed activities contained in 
draft reports or documents. The public comment period is a limited time period during which 
comments will be accepted.  
 
Public health action  
A list of steps to protect public health.  
 
Public health advisory  
A statement made by ATSDR to EPA or a state regulatory agency that a release of hazardous 
substances poses an immediate threat to human health. The advisory includes recommended 
measures to reduce exposure and reduce the threat to human health.  
 
Public health assessment (PHA)  
An ATSDR document that examines hazardous substances, health outcomes, and community 
concerns at a hazardous waste site to determine whether people could be harmed from coming 
into contact with those substances. The PHA also lists actions that need to be taken to protect 
public health [compare with health consultation].  
 
Public health hazard  
A category used in ATSDR's public health assessments for sites that pose a public health hazard 
because of long-term exposures (greater than 1 year) to sufficiently high levels of hazardous 
substances or radionuclides that could result in harmful health effects.  
 
Public health hazard categories  
Public health hazard categories are statements about whether people could be harmed by 
conditions present at the site in the past, present, or future. One or more hazard categories might 
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be appropriate for each site. The five public health hazard categories are no public health hazard, 
no apparent public health hazard, indeterminate public health hazard, public health hazard, and 
urgent public health hazard.  
 
Public health statement 
The first chapter of an ATSDR toxicological profile. The public health statement is a summary 
written in words that are easy to understand. The public health statement explains how people 
might be exposed to a specific substance and describes the known health effects of that 
substance.  
 
Public health surveillance 
The ongoing, systematic collection, analysis, and interpretation of health data. This activity also 
involves timely dissemination of the data and use for public health programs. 
 
Public meeting  
A public forum with community members for communication about a site.  
 
Radioisotope  
An unstable or radioactive isotope (form) of an element that can change into another element by 
giving off radiation.  
 
Radionuclide  
Any radioactive isotope (form) of any element.  
 
RCRA [see Resource Conservation and Recovery Act (1976, 1984)]  
 
Receptor population  
People who could come into contact with hazardous substances [see exposure pathway].  
 
Reference dose (RfD)  
An EPA estimate, with uncertainty or safety factors built in, of the daily lifetime dose of a 
substance that is unlikely to cause harm in humans.  
 
Registry  
A systematic collection of information on persons exposed to a specific substance or having 
specific diseases [see exposure registry and disease registry].  
 
Remedial investigation  
The CERCLA process of determining the type and extent of hazardous material contamination at 
a site.  
 
Resource Conservation and Recovery Act (1976, 1984) (RCRA) 
This Act regulates management and disposal of hazardous wastes currently generated, treated, 
stored, disposed of, or distributed.  
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RFA  
RCRA Facility Assessment. An assessment required by RCRA to identify potential and actual 
releases of hazardous chemicals.  
 
RfD [see reference dose] 
 
Risk  
The probability that something will cause injury or harm.  
 
Risk reduction  
Actions that can decrease the likelihood that individuals, groups, or communities will experience 
disease or other health conditions.  
 
Risk communication  
The exchange of information to increase understanding of health risks.  
 
Route of exposure  
The way people come into contact with a hazardous substance. Three routes of exposure are 
breathing [inhalation], eating or drinking [ingestion], or contact with the skin [dermal contact].  
 
Safety factor [see uncertainty factor]  
 
SARA [see Superfund Amendments and Reauthorization Act]  
 
Sample  
A portion or piece of a whole. A selected subset of a population or subset of whatever is being 
studied. For example, in a study of people the sample is a number of people chosen from a larger 
population [see population]. An environmental sample (for example, a small amount of soil or 
water) might be collected to measure contamination in the environment at a specific location.  
 
Sample size  
The number of units chosen from a population or an environment.  
 
Solvent  
A liquid capable of dissolving or dispersing another substance (for example, acetone or mineral 
spirits).  
 
Source of contamination  
The place where a hazardous substance comes from, such as a landfill, waste pond, incinerator, 
storage tank, or drum. A source of contamination is the first part of an exposure pathway.  
 
Special populations  
People who might be more sensitive or susceptible to exposure to hazardous substances because 
of factors such as age, occupation, sex, or behaviors (for example, cigarette smoking). Children, 
pregnant women, and older people are often considered special populations.  
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Stakeholder  
A person, group, or community who has an interest in activities at a hazardous waste site.  
 
Statistics  
A branch of mathematics that deals with collecting, reviewing, summarizing, and interpreting 
data or information. Statistics are used to determine whether differences between study groups 
are meaningful.  
 
Substance  
A chemical.  
 
Substance-specific applied research  
A program of research designed to fill important data needs for specific hazardous substances 
identified in ATSDR's toxicological profiles. Filling these data needs would allow more accurate 
assessment of human risks from specific substances contaminating the environment. This 
research might include human studies or laboratory experiments to determine health effects 
resulting from exposure to a given hazardous substance.  
 
Superfund [see Comprehensive Environmental Response, Compensation, and Liability Act of 
1980 (CERCLA) and Superfund Amendments and Reauthorization Act (SARA)  
 
Superfund Amendments and Reauthorization Act (SARA)  
In 1986, SARA amended the Comprehensive Environmental Response, Compensation, and 
Liability Act of 1980 (CERCLA) and expanded the health-related responsibilities of ATSDR. 
CERCLA and SARA direct ATSDR to look into the health effects from substance exposures at 
hazardous waste sites and to perform activities including health education, health studies, 
surveillance, health consultations, and toxicological profiles.  
 
Surface water  
Water on the surface of the earth, such as in lakes, rivers, streams, ponds, and springs [compare 
with groundwater].  
 
Surveillance [see public health surveillance]  
 
Survey  
A systematic collection of information or data. A survey can be conducted to collect information 
from a group of people or from the environment. Surveys of a group of people can be conducted 
by telephone, by mail, or in person. Some surveys are done by interviewing a group of people 
[see prevalence survey].  
 
Synergistic effect  
A biologic response to multiple substances where one substance worsens the effect of another 
substance. The combined effect of the substances acting together is greater than the sum of the 
effects of the substances acting by themselves [see additive effect and antagonistic effect].  
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Teratogen  
A substance that causes defects in development between conception and birth. A teratogen is a 
substance that causes a structural or functional birth defect.  
 
Toxic agent  
Chemical or physical (for example, radiation, heat, cold, microwaves) agents that, under certain 
circumstances of exposure, can cause harmful effects to living organisms.  
 
Toxicological profile  
An ATSDR document that examines, summarizes, and interprets information about a hazardous 
substance to determine harmful levels of exposure and associated health effects. A toxicological 
profile also identifies significant gaps in knowledge on the substance and describes areas where 
further research is needed.  
 
Toxicology  
The study of the harmful effects of substances on humans or animals.  
 
Tumor  
An abnormal mass of tissue that results from excessive cell division that is uncontrolled and 
progressive. Tumors perform no useful body function. Tumors can be either benign (not cancer) 
or malignant (cancer).  
 
Uncertainty factor  
Mathematical adjustments for reasons of safety when knowledge is incomplete. For example, 
factors used in the calculation of doses that are not harmful (adverse) to people. These factors are 
applied to the lowest-observed-adverse-effect-level (LOAEL) or the no-observed-adverse-effect-
level (NOAEL) to derive a minimal risk level (MRL). Uncertainty factors are used to account for 
variations in people's sensitivity, for differences between animals and humans, and for 
differences between a LOAEL and a NOAEL. Scientists use uncertainty factors when they have 
some, but not all, the information from animal or human studies to decide whether an exposure 
will cause harm to people [also sometimes called a safety factor].  
 
Urgent public health hazard  
A category used in ATSDR's public health assessments for sites where short-term exposures 
(less than 1 year) to hazardous substances or conditions could result in harmful health effects that 
require rapid intervention.  
 
Volatile organic compounds (VOCs)  
Organic compounds that evaporate readily into the air. VOCs include substances such as 
benzene, toluene, methylene chloride, and methyl chloroform.  
 
Other glossaries and dictionaries: 
Environmental Protection Agency (http://www.epa.gov/OCEPAterms/) 
 
National Center for Environmental Health (CDC) 
(http://www.cdc.gov/nceh/dls/report/glossary.htm) 
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National Library of Medicine (NIH) 
(http://www.nlm.nih.gov/medlineplus/mplusdictionary.html) 
 
For more information on the work of ATSDR, please contact: 
 
Office of Policy and External Affairs 
Agency for Toxic Substances and Disease Registry 
1600 Clifton Road, N.E. (MS E-60) 
Atlanta, GA 30333 
Telephone: (404) 498-0080  
 
 
 
 
